2025 Annual Meeting | P10 - Poster Session 10

Date Tuesday 04/08/25

Time 05:00 PM - 06:00 PM PDT Add To Calendar

Location San Diego Convention Center | Exhibit Hall A

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) General Neurology, Cerebrovascular Disease and Interventional Neurology, Headache, Movement Disorders, Neuro-oncology, Epilepsy/Clinical Neurophysiology (EEG), Multiple Sclerosis, Child Neurology and Developmental Neurology, Neuromuscular and Clinical Neurophysiology (EMG), Aging, Dementia, and Behavioral Neurology, Infectious Disease, Autoimmune Neurology, Neuro Trauma and Critical Care

Learning Objectives View the latest research on a variety of topics. Posters are available to view in-person or online.

CME Available 0.00 CME credit

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator

Teaching Styles Interactive

Program Materials Program Evaluations

Event Timeline
05:00 PM - 06:00 PM PDT	Abstract	1-001 - Tumefactive Demyelinating Lesions: Clinical Features, Neuroimaging, and Outcomes in a Case Series of 32 Patients Neha Sudarshan
05:00 PM - 06:00 PM PDT	Abstract	1-002 - Exome-sequencing of Turkish Families with Multiple Sclerosis: Low Frequency and Rare Variant Contributions into Susceptibility Furkan Büyükgöl
05:00 PM - 06:00 PM PDT	Abstract	1-003 - Evaluation of Clinical and Radiologic Relapses Around Nonviable Pregnancies in Women with Multiple Sclerosis Elle Wade, MD
05:00 PM - 06:00 PM PDT	Abstract	1-004 - Anti-CD20-antibodies and Pregnancy Disease Activity in Women with Multiple Sclerosis Nadine Bast
05:00 PM - 06:00 PM PDT	Abstract	1-005 - History of Head Trauma Increases The Risk of Multiple Sclerosis Diagnosis: A Meta-analysis of 1,619,640 Participants Rashad G. Mohamed, MBBS
05:00 PM - 06:00 PM PDT	Abstract	1-006 - Trends in Multiple Sclerosis-related Mortality Among Older Adults Before and After COVID-19: Insights from CDC WONDER Aidan Keaveny
05:00 PM - 06:00 PM PDT	Abstract	1-007 - Cladribine and Pregnancy in Women with Multiple Sclerosis– A Cohort Study Karen I. Dost-Kovalsky
05:00 PM - 06:00 PM PDT	Abstract	1-008 - B-cell Counts in Pregnancy Exposed Ofatumumab Neonates of Women with Multiple Sclerosis Karen I. Dost-Kovalsky
05:00 PM - 06:00 PM PDT	Abstract	1-009 - African-American MS Patients with and Without Early B-cell Repletion After Anti-CD20 Monoclonal Infusion Therapy Have Similarly Low Levels of Disease Activity Hannah Kopinsky, MD
05:00 PM - 06:00 PM PDT	Abstract	1-010 - Natalizumab Discontinuation in Pregnancy: Evaluating Relapse Risk in MS Patients After the Second Trimester Mahsa Mohajery, MD
05:00 PM - 06:00 PM PDT	Abstract	1-011 - Visual Pathway Structure and Function in Pediatric-onset Multiple Sclerosis (POMS): Are Social Determinants of Health (SDOH) Related? Anna Sosa
05:00 PM - 06:00 PM PDT	Abstract	1-012 - Postpartum Clinical and Radiographic Activity in Patients with Multiple Sclerosis Stratified by Prepartum DMT Use Enrique Alvarez, MD, PhD
05:00 PM - 06:00 PM PDT	Abstract	1-013 - Adults 55 Years and Older with Multiple Sclerosis (MS) Treated with Ocrelizumab: Characteristics and Outcomes Over More Than 13,000 Person-Months Farrah J. Mateen, MD, PhD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	1-014 - Demographic and Regional Mortality Trends in Patients with Multiple Sclerosis and Concomitant Stroke in the United States (1999-2020): A CDC WONDER Analysis Sophia Ahmed, MBBS
05:00 PM - 06:00 PM PDT	Abstract	1-015 - Comorbidity of Familial Mediterranean Fever with Multiple Sclerosis Aksel Siva, MD
05:00 PM - 06:00 PM PDT	Abstract	1-016 - A Systematic Review of Dimethyl Fumarate (DMF) in Pediatric Patients with Multiple Sclerosis (MS) Mohamed Derhab, MD, MBBCH
05:00 PM - 06:00 PM PDT	Abstract	2-001 - Intravenous Immunoglobulin Therapy for Small Fiber Neuropathy: A Comprehensive Systematic Review Frederico M. de Sousa Marinho Mendes Filho
05:00 PM - 06:00 PM PDT	Abstract	2-002 - Is this Guillian Barre Syndrome? A Mini Case Series. Fei Pan, MD
05:00 PM - 06:00 PM PDT	Abstract	2-004 - Epidemiology and Patient Journey in Inclusion Body Myositis (IBM): A Machine Learning (ML) Methodology Applied to Claims Data in the United States (US) Devon Grochowski
05:00 PM - 06:00 PM PDT	Abstract	2-005 - “Myalgia and Rhabdomyolysis from Retained Shrapnel in a Young Caribbean Male: A Unique Report of Lead Poisoning from Gun Shot Wounds in Health Care Disparities” Oscar Pablo Mata, MD
05:00 PM - 06:00 PM PDT	Abstract	2-006 - Immune Checkpoint Inhibitor Therapy Induced Plexopathy Patrick J. Bergquist, MD
05:00 PM - 06:00 PM PDT	Abstract	2-007 - First-in-Human Dose Selection and Pharmacokinetics, Safety, Tolerability, and Immunogenicity of ARGX-119, an Agonist Antibody for Human Muscle-Specific Kinase Rebecca Shilling
05:00 PM - 06:00 PM PDT	Abstract	2-008 - Effectiveness and Safety of Low-Sodium Oxybate in Participants With Narcolepsy or Idiopathic Hypersomnia: Top-line Results From the Phase 4 DUET Study Logan D. Schneider, MD
05:00 PM - 06:00 PM PDT	Abstract	2-009 - Advancing Hamartin Therapy in a TSC1 Mouse Model: AAV Delivery and Enhancement with Extracellular Vesicles Edwina abou haidar, MBBS, MS
05:00 PM - 06:00 PM PDT	Abstract	2-010 - Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS®) Reduces Major Depressive Disorder (MDD) Symptom Severity Jacob J. Shawwa
05:00 PM - 06:00 PM PDT	Abstract	2-011 - Safety and Tolerability of Home Infusions in Down Syndrome Regression Disorder Shermila Pia, MD
05:00 PM - 06:00 PM PDT	Abstract	2-012 - Miglustat: A First-In-Class Enzyme Stabilizer for Late-Onset Pompe Disease Tahseen Mozaffar, MD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	3-002 - Identifying an Optimal Cut-off Value and if Sex Differences Exist in Nigrostriatal Dopamine Transporter Binding of 123I-FP-CIT SPECT in Autopsy Confirmed Lewy Body Disease and/or Alzheimer’s Disease Toji Miyagawa, MD, PhD
05:00 PM - 06:00 PM PDT	Abstract	3-003 - Blood-based ATN (Aß42/40 /pTau181/NfL) Profile: Key Characteristics of Over 17,000 Unique Patient Results Kathleen Bailey, PhD, NP
05:00 PM - 06:00 PM PDT	Abstract	3-006 - Plasma Microbiome Composition among Brain Health Phenotypes in People with HIV (PWH) Mohammadsobhan Sheikh Andalibi, MD
05:00 PM - 06:00 PM PDT	Abstract	3-007 - Perivascular Tau in Autopsy Cases with Definite Cerebral Amyloid Angiopathy Suzete N. Farias Da Guarda, MD, PhD
05:00 PM - 06:00 PM PDT	Abstract	3-008 - Analytical and Clinical Assessment of Plasma p-Tau217, BD-Tau, p-Tau181 and Aß42/Aß40 Assays in Alzheimer’s Disease (AD) Subjects Ahmed Chenna, PhD
05:00 PM - 06:00 PM PDT	Abstract	3-009 - Clinical and Analytical Performance of DuritectTM: A Novel Blood-Based Autoantibody Diagnostic Sceening Platform for Alzheimer’s and Parkinson’s Diseases Cassandra DeMarshall, PhD
05:00 PM - 06:00 PM PDT	Abstract	3-011 - Amyloid ß and Tau Oligomers Disrupt Blood-Brain Barrier in a Human Based in-vitro Microfluidic Neurovascular Unit Model Zahra Kolahchi, MD
05:00 PM - 06:00 PM PDT	Abstract	3-012 - Accuracy of Plasma Biomarkers for Detecting Amyloid Beta Deposits in Participants With Alzheimer’s Disease in ASCENT-2 Clinical Trial of PRX012 Ann D. Johnson, MS
05:00 PM - 06:00 PM PDT	Abstract	3-013 - CSF YKL-40 Level Predicts the Cognitive Progress of De Novo Parkinson’s Disease Qiongyao Li, PhD
05:00 PM - 06:00 PM PDT	Abstract	3-014 - Diagnostic Utility of 18F-Florzolotau PET Imaging in Patients with Cognitive Symptoms: A Real-World Cohort Study Jin-Tai Yu, PhD
05:00 PM - 06:00 PM PDT	Abstract	3-016 - Neuroimaging Markers for Predicting Cognitive Decline in Preclinical Alzheimer’s Disease: A Meta-Analysis fnu teena, MBBS
05:00 PM - 06:00 PM PDT	Abstract	3-017 - Exploring Sex Differences in the Degeneration of the Nucleus Basalis of Meynert and its White Matter Tracts in Neurodegenerative Diseases Tatianna M. Howard, Research Assistant
05:00 PM - 06:00 PM PDT	Abstract	3-018 - Real-World Use of Alpha-Synuclein Seeding Amplification Assay in a Behavioral Neurology Clinic Luke Fischer, MD, PhD
05:00 PM - 06:00 PM PDT	Abstract	3-019 - Conversion of Mild Cognitive Impairment to Alzheimer’s Disease is Associated with Lateral Tract Degeneration of the Nucleus Basalis of Meynert Charlotte Casselton, Research Assistant
05:00 PM - 06:00 PM PDT	Abstract	3-020 - Correlations of CSF Biomarkers of Alzheimer’s Disease with Cognitive Measures in MCI and AD Dementia Gabriel A. Bitar
05:00 PM - 06:00 PM PDT	Abstract	4-001 - Male and Female Differences in Concussion Recovery: The Influence of Time to Clinic Presentation Brandon S. Wright
05:00 PM - 06:00 PM PDT	Abstract	4-002 - Olfactory Function in Former Elite American Football Players Benjamin J. Braunecker
05:00 PM - 06:00 PM PDT	Abstract	4-004 - Exploratory Analysis of Comprehensive Neurocognitive Testing in Post-traumatic Brain Injury (TBI) Clinic Patients with Primary Cognitive Symptoms Claire Joyner
05:00 PM - 06:00 PM PDT	Abstract	4-005 - Examination of the Relationship of Traumatic Brain Injury, Cognitive Dysfunction, and Sleep Impairments in Medical Students Gabby Costain
05:00 PM - 06:00 PM PDT	Abstract	4-006 - Cycling and Concussions: A Comparative Analysis Across Cycling Disciplines Arihant Kalidindi
05:00 PM - 06:00 PM PDT	Abstract	4-007 - The Value of Neurology in Sports Medicine: A MedMal Case Report David Hernan Posas, BS
05:00 PM - 06:00 PM PDT	Abstract	5-001 - Excessive Pallidal Beta-band Activity and Functional Connectivity: A Novel Intracranial Biomarker of Status Dystonicus Arjun Balachandar, MD
05:00 PM - 06:00 PM PDT	Abstract	5-002 - AI-based 3D Anthropometric Modeling for Automated Assessment of Dystonia Patients Shaurjya Mandal, MS
05:00 PM - 06:00 PM PDT	Abstract	5-003 - Long-term Outcomes for Blepharospasm and Meige Syndrome with DBS Surgery Samyukta Senthil, BS
05:00 PM - 06:00 PM PDT	Abstract	5-006 - Perception of Patients with Cervical Dystonia in Residents and Medical Students Melissa Patel, DO
05:00 PM - 06:00 PM PDT	Abstract	5-007 - Dopa-responsive Dystonia Associated with Novel SHQ-1 Variants Shruti Karnani, BS
05:00 PM - 06:00 PM PDT	Abstract	5-008 - Deep Brain Stimulation (DBS) in Pediatric Dystonia: The Youngest Case of Neuromodulation for Refractory Acquired Dystonia and Status Dystonicus with 1-year Follow-up Darshana Vijaywargiya, MBBS
05:00 PM - 06:00 PM PDT	Abstract	5-009 - Breaking the Bend: Successful Anterocollis Treatment with Bilateral Globus Pallidus Internus Deep Brain Stimulation Patricia Jokl Graese, MD
05:00 PM - 06:00 PM PDT	Abstract	5-010 - Evaluation of a Small Molecule Genetic Medicine RTX-317 in Preclinical Models of Huntington's Disease Sridhar Narayan, PhD
05:00 PM - 06:00 PM PDT	Abstract	5-011 - Evaluation of Motor Function in Premanifest Huntington Disease Using Q-motor Digitomotography Anastasia Barnes, MD
05:00 PM - 06:00 PM PDT	Abstract	5-012 - Effect Sizes of Once-daily Valbenazine for Chorea Associated with Huntington’s Disease: A Post-hoc Analysis of KINECT®-HD Data Sean Hinton, PhD
05:00 PM - 06:00 PM PDT	Abstract	5-013 - Cannabis for Tic Control: A Systematic Review and Meta-analysis of Its Efficacy in Tourette Syndrome Management Govind S. Mann, MBBS
05:00 PM - 06:00 PM PDT	Abstract	5-014 - The Effect of Ecopipam and its Metabolites on Cardiac Repolarization, QTcF Stephen Wanaski, PhD
05:00 PM - 06:00 PM PDT	Abstract	5-015 - Deep Brain Stimulation’s Implantation Location Effect on Restless Legs Syndrome: A Systemic Review and Meta-analysis Vinh N. Pham, MD
05:00 PM - 06:00 PM PDT	Abstract	5-016 - Longitudinal Epidemiological Trends in Functional Neurological Disorder Vera Kulikov
05:00 PM - 06:00 PM PDT	Abstract	5-017 - Effect Sizes of Once-daily Valbenazine for Tardive Dyskinesia: A Post-hoc Analysis of KINECT® 3 Data Christine Holman, PharmD
05:00 PM - 06:00 PM PDT	Abstract	5-019 - Improvement in Quality of Life and Functional Status Following Valbenazine Treatment in Patients with Tardive Dyskinesia: Real-world Data from a Chart Extraction and Clinician Survey Michael Serbin
05:00 PM - 06:00 PM PDT	Abstract	5-020 - Connecting the Dots: Correlation Between Headache and Psychosomatic Factors in Functional Movement Disorders Interdisciplinary Clinic Patients Tiffany A. Eatz, MD
05:00 PM - 06:00 PM PDT	Abstract	5-021 - Insights from Clinical Experience with DaxibotulinumtoxinA for the Treatment of Cervical Dystonia Juliana Stoilova, MD
05:00 PM - 06:00 PM PDT	Abstract	5-022 - Structural Differences in Rapid-onset Dystonia Parkinsonism (RDP): A Comparative MRI Study Claire Alcus
05:00 PM - 06:00 PM PDT	Abstract	5-023 - A Retrospective Analysis of a FMD IDC: Considerations That Impact Outcomes Tara Najafi
05:00 PM - 06:00 PM PDT	Abstract	5-024 - Restless Leg Syndrome and End Stage Renal Disease Abdullah A. Alruwaita, MBBS
05:00 PM - 06:00 PM PDT	Abstract	5-026 - Asymmetrical Brain Atrophy in Huntington's Disease: A Post Mortem MRI Study Bianca Le, MA-P
05:00 PM - 06:00 PM PDT	Abstract	5-028 - Do We Agree? Patient and Clinician Ratings of Head Tremor Severity in Botulinum Toxin-treated Isolated Cervical Dystonia Amy Lin, MD
05:00 PM - 06:00 PM PDT	Abstract	5-029 - Pain Localization and Response to Treatment in Cervical Dystonia Alexander Wang, MD
05:00 PM - 06:00 PM PDT	Abstract	5-030 - The Effect of Antidopaminergic Medications on Changes in Clinical Measures of Huntington’s Disease Function, Cognition, Motor Signs, and Progression Randal Hand
05:00 PM - 06:00 PM PDT	Abstract	5-031 - Wheels and Wrists: Mapping Parkinson's Dopamine-driven Mobility Landscape Jun Ha Chang, PhD
05:00 PM - 06:00 PM PDT	Abstract	5-032 - Caught in the “Web”: An Unusual Suspect for Shuffling Gait Prashant Natteru, MBBS
05:00 PM - 06:00 PM PDT	Abstract	6-001 - Relationship of Clinical Phenotype to GFAP Concentrations in CSF and Blood of Individuals with Alexander Disease Amy T. Waldman, MD
05:00 PM - 06:00 PM PDT	Abstract	6-002 - MTOR Inhibition, a Potential Treatment for Leigh Syndrome? Report of Three Cases. Michio Hirano, MD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	6-003 - Assessment of Gross Motor Function in Alexander Disease (AxD) Francesco Gavazzi, MD, MD, PhD
05:00 PM - 06:00 PM PDT	Abstract	6-004 - Severe First Presentation of Ornithine Transcarbamylase Deficiency in a Female Child Following Hyperammonemia Resolution Grace Marie N. Dominguez, MD
05:00 PM - 06:00 PM PDT	Abstract	6-005 - A Rare Case of NAXE Gene Mutation-Related Encephalopathy Masquerading as Post-infectious Cerebellar Ataxia Sebastian Hanna, MD
05:00 PM - 06:00 PM PDT	Abstract	6-007 - The Disease Course of Untreated Patients with Thymidine Kinase 2 Deficiency (TK2d) Aged ≤12 Years at TK2d Symptom Onset: Findings from the Largest International TK2d Dataset Michio Hirano, MD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	6-008 - GDF15 Levels are Elevated in Cerebrospinal Fluid in Alexander Disease Giulia S. Porcari, MD
05:00 PM - 06:00 PM PDT	Abstract	6-009 - Expanding the Clinical Spectrum of NUBPL Associated Disorders: Previously Unidentified NUBPL Variants Uncovered by Genome Sequencing in Sibling Pair Shadi Shams
05:00 PM - 06:00 PM PDT	Abstract	6-010 - Analysis of Potential Biomarkers and Clinical Scale in Atypical CLN2 Enzyme Replacement Therapy Patients Chloe Villars
05:00 PM - 06:00 PM PDT	Abstract	6-011 - Brain Cancer in the US: A Two Decade Study of Incidence Rates and Demographic Variations (1999-2021) Maryam Inam Zaroo, MBBS
05:00 PM - 06:00 PM PDT	Abstract	6-012 - CCDC26 Single-nucleotide Polymorphism Related to Glioblastoma Risk and Worldwide Epidemiology: A Systematic Review and Meta-analysis Samuel Luca R. Pinheiro
05:00 PM - 06:00 PM PDT	Abstract	6-013 - Digital Phenotyping for Prediction of Disease Trajectories in Brain Tumor Patients: Prospective Study Adomas Bunevicius, MD, PhD
05:00 PM - 06:00 PM PDT	Abstract	6-014 - Brain Tumor Reporting and Data System (BT-RADS) Score: A Novel Predictor of the Karnofsky Performance Scale and Progression-free Survival in Glioblastoma Patients Michele Persico, MD
05:00 PM - 06:00 PM PDT	Abstract	6-015 - Demographic Trends in Primary Malignant Brain Tumour-related Mortality in Older Adults in the United States (1999-2020): A Retrospective Analysis Vishnu V. Byroju, MD
05:00 PM - 06:00 PM PDT	Abstract	6-016 - The Impact of Distance in Treating Glioblastoma: A Retrospective Single Center Study Samantha Mohl, MD
05:00 PM - 06:00 PM PDT	Abstract	6-017 - Mortality Trends of Primary Malignant Brain Neoplasms in Adults in the United States from 1999 to 2020: A Gender, Race, and Demographics-based Analysis of CDC WONDER Database Mariam Shabih, MD
05:00 PM - 06:00 PM PDT	Abstract	6-020 - Use of Hypnotics and Risk of Esophagus Cancer: A Systematic Review and Meta-analysis Nuris M. Torres Argota, Sr.
05:00 PM - 06:00 PM PDT	Abstract	7-001 - Brain Health and Traumatic Brain Injury (TBI): Relationship Between Brain Care Score and Disability in Subacute-long Term TBI Maral Sakayan, MD
05:00 PM - 06:00 PM PDT	Abstract	7-002 - A Dynamic Neurological Exam is Associated with Markers of Cerebral Edema After Traumatic Brain Injury (TBI) Luisa M. Rojas, PhD
05:00 PM - 06:00 PM PDT	Abstract	7-003 - Efficacy of Ketogenic Diet (KD) on Glucose Control, ICU Length of Stay (ICU-LOS), and Mortality in Severe Traumatic Brain Injury Karminder Singh, MD
05:00 PM - 06:00 PM PDT	Abstract	7-004 - Machine Learning-driven Prediction of Mortality and Outcomes in Acute Traumatic Subdural Hematoma Hyo Bin You
05:00 PM - 06:00 PM PDT	Abstract	7-005 - Antipsychotic Practice Patterns and Clinical Outcomes in Moderate-to-severe TBI Sebastian Hanna, MD
05:00 PM - 06:00 PM PDT	Abstract	7-006 - A 61-Year-Old Woman with Unresponsiveness and Abnormal Movements Christina Alexandres, MD
05:00 PM - 06:00 PM PDT	Abstract	7-007 - The Role of Electronic Medical Records in Enhancing Protocol Adherence and Outcomes for Traumatic Brain Injury in Low- and Middle-income Countries: A Systematic Review of Neurocritical Care Management Jacob J. Shawwa
05:00 PM - 06:00 PM PDT	Abstract	7-008 - Cardiac arrest: A rare complication of intra thecal baclofen withdrawal Karminder Singh, MD
05:00 PM - 06:00 PM PDT	Abstract	7-009 - Liberal Versus Restrictive Transfusion Strategy in Traumatic Brain Injury: An Updated Meta-analysis Eshita Sharma
05:00 PM - 06:00 PM PDT	Abstract	7-010 - Intracranial Hemorrhage in the Setting of Elevated a-Tocopherol Levels Bilal Darwish, DO
05:00 PM - 06:00 PM PDT	Abstract	8-001 - Multiple Brain Parenchymal Ring Enhancing Lesions With Holocord Myelitis: A Diagnostic Challenge Anand Kumar, MD, DM
05:00 PM - 06:00 PM PDT	Abstract	8-002 - Assessing Condition-Specific Knowledge in Patients with Rare Neuroimmune Disorders Shruti Mahale, BS
05:00 PM - 06:00 PM PDT	Abstract	8-003 - Selective Radiological Vulnerability and Neuropsychiatric Challenges in Anti-DPPX Antibody-Associated Encephalitis Tom Punnen
05:00 PM - 06:00 PM PDT	Abstract	8-004 - IgG4-Related Hypertrophic Pachymeningitis Mimicking Neuromyelitis Optica: a Case Report Carolina Matté Dagostini
05:00 PM - 06:00 PM PDT	Abstract	8-005 - Concurrent Non-Paraneoplastic Anti-NMDA-Receptor and West Nile Virus Encephalitis: Case Report Michelle Seu, MD
05:00 PM - 06:00 PM PDT	Abstract	8-006 - Unraveling Susac Syndrome: A Case of Probable Diagnosis with Large Artery Disease Muhammad Bhatti, MD
05:00 PM - 06:00 PM PDT	Abstract	8-007 - Retina On Fire: A Challenging Case of Recurrent Neuroretinitis in a 52-Year-Old Female Anika Zahoor, MD, MBBS
05:00 PM - 06:00 PM PDT	Abstract	8-008 - Anti-NMDA Receptor Encephalitis with Elevated MOG Antibodies: A Case of Overlapping Autoimmune Syndromes Sylvia Jimenez
05:00 PM - 06:00 PM PDT	Abstract	8-009 - Adult-Onset Leukoencephalopathy with Spheroids in a 30-Year-Old Female Presenting with 10 Years of Mood Disturbances and Memory Impairment Brian Sacks, DO
05:00 PM - 06:00 PM PDT	Abstract	8-010 - Multiple Ring-Enhancing Cerebral Lesions in Central Nervous System Sjogren’s Syndrome Grainne Mulkerrin, MB BCh BAO MSc
05:00 PM - 06:00 PM PDT	Abstract	8-011 - Multimodal Approach to NMOSD Relapse Treatment: Experience with Two Cases Michael Grunstein, DO
05:00 PM - 06:00 PM PDT	Abstract	8-012 - Unraveling the Complexity: A Case Report of Misdiagnosed Autoimmune Encephalitis in Neurofibromatosis Type 1 Lavanya Sambaraju, BS
05:00 PM - 06:00 PM PDT	Abstract	8-013 - A Rare Case of CANDA/CANOMAD Syndrome with Acute Deterioration in the Context of Influenza and Subsequent Spontaneous Recovery. Clara Tierney, MD
05:00 PM - 06:00 PM PDT	Abstract	8-014 - Musical Seizures and Hyperfamiliarity of Faces due to anti-mGluR1 Encephalitis Masquerading as Hashimoto’s Encephalopathy Jensine Sajan, DO
05:00 PM - 06:00 PM PDT	Abstract	8-015 - Three Cases of Refractory Anti-NMDA Encephalitis Responsive to Third-Line Therapies Anatevka S. Ribeiro, MD
05:00 PM - 06:00 PM PDT	Abstract	8-016 - A Case Report of Efgartigimod in the Treatment of Recurrent Severe Anti-NMDAR Encephalitis Complicated with MOGAD Jing Du, MD
05:00 PM - 06:00 PM PDT	Abstract	8-017 - The Hashimoto Encephalopathy Debate: Diagnoses Remain Uncertain Despite Expanded Antibody Testing Siara M. Clos, MD
05:00 PM - 06:00 PM PDT	Abstract	8-018 - Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) and Anti-N-Methyl-D-Aspartate Receptor Encephalitis (NMDARE) Overlapping Syndrome Presenting as Tics and Cognitive Symptoms Thomas Flagiello, MD
05:00 PM - 06:00 PM PDT	Abstract	8-019 - A Case of Insidious Onset Seronegative Neuromyelitis Optica Spectrum Disorder (NMOSD) Rachael Cella
05:00 PM - 06:00 PM PDT	Abstract	8-020 - An Unusual Case of Anti-NMDAR Encephalitis with a Leukodystrophy-Like Presentation Rana K. Zabad, MD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	9-001 - Scalable Extraction of Seizure Frequency Information from Clinical Notes Using the Truveta Language Model Sean Stern
05:00 PM - 06:00 PM PDT	Abstract	9-002 - Localizing and Lateralizing Significance of Initial, Mid-ictal and Ictal-end Head Position in Versive Seizures with Secondary Generalization Akshaya Rathin Sivaji, MD
05:00 PM - 06:00 PM PDT	Abstract	9-003 - Elucidating Phenotypic Characteristics and Burden of Clinical Care Needs in Genetic Developmental and Epileptic Encephalopathies – A Single Center Study. Grayson Hetherington, Student
05:00 PM - 06:00 PM PDT	Abstract	9-005 - Incidence of Somatosensory Aura in Epilepsy: A Systematic Review Ana Leticia Fornari Caprara, MD
05:00 PM - 06:00 PM PDT	Abstract	9-006 - Hippocampal Activity Correlates with Improved Visual Memory in Participants with Idiopathic Generalized Epilepsy Yumnaa Shaheen
05:00 PM - 06:00 PM PDT	Abstract	9-007 - Exploring Dural Sinus Stenosis Rates in Temporal Lobe Epilepsy With and Without Temporal Lobe Encephaloceles Sivani Lingam, MBBS
05:00 PM - 06:00 PM PDT	Abstract	9-008 - Atypical Language Network Reorganization Following Anterior Temporal Resection in an Adult Epilepsy Patient Yuvraj Bhagat, MD
05:00 PM - 06:00 PM PDT	Abstract	9-009 - Epilepsy Etiology in a Latin American Cohort using the 2017 ILAE Classification Irving Fuentes
05:00 PM - 06:00 PM PDT	Abstract	9-010 - A Case Series of Ictal Asystole (IA) During Video EEG (VEEG) Monitoring Kole Sedlack, MD
05:00 PM - 06:00 PM PDT	Abstract	9-011 - Febrile Infection-Related Epilepsy Syndrome in an Adult Successfully Treated with Short-Term Anakinra Tyler Heinrich, DO
05:00 PM - 06:00 PM PDT	Abstract	9-012 - Takotsubo Cardiomyopathy Presenting During an Epilepsy Monitoring Unit Admission: a Possible Fatal Complication Muhammad Hussain, MD
05:00 PM - 06:00 PM PDT	Abstract	9-013 - Somatosensory Reflex Epilepsy in GAD65 Antibody Associated Autoimmune Encephalitis: A Case Report Joanne Lau, MD
05:00 PM - 06:00 PM PDT	Abstract	9-014 - Expanding Horizons Beyond Autoimmune Encephalitis: Extreme Delta Brush Signifying a Toxidrome Christopher A. Sanfilippo, DO
05:00 PM - 06:00 PM PDT	Abstract	9-015 - A Case of Aicardi Syndrome with Positive Outcomes Following Hemispherectomy Ann Zheng, MD
05:00 PM - 06:00 PM PDT	Abstract	9-016 - Ictal Bilateral Thumbs-Up sign: A Case Report Azhar Said, MD
05:00 PM - 06:00 PM PDT	Abstract	9-017 - Porphyria Crisis Resulting in PRES and Status Epilepticus Andrew Eldeiry, MB BCh BAO
05:00 PM - 06:00 PM PDT	Abstract	10-002 - Pure Cerebellitis a Rare Presentation of Scrub Typhus Fever Aditi Mohan, MBBS
05:00 PM - 06:00 PM PDT	Abstract	10-003 - Rare Case of Cerebral Nocardiosis in Immunocompetent Host Shaweta Khosa
05:00 PM - 06:00 PM PDT	Abstract	10-004 - A Fatal Case of CNS Actinomyces Mimicking Tolosa-Hunt Syndrome: Is it Time to Reevaluate Diagnostic Criteria? Courtney Venegas, MD
05:00 PM - 06:00 PM PDT	Abstract	10-005 - From Esophagus to Brain: A Case of Diffuse Abscesses Due to Esophageal Perforation Ariba B. Raza, MD
05:00 PM - 06:00 PM PDT	Abstract	10-006 - Comprehensive Management and Treatment Insights in Disseminated Central Nervous System and Skin Infection by Fusarium Species in Myelodysplastic Syndrome: A Case Report Sepideh Allahdadian, MD
05:00 PM - 06:00 PM PDT	Abstract	10-007 - Cauda Equina Syndrome in the Setting of ESBL E. Coli Spinal Arachnoiditis Following A Prostate Biopsy: Case Report Paul Partyka, DO, PhD
05:00 PM - 06:00 PM PDT	Abstract	10-008 - Basilar Leptomeningitis Secondary to Racemose Neurocysticercosis: A Case Report Jonathon Chon Teng Chio, PhD
05:00 PM - 06:00 PM PDT	Abstract	10-009 - Limitations of Using Radiological Imaging to Determine Treatment Success in Neurocysticercosis Jasleen K. Bains, Undergraduate Student
05:00 PM - 06:00 PM PDT	Abstract	11-001 - Conus Medullaris Syndrome Masquerading as Bilateral L5 or S1 Radiculopathy Anita Venkatesh, MD
05:00 PM - 06:00 PM PDT	Abstract	11-002 - “Bacteria Ate My Lunch”- A Case of Myelo-neuropathy Treated with Antibiotics Bhavani G. Murugesan, MD
05:00 PM - 06:00 PM PDT	Abstract	11-003 - A Challenging Case of Guillain-Barré Syndrome Presenting with Hyperreflexia, Severe Back Pain and Dysautonomia Vanessa Dias Veloso, MD
05:00 PM - 06:00 PM PDT	Abstract	11-004 - Suspected Stiff-Person Syndrome May Represent Alternative Genetic Diagnoses: A Case Series Emma Kaplan, MD
05:00 PM - 06:00 PM PDT	Abstract	11-005 - Two Cases of Adhesive Arachnoiditis Following Intrathecal Nusinersen Julia L. Bassell, MD
05:00 PM - 06:00 PM PDT	Abstract	11-006 - Bilateral Parsonage-Turner Syndrome Due to Cytomegalovirus in Two Immunocompetent Men Sarah L. Mangan, MBBS
05:00 PM - 06:00 PM PDT	Abstract	11-007 - Progressive Non-discogenic L5 and S1 Radiculopathy Persen Sukpornchairak, MD
05:00 PM - 06:00 PM PDT	Abstract	11-008 - Neisseria Sicca Sepsis Associated with Ravulizumab for Myasthenia Gravis: Case Report Shaida Omid, MD
05:00 PM - 06:00 PM PDT	Abstract	11-009 - Apraxia of Lid Opening in Myasthenia Gravis Ryan Naum, DO
05:00 PM - 06:00 PM PDT	Abstract	11-010 - Complex Neuromuscular Presentation: Acquired Rippling Muscle Disease in a Patient with Ocular Myasthenia Gravis and Pathogenic CAPN3 Mutation Andrea Zhang, MD
05:00 PM - 06:00 PM PDT	Abstract	11-011 - Quad Bod: A Case That Highlights the Unique Presentation of Hereditary Inclusion Body Myopathy (HIBM) Samantha DiSalvo, MD
05:00 PM - 06:00 PM PDT	Abstract	11-012 - ICU Management of Severe Myotonic Crisis in the Setting of Beta-Adrenergic Agonist Use: A Case Report Ashna Aggarwal
05:00 PM - 06:00 PM PDT	Abstract	11-013 - Amyloid Myopathy: Not Always What It Seems Gautham V. Upadrasta, MD
05:00 PM - 06:00 PM PDT	Abstract	11-014 - Anal Sphincter Myotonia Leading to Megacolon and Refractory Constipation in Myotonic Dystrophy Type 1: A Rare Case Report Carolina B. Moura, MD
05:00 PM - 06:00 PM PDT	Abstract	11-015 - Hyoscyamine as a Novel Treatment for Intestinal Pseudo-obstruction in Myotonic Dystrophy Type 1 Stephanie M. Roses, MD
05:00 PM - 06:00 PM PDT	Abstract	11-016 - Dysferlinopathy as Cause of Long-term Asymptomatic HyperCKemia and Myalgia Ikreet Cheema, MD
05:00 PM - 06:00 PM PDT	Abstract	11-017 - Camptocormia as Presenting Feature of Myotonic Dystrophy Type 2 Mark T. Roberts, MD
05:00 PM - 06:00 PM PDT	Abstract	11-018 - Co-occurrence of Two Distinct Genetic Disorders in One Family, with Both Disorders Occurring in One Member Karthik Jagannath, MD
05:00 PM - 06:00 PM PDT	Abstract	11-019 - Bilateral Peroneal Neuropathy Associated with Semaglutide Related Rapid Weight Loss: A Case Report Dhaval P. Desai, MD
05:00 PM - 06:00 PM PDT	Abstract	11-020 - Autosomal Dominant Slow Channel Congenital Myasthenia Presenting as Limb Girdle Weakness Sweta Komanduru, DO
05:00 PM - 06:00 PM PDT	Abstract	11-021 - Safety and Efficacy of Subcutaneous Immunoglobulin as Maintenance Therapy in Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Meta-analysis of Randomized Controlled Trials Muhammad I. Yousaf, MD
05:00 PM - 06:00 PM PDT	Abstract	11-022 - Efficacy and Safety of Subcutaneous Immunoglobulin in Patients with Chronic Inflammatory Demyelinating Polyneuropathy: A Systematic Review of RCTs Advait Teli, MBBS
05:00 PM - 06:00 PM PDT	Abstract	11-023 - Real-world Safety Assessment of Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with Subcutaneous IgPro20 Bill Maltas, Other
05:00 PM - 06:00 PM PDT	Abstract	11-024 - Subcutaneous Immunoglobulin (IgPro20) Dose Adjustments for Chronic Inflammatory Demyelinating Polyneuropathy Maintenance Therapy in Clinical Practice Elyse Murphy, RN, Msl
05:00 PM - 06:00 PM PDT	Abstract	11-025 - Treatment Impact of Efgartigimod PH20 SC on I-RODS Daily Activity Assessment in Patients with Chronic Inflammatory Demyelinating Polyneuropathy: Post Hoc Analysis of the Registrational ADHERE Study Richard A. Lewis, MD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	11-026 - Transition from Intravenous Immunoglobulin to Efgartigimod PH20 SC in Participants with Chronic Inflammatory Demyelinating Polyneuropathy: A Phase 4 Study in Progress Jeff Guptill, MD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	11-027 - Phase 3 Trial Designs Evaluating Riliprubart, a C1s-Complement Inhibitor, in Chronic Inflammatory Demyelinating Polyneuropathy Richard A. Lewis, MD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	11-028 - Budget Impact of Subcutaneous Immunoglobulin, Intravenous Immunoglobulin and Efgartigimod Alfa in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in the United States Jacob M. Romano, PharmD
05:00 PM - 06:00 PM PDT	Abstract	11-029 - Impact of Diabetes Mellitus on Clinical Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy Roopa Sharma, MD
05:00 PM - 06:00 PM PDT	Abstract	11-030 - Effectiveness of Combined Rituximab and Chlorambucil or Cyclophosphamide Treatment in Anti-MAG Neuropathy Antoine Gueguen, MD
05:00 PM - 06:00 PM PDT	Abstract	11-031 - Elevated Level of Oxidative DNA Damage and Impaired DNA Repair Efficiency of PBMCs from Chronic Inflammatory Demyelinating Polyneuropathy Beata A. Filipek, MD, PhD
05:00 PM - 06:00 PM PDT	Abstract	11-032 - Improvement in Nerve Size on Ultrasound After IV IG in a Multifactorial Chronic Inflammatory Neuropathy Himanshu Verma, MBBS
05:00 PM - 06:00 PM PDT	Abstract	11-033 - Application of a Clinical-electrophysiologic Model for Distinguishing Chronic Inflammatory Demyelinating Neuropathy (CIDP) in an Australian Cohort Grace Swart, MD
05:00 PM - 06:00 PM PDT	Abstract	11-034 - Real-world Characteristics and Disease Management for a Virtual Longitudinal Cohort of Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Deborah Kuk, MS
05:00 PM - 06:00 PM PDT	Abstract	12-001 - Interim Analysis of CONFIDENCE: A ProspeCtive ObservatioNal Study with Acute Treatment oF rImegepant ODT on ConsistENcy, SatisfaCtion and Tolerability of TrEatment in the Real World Lucy Abraham
05:00 PM - 06:00 PM PDT	Abstract	12-002 - Evaluating the Effect of Rimegepant Versus Oral Triptans Use on Patient-Reported Outcomes Among Adults with Migraine in the United States Simon Dagenais, PhD, MSc
05:00 PM - 06:00 PM PDT	Abstract	12-004 - Assessing Blood Pressure Changes and Hypertension-Related Outcomes in Patients with Migraine Treated with Erenumab: a Systematic Review and Single-Arm Meta-Analysis Aishwarya Koppanatham, MBBS
05:00 PM - 06:00 PM PDT	Abstract	12-005 - The Optimum Dose of Erenumab to Improve Quality of Life in Patients with Episodic Migraines: A Systematic Review, Meta-analysis and Network Meta-analysis. Julio C. Furlan, MD, PhD, MBA, MSc, FAAN
05:00 PM - 06:00 PM PDT	Abstract	12-006 - Comparative Efficacy of AXS-07 vs. Gepants for Acute Treatment of Migraine: A Network Meta-Analysis Stephanie J. Nahas, MD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	12-007 - Economic Impact of Early Vs. Late Initiation of Atogepant for The Preventive Treatment of Migraine Jessica Ailani, MD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	12-008 - A Retrospective Cohort Study Comparing Persistence Between Rimegepant and Oral Triptans for the Acute Treatment of Migraine in the United States Lucy Abraham
05:00 PM - 06:00 PM PDT	Abstract	12-009 - Real-World Long-Term Effectiveness of Fremanezumab in Patients With Migraine Who Switched From Another mAb Targeting the CGRP Pathway – Subgroup Analysis of the FINESSE Full Analysis Verena Ramirez Campos, MD
05:00 PM - 06:00 PM PDT	Abstract	12-010 - Efficacy and Safety of Once-daily Rimegepant 75 mg Orally Disintegrating Tablet for the Short-term Preventive Treatment of Fasting-related Headache Taoufik Alsaadi, MD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	13-001 - Trends in Cerebrovascular Disease and Diabetes Mellitus-Related Mortality in the United States from 1999 to 2020: An integrated Analysis of Comorbid Mortality Emaan Majed
05:00 PM - 06:00 PM PDT	Abstract	13-004 - Development and Validation of a Nomogram Prediction Model for New Stroke in Community Population Yanyan Wang, PhD
05:00 PM - 06:00 PM PDT	Abstract	13-006 - The Impact of Language Barriers on Acute Stroke Treatments Samantha J. Cheng, MD
05:00 PM - 06:00 PM PDT	Abstract	13-007 - Optimizing Telestroke Implementation and Acute Stroke Treatment Delivery through a Rural Telemedicine Initiative Danielle Sblendorio, MD
05:00 PM - 06:00 PM PDT	Abstract	13-008 - Social Determinants of Health with Ischemic Stroke Patients Treated with IV Thrombolysis Within a Public Safety Net Hospital Susan W. Law, DO
05:00 PM - 06:00 PM PDT	Abstract	13-009 - Prevalence of Stroke Mimics in Patients with Sickle Cell Anemia Gabriela Trifan, MD
05:00 PM - 06:00 PM PDT	Abstract	13-010 - Gender, Racial, and Geographical Disparities in Stroke-related Mortality among Children and Younger Adults in the United States: Analysis of Data over Two Decades James Issa, Student
05:00 PM - 06:00 PM PDT	Abstract	13-011 - Optimizing Outcome Prediction for Hispanic Patients with Posterior Circulation Ischemic Strokes: A Comparison of e-NIHSS and NIHSS Alejandro Benavides
05:00 PM - 06:00 PM PDT	Abstract	13-012 - Impact of COVID-19 on Stroke Mortality in Patients with Cardiovascular Comorbidities: A 23-Year U.S. Trend Analysis (1999-2022) Faraz Arshad
05:00 PM - 06:00 PM PDT	Abstract	13-013 - Risk of Stroke in Patients with Chagas Disease: A Meta-Analysis of Observational Studies Victória Siebel
05:00 PM - 06:00 PM PDT	Abstract	13-014 - Demographic and Regional Trends of Stroke-related Mortality in Nicotine Dependent Adults in the United States: Insight from 2001-2022 Syed H. Inam, MD
05:00 PM - 06:00 PM PDT	Abstract	13-016 - Stroke ��ɫ�� in the African American Community Colleen G. Lechtenberg, MD
05:00 PM - 06:00 PM PDT	Abstract	13-017 - Trends in Stroke-Related Mortality in Appalachia Kentucky from 1999 to 2020: A Regional Analysis of Health Disparities Isra Masood, MBBS
05:00 PM - 06:00 PM PDT	Abstract	13-018 - Risk of Stroke Among Mexican Population: A Cross-Sectional Study Applying a Useful Tool from the WSO Jorge Alejandro Arias Vega
05:00 PM - 06:00 PM PDT	Abstract	13-019 - Characteristics of Low-Volume Stroke Thrombectomy Centers in Florida Nathaniel Fleming, MD
05:00 PM - 06:00 PM PDT	Abstract	13-020 - Exploring Racial Disparities in Advanced Care Planning Documentation for Stroke Patients Tiffany Hu, MD
05:00 PM - 06:00 PM PDT	Abstract	14-001 - Cost of Stroke Management: Prospective Study of 100 Cases at the Neurology Department of the Ignace Deen National Hospital Conakry University Hospital Mamadou Diallo, MD
05:00 PM - 06:00 PM PDT	Abstract	14-002 - Limitations of Current Stroke Thrombectomy Disability Triage Sameer Ansari, BS
05:00 PM - 06:00 PM PDT	Abstract	14-004 - Cognitive Limitations after Hemorrhagic Stroke are Less Common in Patients with Private Insurance and Elevated Body Mass Index Saami Zakaria, MD
05:00 PM - 06:00 PM PDT	Abstract	14-008 - : Congruence of the Stroke Specific Quality of Life (SSQOL) Domains and Stroke Survivors’ Perceptions on Physical Wellbeing: A Mixed-Methods Exploratory Sequential Study Devanshi Choksi, MD, MPH
05:00 PM - 06:00 PM PDT	Abstract	14-009 - Factors Predicting In-Hospital Mortality in Ischemic Stroke Patients in Bogotá, Colombia Stefanía Forero Caldas, MD
05:00 PM - 06:00 PM PDT	Abstract	14-011 - Comparing Burr-Hole Drainage with or Without Irrigation in Chronic Subdural Hematoma Patients: A Systematic Review and Meta-Analysis Jamir Pitton Rissardo, MD
05:00 PM - 06:00 PM PDT	Abstract	14-012 - Association of Atrial Fibrillation with Cognitive Decline After Minor, Moderate, and Major Ischemic Stroke: A Post Hoc Analysis Mahmoud M. Elsayed, MD
05:00 PM - 06:00 PM PDT	Abstract	14-013 - Impact of the COVID-19 Pandemic on Acute Stroke Presentation and Outcome Kristen Kelly, MD
05:00 PM - 06:00 PM PDT	Abstract	14-014 - Trends in Emergency Department Length of Stay and Timely Follow-Up Care After Implementation of an ED TIA Pathway Jenna L. Miller, MD
05:00 PM - 06:00 PM PDT	Abstract	14-015 - Implementation of a Clinical Pathway Designed to Improve Time to Antiplatelet Therapy for Patients with TIA in the Emergency Department Jenna L. Miller, MD
05:00 PM - 06:00 PM PDT	Abstract	14-016 - Experience in Treating Acute Ischemic Stroke with Tenecteplase at a Single Center in Bogotá, Colombia Annelise Pereira

Faculty Disclosures
Polina Shichkova, PhD	Dr. Shichkova has received personal compensation for serving as an employee of Biognosys AG.
Marco Tognetti, PhD	Mr. Tognetti has received personal compensation for serving as an employee of Biognosys AG.
Christopher Below, PhD	Dr. Below has received personal compensation for serving as an employee of Biognosys AG.
Aida Kamalian, MD, MPH	Dr. Kamalian has nothing to disclose.
Sara Ho	Sara Ho has nothing to disclose.
Roland Bruderer, PhD	Dr. Bruderer has nothing to disclose.
Lukas Reiter	Dr. Reiter has received personal compensation for serving as an employee of Biognosys.
Yuehan Feng, PhD	Dr. Feng has received personal compensation for serving as an employee of Biognosys AG.
Michael W. Lutz, PhD	Dr. Lutz has nothing to disclose.
Abhay Moghekar, MD	Dr. Moghekar has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Deluca and Weizenbaum. Dr. Moghekar has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Silver Golub and Tieteel. The institution of Dr. Moghekar has received research support from NIH. Dr. Moghekar has a non-compensated relationship as a Medical Advisory Board member with Hydrocephalus Association that is relevant to AAN interests or activities. Dr. Moghekar has a non-compensated relationship as a Medical Advisory Board member with Spinal CSF Leak Foundation that is relevant to AAN interests or activities.
Sean Stern	Mr. Stern has received personal compensation for serving as an employee of SK Life Science.
Clarence Wade	Clarence Wade has nothing to disclose.
Mehraveh Salehi, PhD	Dr. Salehi has nothing to disclose.
Sarah F. Gilson, MD	Dr. Gilson has received personal compensation for serving as an employee of Truveta. Dr. Gilson has stock in Truveta.
Sumati Ramsinghani, Dentist	Mrs. Ramsinghani has nothing to disclose.
Sadra Naddaf Shargh, PhD, DE	Dr. naddaf shargh has nothing to disclose.
Saman Zarandioon	Dr. Zarandioon has nothing to disclose.
Megan Lipps-Choi	Ms. Lipps-Choi has nothing to disclose.
Esther Kim, PhD	Dr. Kim has nothing to disclose.
Sally Omidvar, MSPH, MS	Ms. Omidvar has received personal compensation for serving as an employee of Truveta.
Louis Ferrari	No disclosure on file
Mariama Boubacar Diallo	Dr. Diallo has nothing to disclose.
Mamadou Diallo, MD	Dr. Diallo has nothing to disclose.
Cisse Amara	No disclosure on file
Souleymane Mbara Diallo	No disclosure on file
Anita Venkatesh, MD	Dr. Venkatesh has nothing to disclose.
Michael Stanton, MD, FAAN	Dr. Stanton has nothing to disclose.
Eric L. Logigian, MD, FAAN	Dr. Logigian has nothing to disclose.
George Ibrahim	George Ibrahim has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. George Ibrahim has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synergia. George Ibrahim has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Livanova. George Ibrahim has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Synergia.
Arjun Balachandar, MD	Dr. Balachandar has nothing to disclose.
Lindsey Vogt, MD	Dr. Vogt has nothing to disclose.
Karim Mithani, MD, MEng	Dr. Mithani has received research support from Canadian Institutes of Health Research. Dr. Mithani has received research support from Hospital for Sick Children Clinician-Scientist Training Program. Dr. Mithani has received research support from IMPaCT. Dr. Mithani has received research support from Hold 'Em for Life Oncology Fellowship. Dr. Mithani has received personal compensation in the range of $50,000-$99,999 for serving as a Resident Physician with Ontario Ministry of Health.
Carolina Gorodetsky, MD	Dr. Gorodetsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic Inc . Dr. Gorodetsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic Inc . Dr. Gorodetsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic Inc .
Alfonso Fasano, MD, PhD, FAAN	Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceregate. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Inbrain Neuroelectronics. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Annovis. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CADTH. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorders Society. The institution of Dr. Fasano has received research support from Boston Scientific. The institution of Dr. Fasano has received research support from Medtronic. The institution of Dr. Fasano has received research support from Abbvie. The institution of Dr. Fasano has received research support from Canadian Institutes of Health Research (CIHR). The institution of Dr. Fasano has received research support from Michael J Fox Foundation. The institution of Dr. Fasano has received research support from Bluerock Therapeutics. Dr. Fasano has received publishing royalties from a publication relating to health care. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with CenteR for Advancing Neurological Innovation to Application (CRANIA) that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with HopeNET that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Member with Tremor Research Group that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Co-Chair with Tremor Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with NPH Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with Industry Committee of the IPMDS that is relevant to AAN interests or activities.
Sebastian C. Coleman, PhD	Dr. Coleman has nothing to disclose.
Andrea LeBlanc-Millar, NP	Mrs. LeBlanc-Millar has nothing to disclose.
Sara Breitbart, NP	Ms. Breitbart has nothing to disclose.
Mark Ebden, DPhil	Dr. Ebden has nothing to disclose.
Neha Sudarshan	Miss Sudarshan has nothing to disclose.
M Netravathi, MD	Dr. NETRAVATHI has nothing to disclose.
Jayanth S S, DM	Dr. S S has nothing to disclose.
T A Sangeeth, DM	Dr. Sangeeth has nothing to disclose.
Douglas Weibe	No disclosure on file
Andrea Almeida, MD	Dr. Almeida has nothing to disclose.
Matthew T. Lorincz, MD, PhD	Dr. Lorincz has received personal compensation for serving as an employee of Alexion. Dr. Lorincz has received personal compensation for serving as an employee of Orphalon . Dr. Lorincz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Lorincz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orphalon . Dr. Lorincz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink Neurology. The institution of Dr. Lorincz has received research support from Alexion.
Jere Freeman	No disclosure on file
jason goldstick, PhD	Dr. goldstick has nothing to disclose.
Michael Popovich, MD	Dr. Popovich has nothing to disclose.
Ingrid Ichesco	Ingrid Ichesco has nothing to disclose.
James T. Eckner, MD	An immediate family member of Dr. Eckner has received personal compensation for serving as an employee of Autism Alliance of Michigan. The institution of Dr. Eckner has received research support from NIH. The institution of Dr. Eckner has received research support from Department of Defense. Dr. Eckner has received intellectual property interests from a discovery or technology relating to health care. Dr. Eckner has received personal compensation in the range of $500-$4,999 for serving as a CARE Consortium Publication Committee Member with Indiana University. Dr. Eckner has received personal compensation in the range of $0-$499 for serving as a ��ɫ��al Content Contributor with Move United.
Abigail Bretzin, PhD	The institution of Dr. Bretzin has received research support from Ivy League Big Ten University Presidents.
Maral Sakayan, MD	Dr. Sakayan has nothing to disclose.
Claire Joyner	Miss Joyner has received research support from National Institute of Health. Miss Joyner has received research support from UCI MIND.
Amanda Fang, Undergraduate student	Miss Fang has nothing to disclose.
Arunima Kapoor	Ms. Kapoor has nothing to disclose.
Alexis Conrad	Ms. Conrad has nothing to disclose.
Michael Lopez, PhD	Michael Lopez has nothing to disclose.
Areg Grigorian	Areg Grigorian has nothing to disclose.
Saef Izzy, MD, FAAN	The institution of Dr. Izzy has received research support from NINDS. The institution of Dr. Izzy has received research support from The Gillian Reny Stepping Strong Center for Trauma Innovation. Dr. Izzy has received publishing royalties from a publication relating to health care.
Danh V. Nguyen, PhD	Prof. Nguyen has nothing to disclose.
Bernadette Boden-Albala, DrPH	Ms. Boden-Albala has received research support from NIH.
Patrick M. Chen, MD	Dr. Chen has nothing to disclose.
Deepika Joshi, MD	Dr. Joshi has nothing to disclose.
Varun K. Singh, MD, MBBS	Dr. Singh has nothing to disclose.
Abhishek Pathak, MD, MBBS, DM	Dr. Pathak has nothing to disclose.
Rameshwar N. Chaurasia, MD, DM, FRCP (Edin), FAMS	Dr. Chaurasia has nothing to disclose.
Vijaya Mishra, MD, MBBS, DM	Prof. Mishra has nothing to disclose.
Anand Kumar, MD, DM	Dr. Kumar has nothing to disclose.
Fatima Hussain, MBBS	Miss Hussain has nothing to disclose.
Abeer Tahir	Miss Tahir has nothing to disclose.
Syed N. Hussain	Dr. Hussain has nothing to disclose.
Ahmed Raza	Ahmed Raza has nothing to disclose.
Hamza Ahmed, MBBS	Mr. Ahmed has nothing to disclose.
Emaan Majed	Ms. Majed has nothing to disclose.
Amy T. Waldman, MD	Dr. Waldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio. An immediate family member of Dr. Waldman has or had stock in Pfizer. The institution of Dr. Waldman has received research support from Ionis Pharmaceuticals. The institution of Dr. Waldman has received research support from Roche/Genentech. The institution of Dr. Waldman has received research support from Ionis Pharmaceuticals. The institution of Dr. Waldman has received research support from Calico. Dr. Waldman has received publishing royalties from a publication relating to health care. Dr. Waldman has received publishing royalties from a publication relating to health care.
Joshua Joung, Other	Mr. Joung has nothing to disclose.
Geraldine Liu	An immediate family member of Geraldine Liu has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. An immediate family member of Geraldine Liu has received publishing royalties from a publication relating to health care.
Asako Takanohashi, PhD, DVM	Dr. Takanohashi has nothing to disclose.
Walter Faig	Walter Faig has received personal compensation for serving as an employee of Westat.
Sarah Woidill	Sarah Woidill has nothing to disclose.
Sona Narula, MD	Dr. Narula has received personal compensation in the range of $0-$499 for serving as a Consultant for Medscape .
Adeline Vanderver, MD, FAAN	An immediate family member of Dr. Vanderver has received personal compensation for serving as an employee of Maryland Physician Care. The institution of Dr. Vanderver has received research support from Takeda. The institution of Dr. Vanderver has received research support from Passage Bio. The institution of Dr. Vanderver has received research support from Homology. The institution of Dr. Vanderver has received research support from Eli Lilly. The institution of Dr. Vanderver has received research support from Myrtelle. The institution of Dr. Vanderver has received research support from SynaptixBio. The institution of Dr. Vanderver has received research support from PMD Foundation. The institution of Dr. Vanderver has received research support from Ionis. The institution of Dr. Vanderver has received research support from ISD . The institution of Dr. Vanderver has received research support from Boehringer-Ingelheim. The institution of Dr. Vanderver has received research support from Biogen. The institution of Dr. Vanderver has received research support from Sana. The institution of Dr. Vanderver has received research support from Affinia. The institution of Dr. Vanderver has received research support from BridgeBio. The institution of Dr. Vanderver has received research support from Orchard. The institution of Dr. Vanderver has received research support from Minoryx. The institution of Dr. Vanderver has received research support from Forge Biologics. The institution of Dr. Vanderver has received research support from Vigil. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care.
David B. Abraham, MS	Mr. Abraham has nothing to disclose.
Frederico M. de Sousa Marinho Mendes Filho	Mr. de Sousa Marinho Mendes Filho has nothing to disclose.
Rebeca O. Silva, Student	Miss Silva has nothing to disclose.
Emanuelly L. Barbosa	Ms. Barbosa has nothing to disclose.
Elizabet Taylor P. Weba, Jr., Student	Miss Weba has nothing to disclose.
Christian K. Fukunaga, MS (Medical Student)	Mr. Fukunaga has nothing to disclose.
Giovanna Salema Pascual	Miss Salema Pascual has nothing to disclose.
Rafaela Farias Vidigal Nascimento, MD	Miss Nascimento has nothing to disclose.
Luis O. Nogueira, medical student	Mr. NOGUEIRA has nothing to disclose.
Isabela A. de Almeida	Miss de Almeida has nothing to disclose.
Lucy Abraham	Lucy Abraham has received personal compensation for serving as an employee of Pfizer R&D UK Ltd. Lucy Abraham has stock in Pfizer R&D UK Ltd.
Alexandre Urani	Alexandre Urani has received personal compensation for serving as an employee of Aptar Digital Health.
Giorgio Lambru, PhD	Dr. Lambru has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Lambru has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Lambru has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ELI LILLY. Dr. Lambru has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PFIZER. Dr. Lambru has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LUNDBECK. Dr. Lambru has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dr Reddy's. Dr. Lambru has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oxford cannabinoid technologies.
Richard B. Lipton, MD, FAAN	Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Peter Goadsby, MD, PhD, FRS	Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health LLC. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kallyope. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seaport Therapeutics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr Reddy's. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orion Pharma. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society. The institution of Dr. Goadsby has received research support from NIHR. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has a non-compensated relationship as a Trustee with Migraine Trust that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Trustee with Organisation for Understanding Cluster Headache (UK) that is relevant to AAN interests or activities.
Patricia Pozo-Rosich, MD, PhD	Dr. Pozo-Rosich has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pozo-Rosich has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Organon. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr. Reddy's. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sociedad Española Neurologia.
Todd J. Schwedt, MD, FAAN	Dr. Schwedt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Schwedt has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scilex. Dr. Schwedt has stock in Aural Analytics. Dr. Schwedt has stock in Nocira. Dr. Schwedt has stock in Allevalux. The institution of Dr. Schwedt has received research support from National Institutes of Health. The institution of Dr. Schwedt has received research support from United States Department of Defense. The institution of Dr. Schwedt has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Schwedt has received research support from SPARK Neuro. The institution of Dr. Schwedt has received research support from Henry Jackson Foundation. The institution of Dr. Schwedt has received research support from Pfizer. The institution of Dr. Schwedt has received research support from National Headache Foundation. The institution of Dr. Schwedt has received research support from American Heart Association. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received publishing royalties from a publication relating to health care.
Boryana Galabova	Boryana Galabova has received personal compensation for serving as an employee of Pfizer.
Karin Hygge Blakeman	Karin Hygge Blakeman has received personal compensation for serving as an employee of Pfizer. Karin Hygge Blakeman has stock in Pfizer.
Feng Dai, PhD	Dr. Dai has received personal compensation for serving as an employee of Pfizer.
Noor A. Lari, MBBS	Dr. LARI has nothing to disclose.
Noor Ahmad Lari	No disclosure on file
Benjamin J. Braunecker	Mr. Braunecker has nothing to disclose.
Jenna R. Groh, BA	Ms. Groh has nothing to disclose.
Charles H. Adler, MD, PhD, FAAN	Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Michael Alosco, PhD	The institution of Michael Alosco, PhD has received research support from NIH. The institution of Michael Alosco, PhD has received research support from Life Molecular Imaging Inc.
David W. Dodick, MD, FAAN	Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation for serving as an employee of Atria Health. Dr. Dodick has received personal compensation for serving as an employee of Thomas Jefferson University . Dr. Dodick has received personal compensation for serving as an employee of Norwegian University of Science and Technology. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharm Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Practice Australia. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical ��ɫ�� Alliance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of the Pacific . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medica Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJ Healthcare. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vector Psychometrics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thomas Jefferson University. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medforce. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision HEOR. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canadian Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of New England. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Japan. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axon Therapeutics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cephalgia Group. Dr. Dodick has stock in Healint. Dr. Dodick has stock in Theranica. Dr. Dodick has stock in Aural Analytics . Dr. Dodick has stock in Epien. Dr. Dodick has stock in Matterhorn. Dr. Dodick has stock in Ontologics. Dr. Dodick has stock in Precon Health. Dr. Dodick has stock in King Devick Technologies. Dr. Dodick has stock in Nocira. Dr. Dodick has stock in Exsano. Dr. Dodick has stock in Palion. Dr. Dodick has stock in AYYA Biosciences. Dr. Dodick has stock in Perfood. Dr. Dodick has stock in Cephalgia Group. Dr. Dodick has stock in Atria Health. Dr. Dodick has stock in Man and Science. Dr. Dodick has stock in Eigenlyfe. An immediate family member of Dr. Dodick has stock in ScotiaLyfe. Dr. Dodick has stock in Axon Therapeutics. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with ��ɫ�� that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to AAN interests or activities.
Yorghos Tripodis	Yorghos Tripodis has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association.
Laura J. Balcer, MD, MSCE, FAAN	An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Charles Bernick, MD	Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Optina. Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corium. Dr. Bernick has stock in Aurora. The institution of Dr. Bernick has received research support from UFC. The institution of Dr. Bernick has received research support from Top Rank Promotions. The institution of Dr. Bernick has received research support from Haymon Boxing.
Sarah J. Banks, PhD	No disclosure on file
William Barr	William Barr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Law firms involved in litigation in cases with concussion and/or alleged CTE. . William Barr has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Law firms involved in litigation in cases with concussion and/or alleged CTE. . An immediate family member of William Barr has received publishing royalties from a publication relating to health care.
Jennifer V. Wethe, PhD	Dr. Wethe has received intellectual property interests from a discovery or technology relating to health care. Dr. Wethe has received intellectual property interests from a discovery or technology relating to health care.
Joseph Palmisano, MPH, MA	Mr. Palmisano has nothing to disclose.
Brett Martin, MS	Mr. Martin has nothing to disclose.
Kaitlin Hartlage	Ms. Hartlage has received personal compensation for serving as an employee of Uprise Health. Ms. Hartlage has received personal compensation for serving as an employee of ASCO.
Robert Cantu, MD	Dr. Cantu has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Multiple law firms .
Yonas E. Geda, MD	The institution of Dr. Geda has received research support from NIH.
Douglas I. Katz, MD, FAAN	Dr. Katz has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law firms. The institution of Dr. Katz has received research support from NINDS/NIH. Dr. Katz has received publishing royalties from a publication relating to health care.
Jesse B. Mez, MD	The institution of Dr. Mez has received research support from NIH, DOD.
Jeffrey L. Cummings, MD, FAAN	Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia, Actinogen, Acumen, AlphaCognition, ALZpath, Aprinoia, AriBio, Artery, Biogen, Biohaven, BioVie, BioXcel, Bristol-Myers Squib, Cassava, Cerecin, Diadem, Eisai, GAP Foundation, GemVax, Janssen, Jocasta, Karuna, Lighthouse, Lilly, Lundbeck, LSP/eqt, Mangrove Therapeutics, Merck, NervGen, New Amsterdam, Novo Nordisk, Oligomerix, ONO, Optoceutics, Otsuka, Oxford Brain Diagnostics, Prothena, ReMYND, Roche, Sage Therapeutics, Signant Health, Simcere, sinaptica, Suven, TrueBinding, Vaxxinity, and Wren pharmaceutical, assessment, and investment companies. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia, Biogen, Genentech, Grifols, Janssen, Karuna, Otsuka, reMYND, Roche, Signant Health. Dr. Cummings has stock in Artery, Vaxxinity, Behrens, Alzheon, MedAvante-Prophase, and Acumen. Dr. Cummings has received research support from NIH. Dr. Cummings has received research support from NIGMS. Dr. Cummings has received intellectual property interests from a discovery or technology relating to health care.
Martha Shenton	Martha Shenton has nothing to disclose.
Eric M. Reiman, MD	Dr. Reiman has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Denali, Green Valley, Zinfandel, and Takeda. Dr. Reiman has received stock or an ownership interest from Alkahest, Alzheon, Aural Analytics, Denali, and United Neuroscience.. Dr. Reiman has received intellectual property interests from a discovery or technology relating to health care. Dr. Reiman has received personal compensation in the range of $500-$4,999 for serving as a Member, National Advisory Council on Aging (NACA) with NIA.
Robert Stern, PhD	Robert Stern, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Robert Stern, PhD has received research support from Eisai. The institution of Robert Stern, PhD has received research support from Lilly. The institution of Robert Stern, PhD has received research support from ATRI/NIA. Robert Stern, PhD has received publishing royalties from a publication relating to health care. Robert Stern, PhD has a non-compensated relationship as a Member with NFLPA Mackey-White Committee that is relevant to AAN interests or activities.
Shruti Mahale, BS	Ms. Mahale has nothing to disclose.
Peter Sguigna, MD	Dr. Sguigna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Sguigna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Sguigna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. The institution of Dr. Sguigna has received research support from Genentech. The institution of Dr. Sguigna has received research support from Clene Nanomedicine. The institution of Dr. Sguigna has received research support from The International Progressive Multiple Sclerosis Alliance through the National Multiple Sclerosis Society. The institution of Dr. Sguigna has received research support from PCORI. The institution of Dr. Sguigna has received research support from DOD/CDMRP. The institution of Dr. Sguigna has received research support from Alexion. Dr. Sguigna has received intellectual property interests from a discovery or technology relating to health care.
Lauren Tardo, MD	Dr. Tardo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Tardo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NeurologyLive. Dr. Tardo has received personal compensation in the range of $500-$4,999 for serving as a consultant with CanDoMS. Dr. Tardo has a non-compensated relationship as a Tardo with The MOG Project that is relevant to AAN interests or activities.
Linda Nguyen, MD, PhD	Dr. Nguyen has nothing to disclose.
Gabrielle DeFiebre, PhD	Dr. DeFiebre has received personal compensation for serving as an employee of Siegel Rare Neuroimmune Association.
Kyle M. Blackburn, MD	Dr. Blackburn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx.
James (Graham) Cross, MD	Dr. Cross has nothing to disclose.
Laurel J. Cherian, MD, FAAN	The institution of Dr. Cherian has received research support from NIH.
Michael Chen, MD	Dr. Chen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RapidPulse. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Balt. Dr. Chen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Chen has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Society of Neurointerventional Surgery. Dr. Chen has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neurointerventional Surgery. Dr. Chen has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Johnson.
Sameer Ansari	Mr. Ansari has nothing to disclose.
Bobak Khalili, Medical Student	Mr. Khalili has nothing to disclose.
Akshaya Rathin Sivaji, MD	Dr. Sivaji has nothing to disclose.
Suraj Thyagaraj	Suraj Thyagaraj has nothing to disclose.
Neel Fotedar, MD	Dr. Fotedar has received research support from NINDS.
Imtiaz Nazam, MD	Dr. Nazam has nothing to disclose.
Fizza Tariq, MD	Dr. Tariq has nothing to disclose.
Simon Dagenais, PhD, MSc	Dr. Dagenais has received personal compensation for serving as an employee of Pfizer, Inc.. Dr. Dagenais has stock in Pfizer, Inc.. Dr. Dagenais has received publishing royalties from a publication relating to health care.
Jessica Ailani, MD, FAAN	Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as a Consultant for Eli Lilly. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspya. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kallyope. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Self Magazine. The institution of Dr. Ailani has received research support from Ipsen. The institution of Dr. Ailani has received research support from Parema. The institution of Dr. Ailani has received research support from Lundbeck. The institution of Dr. Ailani has received research support from Merz. The institution of Dr. Ailani has received research support from Pfizer. Dr. Ailani has received research support from Mi-Helper. The institution of Dr. Ailani has received research support from ShiraTronic. Dr. Ailani has a non-compensated relationship as a Executive Board Member with American Headache Society that is relevant to AAN interests or activities.
Nemin Chen, PhD	Ms. Chen has received personal compensation in the range of $100,000-$499,999 for serving as a Biostatistician with Oracle Life Sciences.
Jessica Cirillo	Mrs. Cirillo has received personal compensation for serving as an employee of Pfizer. Mrs. Cirillo has stock in Pfizer.
Alexis Turko	Ms. Turko has received personal compensation for serving as an employee of Pfizer.
Toji Miyagawa, MD, PhD	Dr. Miyagawa has nothing to disclose.
Scott Przybelski	Scott Przybelski has nothing to disclose.
Cynthia Vernon	Cynthia Vernon has nothing to disclose.
Paul Min	No disclosure on file
Leah K. Forsberg, PhD	Ms. Forsberg has nothing to disclose.
Julie A. Fields, PhD	The institution of Dr. Fields has received research support from National Institutes of Health. The institution of Dr. Fields has received research support from Patient-Centered Outcomes Research Institute.
Stuart J. McCarter, MD	The institution of Dr. McCarter has received research support from NIH. The institution of Dr. McCarter has received research support from American Academy of Sleep Medicine Foundation.
Tanis J. Ferman, PhD	Ms. Ferman has nothing to disclose.
Vijay K. Ramanan, MD, PhD	The institution of Dr. Ramanan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Daridorexant trial for AD prevention (funded by Weston Family Foundation). The institution of Dr. Ramanan has received research support from the National Institutes of Health. The institution of Dr. Ramanan has received research support from the Mangurian Foundation for Lewy Body Disease Research. The institution of Dr. Ramanan has received research support from as part of clinical trials sponsored by the Alzheimer's Association, Eisai, the Alzheimer's Treatment and Research Institute at USC, and Transposon Therapeutics, Inc.. The institution of Dr. Ramanan has received research support from Medscape. The institution of Dr. Ramanan has received research support from Expert Perspectives in Medicine. The institution of Dr. Ramanan has received research support from Roche/ADLM. The institution of Dr. Ramanan has received research support from American College of Radiology. Dr. Ramanan has received personal compensation in the range of $500-$4,999 for serving as a Conference Speaker/Organizer (Honoraria) with AANI. Dr. Ramanan has received personal compensation in the range of $500-$4,999 for serving as a Speaker/CME Content with Clinical Care Options.
Jonathan Graff-Radford, MD, FAAN	Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Open evidence . The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as a Faculty Member with IMPACT AD .
David T. Jones, MD	Dr. Jones has stock in Cephlodyne Neurotechnologies, Inc.. Dr. Jones has received intellectual property interests from a discovery or technology relating to health care.
Rodolfo Savica, MD, PhD, FAAN	The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
Ross Reichard	Ross Reichard has nothing to disclose.
Joseph E. Parisi, MD	Dr. Parisi has nothing to disclose.
Aivi Nguyen	Aivi Nguyen has nothing to disclose.
Dennis W. Dickson, MD	Dr. Dickson has nothing to disclose.
Melissa Murray, PhD	Dr. Murray has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avid Radiopharmaceuticals. The institution of Dr. Murray has received research support from National Institute on Aging. The institution of Dr. Murray has received research support from Alzheimer's Association. The institution of Dr. Murray has received research support from Chan Zuckerberg Initiative.
Gregory S. Day, MD, MSc, FAAN	Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has or had stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with ��ɫ��. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing ��ɫ��, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a ��ɫ��al Case Development + Presentation (video) with PeerDirect (P\S\L Group). Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development / Presentation (non-CME) with MJH Life Sciences (NeurologyLive). Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.
Neill R. Graff-Radford, MD, FAAN	The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
Erik K. St. Louis, MD	The institution of Dr. St. Louis has received research support from NIH. Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care.
Manoj K. Jain, MD, MBBS	Dr. Jain has nothing to disclose.
Kejal Kantarci, MD	The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF. The institution of Dr. Kantarci has received research support from Eisai. The institution of Dr. Kantarci has received research support from BioArctic.
Val J. Lowe, MD	Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Bradley F. Boeve, MD, FAAN	Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Valentina Emmanuele, MD, PhD	Dr. Emmanuele has nothing to disclose.
Alexander Goldberg, PhD	Dr. Goldberg has nothing to disclose.
Kristin Engelstad	No disclosure on file
Linn E. Katus, DO	The institution of Dr. Katus has received research support from Parkinson's Foundation.
Jennifer Bain, MD, PhD	Dr. Bain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Consulting. Dr. Bain has received personal compensation in the range of $0-$499 for serving as a Consultant for M3 Consulting. Dr. Bain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Legal Company . Dr. Bain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grin Therapeutics. The institution of Dr. Bain has received research support from Yellow Brick Road Project.
James Garvin	No disclosure on file
Darryl C. De Vivo, MD, FAAN	Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen and Novartis. Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspa Therapeutics.
Michio Hirano, MD, FAAN	Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Biopharma SRL. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision Biosciences. Dr. Hirano has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Biopharma SRL. Dr. Hirano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apollo Communication. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Envision Communications. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ��ɫ��. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Cure SMA. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Muscular Dystrophy Association. The institution of Dr. Hirano has received research support from UCB. The institution of Dr. Hirano has received research support from Cyclerion. The institution of Dr. Hirano has received research support from Astellas. The institution of Dr. Hirano has received research support from Tisento Therapeutics. The institution of Dr. Hirano has received research support from Stealth Biotherapeutics. The institution of Dr. Hirano has received research support from Abliva. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received personal compensation in the range of $0-$499 for serving as a Study Section Reviewer with NIH. Dr. Hirano has a non-compensated relationship as a Research Advisory Board member with Muscular Dystrophy Association that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific and Medical Advisory Board member with United Mitochondrial Disease Foundation that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific Advisory Board member with Barth Syndrome Foundation that is relevant to AAN interests or activities.
Aditi Mohan, MBBS	Dr. Mohan has nothing to disclose.
Kapil D. Nayar, MD	Dr. nayar has nothing to disclose.
Shaurjya Mandal, MS	Mr. Mandal has nothing to disclose.
Divya Nayar, MD	Dr. Nayar has nothing to disclose.
Luisa M. Rojas, PhD	Dr. Rojas has nothing to disclose.
Sanhita Nittala	Miss Nittala has nothing to disclose.
Adam Ferguson	The institution of Adam Ferguson has received research support from NIH. The institution of Adam Ferguson has received research support from VA. The institution of Adam Ferguson has received research support from DoD. The institution of Adam Ferguson has received research support from Wings for Life Foundation. The institution of Adam Ferguson has received research support from Craig H Neilsen Foundation. Adam Ferguson has received intellectual property interests from a discovery or technology relating to health care.
H. E. Hinson, MD, MCR, FAAN	Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
Hannah L. Radabaugh, PhD	Dr. Radabaugh has nothing to disclose.
Bhavani G. Murugesan, MD	Dr. Murugesan has nothing to disclose.
Vishal Mandge, MD	Dr. Mandge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono.
Alexis Lorio, MD	Miss Lorio has nothing to disclose.
Fei Pan, MD	Dr. Pan has nothing to disclose.
Anitha Raghunath, MD	Dr. Raghunath has nothing to disclose.
Purushottam Singh, MD	Dr. Singh has nothing to disclose.
Pawan Dhull, MD, MBBS	Dr. Dhull has nothing to disclose.
Aditya Gupta, MD, MBBS, DNB Neurology	Dr. Gupta has nothing to disclose.
Anirban Gupta, MD, MBBS, DM Neurology	Dr. Gupta has nothing to disclose.
Subrat K. Nanda, MD	Dr. Nanda has nothing to disclose.
Furkan Büyükgöl	Furkan Büyükgöl has nothing to disclose.
Umut Voyvoda	Umut Voyvoda has nothing to disclose.
Alper Bulbul	Alper Bulbul has nothing to disclose.
Osman Ugur Sezerman, PhD	Prof. Sezerman has nothing to disclose.
Elif Everest, PhD	Ms. Everest has received personal compensation in the range of $50,000-$99,999 for serving as a postdoctoral visiting fellow with National Institutes of Health.
Meryem A. Tuncer, MD	Dr. Tuncer has nothing to disclose.
Bedriye Karaman, MD	Dr. karaman has nothing to disclose.
Caner Feyzi Demir	Caner Feyzi Demirkaya has nothing to disclose.
Cavit Boz, MD	Dr. Boz has nothing to disclose.
Cihat Uzunkopru	Cihat Uzunkopru has nothing to disclose.
Haluk Gumus	Haluk Gumus has nothing to disclose.
Husnu Efendi, MD	The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alexion. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Roche. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Novartis.
Mehmet Fatih Yetkin	Mehmet Fatih Yetkin has nothing to disclose.
Mehmet Tecellioglu	No disclosure on file
Meral Seferoglu	No disclosure on file
Murat Kurtuncu, MD	Dr. Kurtuncu has nothing to disclose.
Murat Terzi, PhD	Dr. Terzi has nothing to disclose.
Ayse Nur Yuceyar, MD	No disclosure on file
Omer F. Turan, MD	Dr. Turan has nothing to disclose.
Ozlem Ethemoglu	No disclosure on file
Rana Karabudak, MD	Dr. Karabudak has nothing to disclose.
Sena Destan Bunul	Sena Destan Bunul has nothing to disclose.
Sedat Sen	No disclosure on file
Serkan Demir, MD	Dr. Demir has nothing to disclose.
Taskin Duman	Dr. Duman has nothing to disclose.
Tuncay Gunduz, MD	The institution of Dr. Gunduz has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Pharmaceuticals. Dr. Gunduz has received research support from Turkish Neuroimmunology Society.
Ufuk Aluclu, PhD	No disclosure on file
Yesim Beckmann, MD	Dr. Beckmann has nothing to disclose.
Kaya Bilguvar, MD, MBBS, PhD	Dr. Bilguvar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global Advisors. The institution of Dr. Bilguvar has received research support from NIH. The institution of Dr. Bilguvar has received research support from TUBITAK. Dr. Bilguvar has received intellectual property interests from a discovery or technology relating to health care. Dr. Bilguvar has received publishing royalties from a publication relating to health care. Dr. Bilguvar has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Bade Gulec	Bade Gulec has nothing to disclose.
Melih Tutuncu, MD	Dr. Tutuncu has nothing to disclose.
Ugur Uygunoglu	Ugur Uygunoglu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Turkey . The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec/Gen Pharma of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck-Serono of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanovel of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genveon of Turkey.
Sabahattin Saip	Sabahattin Saip has nothing to disclose.
Aksel Siva, MD	Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ali Raif Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanovel Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants.
Eda Turanli	The institution of Eda Turanli has received research support from Scientific and Technological Research Council of Turkey (TÜBITAK). The institution of Eda Turanli has received research support from Turkish MS Society. The institution of Eda Turanli has received research support from Acibadem University Scientific Research Projects Commission . The institution of Eda Turanli has received research support from Istanbul University Scientific Research Projects Commission .
Kathleen Bailey, PhD, NP	Dr. Bailey has received personal compensation for serving as an employee of Labcorp.
David Alfego, PhD	Dr. Alfego has received personal compensation for serving as an employee of Labcorp.
Deborah Boles	Deborah Boles has received personal compensation for serving as an employee of Laboratory Corporation of America. Deborah Boles has stock in Laboratory Corporation of America.
Ayla B. Harris	Mrs. Harris has received personal compensation for serving as an employee of Labcorp. Mrs. Harris has stock in Labcorp.
Bradley Collier	Dr. Collier has received personal compensation for serving as an employee of Labcorp. Dr. Collier has stock in Labcorp.
Charles Walworth, MD	Dr. Walworth has nothing to disclose.
John Winslow, PhD	Dr. Winslow has received personal compensation for serving as an employee of Labcorp/Monogram Biosciences. Dr. Winslow has received personal compensation for serving as an employee of Labcorp/Monogram Biosciences. Dr. Winslow has stock in Labcorp. Dr. Winslow has received intellectual property interests from a discovery or technology relating to health care.
Robert Martone, Other	Mr. Martone has received personal compensation for serving as an employee of Labcorp. Mr. Martone has stock in Pfizer. Mr. Martone has stock in AbbVie. Mr. Martone has stock in Labcorp.
Joseph Volpe, PhD	Dr. Volpe has received personal compensation for serving as an employee of Labcorp.
Vanessa Dias Veloso, MD	Dr. Dias Veloso has nothing to disclose.
Clare M. Lambert, MD	Dr. Lambert has nothing to disclose.
Ahmed Ali, MD	Mr. Ali has nothing to disclose.
Charalampia Koutsioumpa, MD, PhD	Dr. Koutsioumpa has nothing to disclose.
Sirisha Sanamandra, MBBS	Dr. Sanamandra has nothing to disclose.
Hamza M. Ahmed, MBBS	Dr. Ahmed has nothing to disclose.
Ahmad Al-Awwad, MD	Dr. Al-Awwad has nothing to disclose.
Jessica V. Amos, MD	Mrs. Amos has nothing to disclose.
Jasmin Williams, MD	Ms. Williams has nothing to disclose.
Rachel Forman, MD	Dr. Forman has nothing to disclose.
Qifan Wu, MS	Mr. Wu has received personal compensation for serving as an employee of YALE CORE. Mr. Wu has received personal compensation for serving as an employee of YALE CORE.
Richa Sharma, MD	Dr. Sharma has received research support from NIH. Dr. Sharma has received intellectual property interests from a discovery or technology relating to health care.
Kevin N. Sheth, MD, FAAN	Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Adam De Havenon, MD, FAAN	Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
Yuan Lu, PhD	Dr. Lu has nothing to disclose.
Nitish Chourasia, MD	Dr. Chourasia has nothing to disclose.
Grayson Hetherington, Student	Mr. Hetherington has received research support from NIH Medical Student Research Fellowship Program (MSRF) at the College of Medicine of the University of Tennessee Health Science Center.
James W. Wheless, MD, FAAP, FACP, FAAN, FAES, FCNS, FAAN	Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azurity. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for LivaNova. Dr. Wheless has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelius.
Emily S. Bonkowski, CGC	Ms. Bonkowski has nothing to disclose.
Basanagoud Mudigoudar, MD	Dr. Mudigoudar has nothing to disclose.
Mohamed E. Haseeb, MD	Dr. Haseeb has nothing to disclose.
Hazem Mohammed	Hazem Mohammed has nothing to disclose.
Hatem Yaser	Dr. Yaser has nothing to disclose.
George M. Hanen, MBBS	Dr. Hanen has nothing to disclose.
Mohamed Nasser	Dr. Nasser has nothing to disclose.
shehab yasser	Dr. yasser has nothing to disclose.
Zeyad Bady	Zeyad Bady has nothing to disclose.
Mohamed S. Shehata, MBBS	Dr. Shehata has nothing to disclose.
Shaweta Khosa	Ms. Khosa has nothing to disclose.
Gurveer S. Khosa, MBBS	Dr. Khosa has nothing to disclose.
Sanjay Anandaram, MD	Dr. Anandaram has nothing to disclose.
Matthew Remz, MD	Dr. Remz has nothing to disclose.
Pamela R. Zeilman, NP	Mrs. Zeilman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PMD Alliance.
Rohini M. Kumar, Student	Miss Kumar has nothing to disclose.
Samyukta Senthil, BS	Miss Senthil has nothing to disclose.
Aparna Wagle-Shukla, MD, FAAN	Dr. Wagle-Shukla has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Encora. Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Tremor research group. The institution of Dr. Wagle-Shukla has received research support from NIH. Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving as a reviewer with NIH.
Sarah Frances	Miss Frances has nothing to disclose.
James M. Noble, MD, FAAN	Dr. Noble has received stock or an ownership interest from NoMo Diagnostics. The institution of Dr. Noble has received research support from National Institute on Aging.
Niraj A. Arora, MD	Dr. Arora has nothing to disclose.
Dhaval H. Shastri, MD	Dr. Shastri has nothing to disclose.
Utsav Patel	Utsav Patel has nothing to disclose.
Ambuj Kumar, MD	Dr. Kumar has nothing to disclose.
Brad Ferguson, PhD	Dr. Ferguson has nothing to disclose.
Hariom L. Yadav, PhD	Dr. Yadav has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Postbiotics INc. Dr. Yadav has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for MusB Research. Dr. Yadav has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for MusB LLC. Dr. Yadav has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for BiomAge Health. Dr. Yadav has received intellectual property interests from a discovery or technology relating to health care. Dr. Yadav has received intellectual property interests from a discovery or technology relating to health care. Dr. Yadav has received intellectual property interests from a discovery or technology relating to health care. Dr. Yadav has received intellectual property interests from a discovery or technology relating to health care.
Kamleshun Ramphul	Kamleshun Ramphul has nothing to disclose.
Prince K. Pekyi-Boateng, MBBS	Dr. Pekyi-Boateng has nothing to disclose.
Shaheen Sombans, MBBS	Dr. Sombans has nothing to disclose.
Renuka Verma	Renuka Verma has nothing to disclose.
Maya Gabel, MD	Dr. Gabel has nothing to disclose.
Francesco Gavazzi, MD, MD, PhD	The institution of Dr. Gavazzi has received research support from NIH. The institution of Dr. Gavazzi has received research support from NIH, NINDS. The institution of Dr. Gavazzi has received research support from IONIS Pharmaceuticals.
Tracy Kornafel	Tracy Kornafel has nothing to disclose.
Samuel Pierce	Samuel Pierce has nothing to disclose.
Kathryn Gallison, Other	The institution of Miss Gallison has received research support from Ionis Pharmaceuticals.
Zhao Zhong Chong	Zhao Zhong Chong has nothing to disclose.
Nizar Souayah, MD, FAAN	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Elle Wade, MD	The institution of Dr. Wade has received research support from National Multiple Sclerosis Society .
Enrique Alvarez, MD, PhD	Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Anna Shah, MD	The institution of Dr. Shah has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. The institution of Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Shah has received research support from Rocky Mountain MS Center. The institution of Dr. Shah has received research support from Genentech/Roche. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving as a ��ɫ��al Speaker with Rocky Mountain MS Center.
Alexis Conrad	No disclosure on file
Bruce Albala, PhD	No disclosure on file
Artur Vestena Rossato	Mr. Vestena Rossato has nothing to disclose.
Eduardo G. de Almeida	Mr. de Almeida has nothing to disclose.
TAIS L. DENICOL, MD	Miss DENICOL has nothing to disclose.
Carolina Matté Dagostini	Miss Matté Dagostini has nothing to disclose.
Marlise D. ribeiro, PhD	Prof. ribeiro has nothing to disclose.
Liselotte Menke Barea, MD	Mrs. Menke Barea has nothing to disclose.
Yanyan Wang, PhD	Dr. Wang has nothing to disclose.
Fei Han	Fei Han has nothing to disclose.
Yi-Cheng Zhu, MD, PhD	Dr. Zhu has nothing to disclose.
Ding-Ding Zhang	Ding-Ding Zhang has nothing to disclose.
Grace Marie N. Dominguez, MD	Dr. Dominguez has nothing to disclose.
Katherine M. Wojcicki, DO	Dr. Wojcicki has nothing to disclose.
Aishwarya Koppanatham, MBBS	Ms. Koppanatham has nothing to disclose.
Henrique Alexsander F. Neves, Sr.	Mr. Neves has nothing to disclose.
Luana M. Makita	Miss Makita has nothing to disclose.
Rafael d. Kleimmann, Medical Student	Mr. Kleimmann has nothing to disclose.
Giovana S. Kojima	Mrs. Kojima has nothing to disclose.
Rafael R. Oliveira	Mr. Oliveira has nothing to disclose.
Vinicius S. Alves, Sr., Medical student	Dr. Alves has nothing to disclose.
Angela Maria Sandini Corso	Miss Sandini Corso has nothing to disclose.
Pedro A. Kowacs, MD, FAAN	Dr. Kowacs has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis.
Elcio J. Piovesan, MD	Dr. Piovesan has nothing to disclose.
Devon Grochowski	Ms. Grochowski has received personal compensation for serving as an employee of IPM.ai, Real Chemistry.
David C. Bradley	Mr. Bradley has nothing to disclose.
Raymond Mankoski	Raymond Mankoski has received personal compensation for serving as an employee of The NemetzGroup LLC.
Karen Tubridy, PharmD	Ms. Tubridy has received personal compensation for serving as an employee of Abcuro. Ms. Tubridy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Verseau Therapeutics. Ms. Tubridy has stock in Akebia Therapeutics.
Nadine Bast	Mrs. Bast has received personal compensation in the range of $0-$499 for serving as a Manuscript Writer with Thieme Verlag.
Karen I. Dost-Kovalsky	Ms. Dost-Kovalsky has nothing to disclose.
Sabrina Haben	Sabrina Haben has nothing to disclose.
Natalia Friedmann	Mrs. Friedmann has nothing to disclose.
Theresa Oganowski	Ms. Oganowski has nothing to disclose.
Ralf Gold, MD	Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Kerstin Hellwig	Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche . The institution of Kerstin Hellwig has received research support from Roche . The institution of Kerstin Hellwig has received research support from Merck . The institution of Kerstin Hellwig has received research support from Biogen. The institution of Kerstin Hellwig has received research support from Genzyme . The institution of Kerstin Hellwig has received research support from Novartis . The institution of Kerstin Hellwig has received research support from BMS .
Sandra Thiel	Ms. Thiel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer Healthcare .
Hyo Bin You	Mr. You has received personal compensation for serving as an employee of Dasion.AI. Mr. You has received personal compensation for serving as an employee of IXL Learning.
Hamza Ahmed, student	Mr. Ahmed has nothing to disclose.
Saami Zakaria, MD	Dr. Zakaria has nothing to disclose.
Kara R. Melmed, MD	Dr. Melmed has nothing to disclose.
Benjamin Brush, MD	Dr. Brush has nothing to disclose.
Aaron Lord, MD	Dr. Lord has nothing to disclose.
Lindsey Gurin, MD	Dr. Gurin has received personal compensation in the range of $0-$499 for serving as a physician reviewer with Healthcare Quality Strategies, Inc. Dr. Gurin has received personal compensation in the range of $500-$4,999 for serving as a consultant with Human Services Research Institute.
Jennifer A. Frontera, MD	Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FirstKindMedical. Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Physician ��ɫ�� Resource. The institution of Dr. Frontera has received research support from NIH. The institution of Dr. Frontera has received research support from Alexion. Dr. Frontera has received publishing royalties from a publication relating to health care.
Koto Ishida, MD, FAAN	Dr. Ishida has received publishing royalties from a publication relating to health care.
Jose L. Torres, MD	Dr. Torres has nothing to disclose.
Cen Zhang, MD	Dr. Zhang has nothing to disclose.
Leah P. Dickstein, MD	Dr. Dickstein has nothing to disclose.
David E. Kahn, MD	An immediate family member of Dr. Kahn has received personal compensation for serving as an employee of Essai.
Ting Zhou, MD	Dr. Zhou has nothing to disclose.
Ariane Lewis, MD, FAAN	Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seminars in Neurology. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.
Baibing Chen, MD, MPH	Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Contributor with CNBC.
Natalie Bristol, MD	Dr. Bristol has nothing to disclose.
Isha Snehal, MBBS	Dr. Snehal has nothing to disclose.
Subin Mathew, MD	Dr. Mathew has nothing to disclose.
Courtney Venegas, MD	Dr. Venegas has nothing to disclose.
Emma Kaplan, MD	Dr. Kaplan has nothing to disclose.
Susan Shin, MD	Dr. Shin has nothing to disclose.
Leslie J. Higuita, MD	Dr. Higuita has nothing to disclose.
Uwe Walter, MD, FEAN	Prof. Walter has received personal compensation for serving as an employee of Rostock University Medical Center. Prof. Walter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Canon Medical Systems Europe B.V.. Prof. Walter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen Pharma GmbH. Prof. Walter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme (Publisher) Stuttgart. Prof. Walter has stock in Novo Nordisk. Prof. Walter has stock in BioNTech. The institution of Prof. Walter has received research support from German Federal Ministry of ��ɫ�� and Research (BMBF). Prof. Walter has received publishing royalties from a publication relating to health care.
Philipp Albrecht, PhD	Dr. Albrecht has received personal compensation for serving as an employee of Abbvie. Dr. Albrecht has received personal compensation for serving as an employee of Biogen. Dr. Albrecht has received personal compensation for serving as an employee of Bristol Myers Squibb. Dr. Albrecht has received personal compensation for serving as an employee of Ipsen. Dr. Albrecht has received personal compensation for serving as an employee of Merck. Dr. Albrecht has received personal compensation for serving as an employee of Merz. Dr. Albrecht has received personal compensation for serving as an employee of Novartis. Dr. Albrecht has received personal compensation for serving as an employee of Roche. Dr. Albrecht has received personal compensation for serving as an employee of Sanofi. Dr. Albrecht has received personal compensation for serving as an employee of Lilly.
Warner Carr	Warner Carr has nothing to disclose.
Haralad Hefter	No disclosure on file
Yining Hao, MD, PhD	Dr. Hao has nothing to disclose.
Wei-Shi Liu, MD	Dr. Liu has nothing to disclose.
Yi *. Zhang, PhD	Dr. Zhang has nothing to disclose.
Jiahao Ji, MD, MBBS	Mr. Ji has nothing to disclose.
Yu He	Yu He has nothing to disclose.
Peng Yuan	Dr. Yuan has received personal compensation for serving as an employee of Fudan University. The institution of Dr. Yuan has received research support from Fudan University.
Jintai Yu	No disclosure on file
Gabby Costain	Miss Costain has nothing to disclose.
Matthew McEchron, PhD	Mr. McEchron has nothing to disclose.
Jordanne Kirschke	Ms. Kirschke has nothing to disclose.
Mostafa El Din Moawad	Mostafa El Din Moawad has nothing to disclose.
Mohamed Alsaied	Dr. Alsaied has nothing to disclose.
Ibrahim Serag, MD	Dr. Serag has nothing to disclose.
Ibraheem Alkhawaldeh	Ibraheem Alkhawaldeh has nothing to disclose.
Abdallah Abbas	Dr. Abbas has nothing to disclose.
Karim A. Mohamed, MSc in biotechnology	Dr. Mohamed has nothing to disclose.
Ahmed Mostafa Amin, MBBS	Dr. Amin has nothing to disclose.
Dalia Kamal Ewis	No disclosure on file
Mohamed El Moslemani, MD	Dr. El Moslemani has nothing to disclose.
Abdelfattah Arafa, MBBS	Dr. Arafa has nothing to disclose.
Mariam Elewidi, MD	Dr. Elewidi has nothing to disclose.
Mohamed Elfil, MBBCh	Dr. Elfil has nothing to disclose.
Mohamed Abouzid	Mohamed Abouzid has nothing to disclose.
Seif Elhadidi, PhD	Dr. ELHADIDI has nothing to disclose.
Ahmed Negida, MD, PhD	Dr. Negida has nothing to disclose.
Maria Daniela Orellana Zambrano, MD	Dr. Orellana Zambrano has nothing to disclose.
Luis Manzano-Hernandez, MD	Dr. Manzano-Hernandez has nothing to disclose.
Carlota Rodriguez, PhD	Miss Rodriguez has nothing to disclose.
Antonio Cristóbal Luque Ambrosiani, MD	Dr. Luque Ambrosiani has nothing to disclose.
Diego Villagran Sancho, Sr., MD	Dr. Villagran Sancho has nothing to disclose.
Elena Zapata Arriaza, MD, PhD	Dr. Zapata Arriaza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University Hospital of Montpellier, Public Health Establishment.
Francisco Moniche, MD, PhD	Dr. Moniche has nothing to disclose.
Jamir Pitton Rissardo, MD	Dr. Pitton Rissardo has nothing to disclose.
Ana Leticia Fornari Caprara, MD	Dr. Fornari Caprara has nothing to disclose.
Vishnu V. Byroju, MD	Dr. Byroju has nothing to disclose.
Aswathi Sajeendran, MD	Dr. Sajeendran has nothing to disclose.
Oscar Pablo Mata, MD	Dr. Mata has nothing to disclose.
Cesar Jara Silva Acosta, DO	Dr. Jara Silva Acosta has nothing to disclose.
Marisol Trejos, MD	Dr. Trejos has nothing to disclose.
Solomon Nittala, DO	Dr. Nittala has nothing to disclose.
Alexander Gasser, MD	Dr. Gasser has nothing to disclose.
Nicholas Sequeira, MD	Dr. Sequeira has nothing to disclose.
Mohammad M. Alavinia, MD, PhD	Dr. Alavinia has nothing to disclose.
Julio C. Furlan, MD, PhD, MBA, MSc, FAAN	The institution of Dr. Furlan has received research support from Wings for Life Spinal Cord Research Foundation. The institution of Dr. Furlan has received research support from Craig H Neilsen Foundation. The institution of Dr. Furlan has received research support from Ontario Neurotrauma Foundation. The institution of Dr. Furlan has received research support from Cervical Spine Research Society. The institution of Dr. Furlan has received research support from J P Bickell Foundation. The institution of Dr. Furlan has received research support from Praxis Spinal Cord Institute. The institution of Dr. Furlan has received research support from Cervical Spine Research Society. The institution of Dr. Furlan has received research support from CRANIA. The institution of Dr. Furlan has received research support from Craig H Neilsen Foundation. The institution of Dr. Furlan has received research support from Cervical Spine Research Society. The institution of Dr. Furlan has received research support from Cervical Spine Research Society. The institution of Dr. Furlan has received research support from Tanenbaum Institute for Science in Sport. .
Sean D. Ruland, MD	Dr. Ruland has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up to Date. Dr. Ruland has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law Firms.
Ravi Garg, MD	Dr. Garg has nothing to disclose.
Michelle Seu, MD	Dr. Seu has nothing to disclose.
Miloni Shah	Miloni Shah has nothing to disclose.
Antonio H. Iglesias, MD	Dr. Iglesias has nothing to disclose.
Moaz E. Abouelmagd, MD	Dr. Abouelmagd has nothing to disclose.
Maickel K. AbdelMeseh, MBBS	Dr. AbdelMeseh has nothing to disclose.
Atef A. Hassan, MD	Dr. Hassan has nothing to disclose.
Mohammed Ahmed Ali	Mr. Ali has nothing to disclose.
Rashad G. Mohamed, MBBS	Dr. Mohamed has nothing to disclose.
Abdelrahman M. Mady, MD	Dr. Mady has nothing to disclose.
Mahmoud D. Hindawi, MBBS	Dr. Hindawi? has nothing to disclose.
Mostafa M. Meshref, MD	Dr. Meshref has nothing to disclose.
Julia L. Bassell, MD	Dr. Bassell has nothing to disclose.
Jacinda B. Sampson, MD, PhD	Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viking Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sampson has received research support from Marigold Foundation. Dr. Sampson has a non-compensated relationship as a Scientific Advisory Committee with Myotonic Dystrophy Foundation that is relevant to AAN interests or activities.
John W. Day, MD, PhD	Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Gene Therapy. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PepGen. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Epirium Bio. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Biosciences. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Muscular Dystrophy Association. The institution of Dr. Day has received research support from Astellas Pharma. The institution of Dr. Day has received research support from Novartis Gene Therapy. The institution of Dr. Day has received research support from Biogen. The institution of Dr. Day has received research support from Roche/Genentech. The institution of Dr. Day has received research support from Sanofi/Genzyme. The institution of Dr. Day has received research support from Sarepta. The institution of Dr. Day has received research support from Scholar Rock. The institution of Dr. Day has received research support from AMO Pharma. The institution of Dr. Day has received research support from AnnJi. Dr. Day has received research support from CureSMA. The institution of Dr. Day has received research support from Muscular Dystrophy Association. The institution of Dr. Day has received research support from Ionis Pharmaceuticals. The institution of Dr. Day has received research support from NMD Pharma. The institution of Dr. Day has received research support from SMA Foundation. Dr. Day has received intellectual property interests from a discovery or technology relating to health care.
Connie Wolford, NP	Ms. Wolford has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Karolina A. Watson, NP	Mrs. Watson has nothing to disclose.
Ana Carolina Tesi Rocha, MD	Dr. Tesi Rocha has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Tesi Rocha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Tesi Rocha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Tesi Rocha has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Tesi Rocha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenxbio. Dr. Tesi Rocha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ITALPHARMACO. Dr. Tesi Rocha has received personal compensation in the range of $500-$4,999 for serving as a Speaker at Symposium with Roche.
Michael S. Kung, MD	Dr. Kung has nothing to disclose.
Naman D. Shah, MD	Dr. Shah has nothing to disclose.
Harshul Zaveri, MD	Dr. Zaveri has nothing to disclose.
Adam Z. Kalawi, MD	Dr. Kalawi has nothing to disclose.
Sebastian Hanna, MD	Mr. Hanna has nothing to disclose.
Rick Gill, MD	Dr. Gill has nothing to disclose.
Alexandria Pecoraro, MD	Dr. Pecoraro has nothing to disclose.
Vikram Prabhu	Vikram Prabhu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zeiss.
Ariba B. Raza, MD	Dr. Raza has nothing to disclose.
Shawn Choe, MD	Dr. Choe has nothing to disclose.
Ashish Ramesh	Mr. Ramesh has nothing to disclose.
Sonja Darwish, MD	Dr. Darwish has nothing to disclose.
Yama Akbari, MD, PhD	Dr. Akbari has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for AZ Injury Law. The institution of Dr. Akbari has received research support from NIH. The institution of Dr. Akbari has received research support from Hamamatsu Photonics KK. Dr. Akbari has received intellectual property interests from a discovery or technology relating to health care.
Sara J. Stern-Nezer, MD	Dr. Stern-Nezer has nothing to disclose.
Cyrus K. Dastur, MD	Dr. Dastur has nothing to disclose.
Walter W. Valesky, Jr., MD	Dr. Valesky has nothing to disclose.
Michelle F. Goodwin, MD	Dr. Goodwin has nothing to disclose.
Wengui Yu, MD, PhD	Dr. Yu has nothing to disclose.
Jeff W. Chen, MD, PhD	The institution of Dr. Chen has received research support from Mitsubishi.
Jeffry Nahmias, MD, MHPE	Dr. Nahmias has nothing to disclose.
Gracie Little	Mrs. Little has nothing to disclose.
Ananya Vasudhar, MBBS	Dr. Vasudhar has nothing to disclose.
Muhammad Bhatti, MD	Dr. Bhatti has nothing to disclose.
Lindsey M. Ladd, DO	Dr. Ladd has nothing to disclose.
Kunal Bhatia, MD	Dr. Bhatia has nothing to disclose.
Subash K. Dey	Dr. Dey has nothing to disclose.
Samantha J. Cheng, MD	Dr. Cheng has nothing to disclose.
Charles Esenwa, MD	Dr. Esenwa has nothing to disclose.
Lauren Gluck, MD	Dr. Gluck has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeautics. Dr. Gluck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Gluck has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Rare Disease. Dr. Gluck has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Gluck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb.
Oleg Otlivanchik, MD	Dr. Otlivanchik has nothing to disclose.
Gautham V. Upadrasta, MD	Dr. Upadrasta has nothing to disclose.
Sarah Wang, MD	Dr. Wang has nothing to disclose.
Liane E. Hunter, MD, PhD	Dr. Hunter has nothing to disclose.
Austin M. Saline, MD	Dr. Saline has nothing to disclose.
Michelle Ganat, MD	Dr. Ganat has nothing to disclose.
Stella Iskandarian, MD	Dr. Iskandarian has nothing to disclose.
Daniel L. Labovitz, MD	An immediate family member of Dr. Labovitz has received personal compensation for serving as an employee of Herrick Feinstein.
Esther Levison, MD	Dr. Levison has nothing to disclose.
Melissa Patel, DO	Dr. Patel has nothing to disclose.
Danielle Sblendorio, MD	Dr. Sblendorio has nothing to disclose.
Kierstan N. Pyle	Miss Pyle has nothing to disclose.
Michelle M. Coleman, MD	Miss Coleman has nothing to disclose.
Adeel A. Memon, MD	The institution of Dr. Memon has received research support from NIH/NINDS.
Maria Camila Moreno Escobar, MD	Dr. Moreno Escobar has nothing to disclose.
Jessica Frey, MD	The institution of Dr. Frey has received research support from Tourette Association of America.
Ann Murray, MD	Dr. Murray has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insightec. Dr. Murray has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic .
Gauri V. Pawar, MD, FAAN	Dr. Pawar has nothing to disclose.
Delanie Talkington	Delanie Talkington has nothing to disclose.
Patrick Sheehan	Patrick Sheehan has nothing to disclose.
Patrick J. Bergquist, MD	Dr. Bergquist has nothing to disclose.
Alexis B. Coalson, DO	Dr. Coalson has nothing to disclose.
Jordan M. Yaukey, DO	Dr. Yaukey has nothing to disclose.
Sepideh Allahdadian, MD	Dr. Allahdadian has nothing to disclose.
James Grogan, MD	Dr. Grogan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Lydia Kauffman, MD	Dr. Kauffman has nothing to disclose.
Eiman Zeeshan, BDS	Miss Zeeshan has nothing to disclose.
Fnu Javairia	Ms. Javairia has nothing to disclose.
Javeria Javeid	Mrs. Javeid has nothing to disclose.
Taimoon Rasheed	Taimoon Rasheed has nothing to disclose.
Moeen Ikram, MBBS	Mr. IKRAM has nothing to disclose.
Sarosh Ali, MBBS	Dr. Ali has nothing to disclose.
Aidan Keaveny	Mr. Keaveny has nothing to disclose.
Syed H. Inam, MD	Dr. Inam has nothing to disclose.
Ronald J. Ellis, MD, PhD, FAAN	Dr. Ellis has nothing to disclose.
Lora Khatib	Ms. Khatib has nothing to disclose.
BIN TANG	BIN TANG has nothing to disclose.
Donald Franklin, Jr., Research Administrator	Mr. Franklin has nothing to disclose.
Robert K Heaton	The institution of Robert K Heaton has received research support from NIH. Robert K Heaton has received intellectual property interests from a discovery or technology relating to health care. Robert K Heaton has received intellectual property interests from a discovery or technology relating to health care.
Scott L. Letendre, MD	The institution of Dr. Letendre has received research support from National Institutes of Health. The institution of Dr. Letendre has received research support from University at Buffalo. Dr. Letendre has received publishing royalties from a publication relating to health care.
Rob Knight, PhD	Prof. Knight has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cybele Microniome, Inc. . Prof. Knight has received personal compensation in the range of $0-$499 for serving as a Consultant for DayTwo, Ltd.. Prof. Knight has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BiomeSense, Inc. . Prof. Knight has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for GenCirq, Inc. . Prof. Knight has stock in Biota, Inc.. Prof. Knight has stock in Micronoma.
Mohammadsobhan Sheikh Andalibi, MD	Dr. Sheikh Andalibi has nothing to disclose.
Sarah L. Mangan, MBBS	Dr. Mangan has nothing to disclose.
Shameer Rafee, MBBS	Dr. Rafee has nothing to disclose.
Christopher McGuigan, MD	An immediate family member of Prof. McGuigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. McGuigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. McGuigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Prof. McGuigan has received research support from Novartis.
Justin Kinsella, MD	Dr. Kinsella has nothing to disclose.
Sara Hooshmand, MD	Dr. Hooshmand has nothing to disclose.
Alejandro A. Rabinstein, MD, FAAN	Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care.
Mill Etienne, MD, MPH, FAAN	Dr. Etienne has nothing to disclose.
Arihant Kalidindi	Mr. Kalidindi has nothing to disclose.
Rahim Hirani, MD/PhD candidate	Mr. Hirani has nothing to disclose.
Megan Darrell, BA	Miss Darrell has nothing to disclose.
Atikul Miah	Mr. Miah has nothing to disclose.
Alishah Ahmadi	Mr. Ahmadi has nothing to disclose.
Amos Baruch	Dr. Baruch has received personal compensation for serving as an employee of Calico Life Science.
Ellen Ingalla	Ellen Ingalla has received personal compensation for serving as an employee of Calico.
Matthew Rosebraugh, PhD	Dr. Rosebraugh has received personal compensation for serving as an employee of AbbVie Inc. Dr. Rosebraugh has stock in AbbVie Inc..
Yi Rang Han, PhD	Dr. Han has received personal compensation for serving as an employee of AbbVie.
Adrian Serone	Adrian Serone has received personal compensation for serving as an employee of Calico Life Sciences, LLC.
Steven Fausch	Steven Fausch has received personal compensation for serving as an employee of Abbvie. Steven Fausch has stock in Abbvie.
Jyoti Asundi	Jyoti Asundi has received personal compensation for serving as an employee of Calico Life Sciences.
Chunlian Zhang	Chunlian Zhang has nothing to disclose.
Jose Zavala-Solorio	Jose Zavala-Solorio has nothing to disclose.
Malleswari Challagundla	Malleswari Challagundla has received personal compensation for serving as an employee of AbbVie Deutschland GmbH & Co. KG. Malleswari Challagundla has stock in AbbVie Deutschland GmbH & Co. KG.
Christina Boch	Christina Boch has received personal compensation for serving as an employee of AbbVie. Christina Boch has stock in AbbVie.
Charlie Cao	Charlie Cao has received personal compensation for serving as an employee of Calico Life Sciences.
Eric Mohler	Eric Mohler has received personal compensation for serving as an employee of AbbVie. Eric Mohler has stock in AbbVie.
Carmela Sidrauski	Carmela Sidrauski has received personal compensation for serving as an employee of Calicolabs. Carmela Sidrauski has received intellectual property interests from a discovery or technology relating to health care.
Joshua Bonkowsky, MD, PhD	Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Passage Bio. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bonkowsky has stock in Orchard. The institution of Dr. Bonkowsky has received research support from NIH. The institution of Dr. Bonkowsky has received research support from ELA. An immediate family member of Dr. Bonkowsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Bonkowsky has received publishing royalties from a publication relating to health care. Dr. Bonkowsky has received publishing royalties from a publication relating to health care.
Anna Jeong, MD	Dr. Jeong has received personal compensation for serving as an employee of AbbVie. An immediate family member of Dr. Jeong has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Stryker. Dr. Jeong has stock in AbbVie.
Bill Cho, MD, PhD	Dr. Cho has received personal compensation for serving as an employee of Calico. Dr. Cho has stock in Roche.
ANU GOPATHI	ANU GOPATHI has nothing to disclose.
Yumnaa Shaheen	Ms. Shaheen has nothing to disclose.
Jane B. Allendorfer, PhD	The institution of Dr. Allendorfer has received research support from National Institutes of Health. The institution of Dr. Allendorfer has received research support from Evelyn F. McKnight Brain Institute. The institution of Dr. Allendorfer has received research support from LivaNova, Inc. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Cleveland Clinic. Dr. Allendorfer has received personal compensation in the range of $0-$499 for serving as a Examiner with University of Auckland. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International League Against Epilepsy. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Department of Defense. Dr. Allendorfer has a non-compensated relationship as a Scientific Program Committee Member with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Allendorfer has a non-compensated relationship as a Editorial Board Member with Epilepsy and Behavior Reports that is relevant to AAN interests or activities.
Jerzy P. Szaflarski, MD, PhD, FAAN	Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.
Lawrence W. Ver Hoef, MD	Dr. Ver Hoef has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Bowling & Christiansen. The institution of Dr. Ver Hoef has received research support from NIH. The institution of Dr. Ver Hoef has received research support from AES.
Brandon Mitchell, BS	Mr. Mitchell has nothing to disclose.
Adam M. Goodman, PhD	Dr. Goodman has nothing to disclose.
Roy C. Martin, PhD	Prof. Martin has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elseiver Publishers. The institution of Prof. Martin has received research support from NIH.
Charity J. Morgan, PhD	Dr. Morgan has nothing to disclose.
Jakaiya S. Bryant	Miss Bryant has nothing to disclose.
Yun Lien, MSc	Miss Lien has nothing to disclose.
Jennifer B. Pilkington	Mrs. Pilkington has nothing to disclose.
Anna Moyana, GR, CERT -CNIN	Mrs. Moyana has nothing to disclose.
yang zhao, PhD	Dr. zhao has received personal compensation for serving as an employee of Axsome. Dr. zhao has stock in Axsome.
Amanda Erbe	Ms. Erbe has received personal compensation for serving as an employee of RTI Health Solutions.
Andrew M. Blumenfeld, MD, FAAN	Dr. Blumenfeld has received personal compensation for serving as an employee of The Los Angeles Headache Center. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctors. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GLG. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revance. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Axsome. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cedar Sinai. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AXSOME.
Stephanie J. Nahas, MD, FAAN	Dr. Nahas has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for AbbVie. Dr. Nahas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Nahas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Nahas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Nahas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Nahas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch Health. Dr. Nahas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Nahas has received publishing royalties from a publication relating to health care. Dr. Nahas has received publishing royalties from a publication relating to health care. Dr. Nahas has received personal compensation in the range of $500-$4,999 for serving as a expert for CME activities with Medscape/WebMD. Dr. Nahas has a non-compensated relationship as a Board Member-at-Large with American Headache Society that is relevant to AAN interests or activities. Dr. Nahas has a non-compensated relationship as a Executive Board Member with The Headache Alliance that is relevant to AAN interests or activities.
Christopher Graham, MS	Mr. Graham has nothing to disclose.
Valentina Perosa, MD	Dr. Perosa has nothing to disclose.
Suzete N. Farias Da Guarda, MD, PhD	Prof. Farias Da Guarda has nothing to disclose.
Steven M. Greenberg, MD, PhD, FAAN	Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squib. The institution of Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Greenberg has received research support from National Institutes of Health. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Anand Viswanathan, MD	Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam Pharmaceuticals. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals.
Thijs W. van Harten, PhD	Dr. van Harten has nothing to disclose.
Kali vom Eigen, BA	Ms. vom Eigen has nothing to disclose.
Susanne J. van Veluw, PhD	Dr. van Veluw has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. The institution of Dr. van Veluw has received research support from NIH. The institution of Dr. van Veluw has received research support from Sanofi. The institution of Dr. van Veluw has received research support from Leducq Foundation. The institution of Dr. van Veluw has received research support from American Heart Association. The institution of Dr. van Veluw has received research support from Frechette Family Foundation. The institution of Dr. van Veluw has received research support from BrightFocus Foundation. The institution of Dr. van Veluw has received research support from Therini Bio.
Corinne Auger	Ms. Auger has nothing to disclose.
Amelia K. Adcock, MD	The institution of an immediate family member of Dr. Adcock has received research support from NIH.
Scott Findley, MD	The institution of Dr. Findley has received research support from Health and Resource Services Administration.
Reagan Curtis, PhD	Prof. Curtis has nothing to disclose.
Sivani Lingam, MBBS	Dr. Lingam has nothing to disclose.
Akshaya Prabhakaran Sudha, MBBS	Dr. Prabhakaran Sudha has nothing to disclose.
William W. Liu, MD	Mr. Liu has nothing to disclose.
Vishal Shah, MBBS	Dr. Shah has nothing to disclose.
Jennifer Cheng, MD	Jennifer Cheng, MD has nothing to disclose.
Kelly Dahlstrom, DO	Dr. Dahlstrom has nothing to disclose.
Michael G. Abraham, MD	Dr. Abraham has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stryker Neurovascular.
Patrick Landazuri, MD, FAAN	Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuropace. Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuropace. Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Federal Public Defender - District of Kansas. Dr. Landazuri has received publishing royalties from a publication relating to health care.
Shruti Karnani, BS	Ms. Karnani has nothing to disclose.
Matthew Feldman, MD	Dr. Feldman has nothing to disclose.
Taylor Peabody, MD	Dr. Peabody has nothing to disclose.
Victor D. Armengol, MD	Dr. Armengol has nothing to disclose.
Jason H. Margolesky, MD, FAAN	Dr. Margolesky has nothing to disclose.
Paul Partyka, DO, PhD	Dr. Partyka has nothing to disclose.
Yakov Isakov, DO	Dr. Isakov has nothing to disclose.
Paul Wright, MD, FAAN	Dr. Wright has nothing to disclose.
Caleigh S. Roach	Miss Roach has nothing to disclose.
Matthew A. Kis, BS	Mr. Kis has nothing to disclose.
Mikhail Marasigan	Mr. Marasigan has nothing to disclose.
Eugenio Reina	Mr. Reina has nothing to disclose.
Harini Adivikolanu	Ms. Adivikolanu has received personal compensation for serving as an employee of RegenMed LLC.
Brett Weiss	Mr. Weiss has nothing to disclose.
Ansh J. Bhatt, MD/MBA Student	Mr. Bhatt has nothing to disclose.
Jacob J. Shawwa	Mr. Shawwa has nothing to disclose.
Alan Ho, BA	Mr. Ho has received personal compensation for serving as an employee of Neurobit Innovations.
Joyce Kaufman, MD	Dr. Kaufman has nothing to disclose.
Andres Nascimento Osorio	Andres Nascimento Osorio has nothing to disclose.
Yuanjun Ma, PhD	Ms. Ma has nothing to disclose.
Nada Boudiaf	Mrs. Boudiaf has nothing to disclose.
Richard K. Kim, MD	Dr. Kim has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for RKK Consulting, Inc..
Susan Vanmeter, MD	Dr. Vanmeter has received personal compensation for serving as an employee of UCB. Dr. Vanmeter has stock in UCB.
Marcus Brunnert	Mr. Brunnert has received personal compensation for serving as an employee of UCB Biosciences GmbH. Mr. Brunnert has stock in Amgen.
Cristina Dominguez, MD, PhD	Dr. dominguez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Dr. dominguez has received research support from UCB.
Bashar Katirji, MD, FAAN	Dr. Katirji has nothing to disclose.
Persen Sukpornchairak, MD	Dr. Sukpornchairak has nothing to disclose.
Abdalmalik Bin Khunayfir, MD	Dr. Bin Khunayfir has nothing to disclose.
Eric J. Seachrist, MD	Dr. Seachrist has or had stock in Medtronic.Dr. Seachrist has or had stock in Pfizer. The institution of Dr. Seachrist has received research support from Bristol Myers Squibb. Dr. Seachrist has a non-compensated relationship as a Topic Group, QOD Committee, and Wellness Program Committee with ��ɫ�� that is relevant to AAN interests or activities.
Anika Zahoor, MD, MBBS	Dr. Zahoor has nothing to disclose.
Abdul R. Tarabishy, MD	Dr. Tarabishy has nothing to disclose.
Subtain Ali, MD	Dr. Ali has nothing to disclose.
Juvairia Yousuf	Miss Yousuf has nothing to disclose.
Baneen Fatima, MBBS	Miss Fatima has nothing to disclose.
Simra F. Hasan, MBBS	Miss Hasan has nothing to disclose.
Iqra I. Bhojani, MBBS	Dr. Bhojani has nothing to disclose.
Anabia N. Hasan, Jr., MBBS	Miss Hasan has nothing to disclose.
Abdul Hannan Siddiqui, MBBS	Dr. Siddiqui has nothing to disclose.
Barkah Ali, MBBS	Dr. Ali has nothing to disclose.
Abdul Moeed, MBBS	Dr. Moeed has nothing to disclose.
Muhammad Ahmed	Mr. Ahmed has nothing to disclose.
Faris Fayyaz, MBBS	Mr. Fayyaz has nothing to disclose.
Tonke van Bragt, MSc	The institution of Mrs. van Bragt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Mrs. van Bragt has stock in argenx.
Christa Kneip, PhD	Dr. Kneip has received personal compensation for serving as an employee of argenx.
Sofie Priem	No disclosure on file
Xinghong Leng	Dr. Leng has received personal compensation for serving as an employee of argenx. Dr. Leng has stock in argenx.
Rachelle D. Mutch, MD	Dr. Mutch has nothing to disclose.
Sonya Patel, MD	Dr. Patel has nothing to disclose.
Peter Vanhoenacker, PhD	Dr. Vanhoenacker has received personal compensation for serving as an employee of argenx. Dr. Vanhoenacker has stock in argenx.
Cristina Vaghi, PhD	Dr. Vaghi has received personal compensation for serving as an employee of argenx.
Rebecca Shilling	Rebecca Shilling has received personal compensation for serving as an employee of argenx pharmaceuticals. Rebecca Shilling has stock in argenx pharmaceuticals. Rebecca Shilling has received intellectual property interests from a discovery or technology relating to health care.
Roeland Vanhauwaert, PhD	Mr. Vanhauwaert has stock in argenx.
Anjana Lalla	Anjana Lalla has nothing to disclose.
Pranav Gandhi	Pranav Gandhi has received personal compensation for serving as an employee of AbbVie. Pranav Gandhi has stock in AbbVie Inc.
Karen Carr, PhD	Dr. Carr has nothing to disclose.
Brett Dabruzzo, PharmD	Dr. Dabruzzo has received personal compensation for serving as an employee of AbbVie. Dr. Dabruzzo has stock in AbbVie.
Rashmi B. Halker Singh, MD, FAAN	Dr. Halker Singh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Halker Singh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Halker Singh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Halker Singh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Neurology & Neuroscience Reports. Dr. Halker Singh has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache Journal. Dr. Halker Singh has received publishing royalties from a publication relating to health care. Dr. Halker Singh has received personal compensation in the range of $5,000-$9,999 for serving as a CME speaker with Pri-med. Dr. Halker Singh has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Medscape.
David Hernan Posas, BS	Mr. Posas has nothing to disclose.
José H. Posas, MD, FAAN	Dr. Posas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Posas has or had stock in Dane Health.Dr. Posas has or had stock in Brainscope.Dr. Posas has a non-compensated relationship as a Advisor with Dane Health that is relevant to AAN interests or activities. Dr. Posas has a non-compensated relationship as a Lecturer with Concussion Corner Academy that is relevant to AAN interests or activities. Dr. Posas has a non-compensated relationship as a Advisor with Brainscope that is relevant to AAN interests or activities.
Brandon Yee	Brandon Yee has received personal compensation for serving as an employee of Labcorp. Brandon Yee has stock in Lacborp.
Youssouf Badal	Youssouf Badal has nothing to disclose.
Ahmed Chenna, PhD	Dr. Chenna has received personal compensation for serving as an employee of LabCorp-monogram Biosciences. Dr. Chenna has or had stock in LabCorp.
Christos J. Petropoulos, PhD	Dr. Petropoulos has received personal compensation for serving as an employee of Labcorp-Monogram Biosciences. Dr. Petropoulos has stock in Laboratory Corporation of America Holdings. Dr. Petropoulos has received intellectual property interests from a discovery or technology relating to health care.
Camila Narvaez Caicedo, MD	Dr. Narvaez Caicedo has nothing to disclose.
Xiang Fang, MD, PhD, FAAN	Dr. Fang has nothing to disclose.
Sylvia Jimenez	Ms. Jimenez has nothing to disclose.
Xiangping Li, MD, FAAN	Dr. Li has nothing to disclose.
Devanshi Choksi, MD, MPH	Dr. Choksi has nothing to disclose.
Mary Craven	Ms. Craven has nothing to disclose.
Taylor McVeigh	Taylor McVeigh has nothing to disclose.
Akashleena Mallick, MD, MBBS	Dr. Mallick has nothing to disclose.
Tanzeela Ranman	Ms. Ranman has nothing to disclose.
Christina Kourkoulis	No disclosure on file
Samantha Mora	Samantha Mora has nothing to disclose.
Jonathan Rosand, MD	Dr. Rosand has received personal compensation for serving as an employee of Massachusetts General Hospital. Dr. Rosand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Rosand has received research support from NIH. The institution of Dr. Rosand has received research support from American Heart Association. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as a Peer reviewer with National Institutes of Health. Dr. Rosand has a non-compensated relationship as a Trustee with Columbia University that is relevant to AAN interests or activities.
Nirupama Yechoor, MD	Dr. Yechoor has nothing to disclose.
Yuvraj Bhagat, MD	Dr. Bhagat has nothing to disclose.
Rachel D. Feldstein, MD	Ms. Feldstein has nothing to disclose.
Maysaa M. Basha, MD, FAAN	Dr. Basha has nothing to disclose.
Jack Grazi, MD	Dr. Grazi has nothing to disclose.
Susan W. Law, DO	Dr. Law has nothing to disclose.
James Soh, MD, PhD	Dr. Soh has nothing to disclose.
Derrek Kang, MD	Dr. Kang has nothing to disclose.
Anna Huang, MPH	Ms. Huang has nothing to disclose.
Aaron Jenkins	Aaron Jenkins has received personal compensation for serving as an employee of Pfizer Ltd. Aaron Jenkins has stock in Pfizer Ltd.
Jo Atkinson, MBChB	Dr. Atkinson has received personal compensation for serving as an employee of Pfizer Ltd. Dr. Atkinson has stock in Pfizer Inc.
Carl H. Henriksen, Jr., MS	Mr. Henriksen has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Pfizer, Inc. Mr. Henriksen has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Emory University. Mr. Henriksen has received personal compensation in the range of $50,000-$99,999 for serving as a Data Analyst with University of Florida.
Martin Ho	Mr. Ho has nothing to disclose.
Motomori Lewis	Motomori Lewis has received personal compensation for serving as an employee of Pfizer.
Darshana Vijaywargiya, MBBS	Dr. Vijaywargiya has nothing to disclose.
Ai Sakonju, MD	Dr. Sakonju has nothing to disclose.
Nienke P. Dosa, MD	Dr. Dosa has nothing to disclose.
Karminder Singh, MD	Dr. Singh has nothing to disclose.
David M. Simpson, MD, FAAN	Dr. Simpson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Simpson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz.
Shaida Omid, MD	Dr. Omid has nothing to disclose.
Giulia S. Porcari, MD	The institution of Dr. Porcari has received research support from NIH/NINDS (T32 - NS-061779).
Arastoo Vossough, MD	Dr. Vossough has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Syneos Health. Dr. Vossough has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for DeepSight. Dr. Vossough has received publishing royalties from a publication relating to health care.
Mix Wannasarnmetha, MD	Dr. Wannasarnmetha has nothing to disclose.
Jonathon Chon Teng Chio, PhD	Dr. Chio has nothing to disclose.
Eleftheria Vyras, MBBS	Dr. Vyras has nothing to disclose.
Grant Hansen, MD	Grant Hansen, MD has nothing to disclose.
Elizabeth Crabtree-Hartman, MD	Dr. Crabtree-Hartman has nothing to disclose.
Nina Blum	Miss Blum has nothing to disclose.
Logan D. Schneider, MD	Dr. Schneider has received personal compensation for serving as an employee of Alphabet, Inc. Dr. Schneider has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avadel Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Axsome. Dr. Schneider has received intellectual property interests from a discovery or technology relating to health care.
Deborah Nichols, MS	No disclosure on file
Teresa Steininger	Teresa Steininger has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Teresa Steininger has stock in Jazz Pharmaceuticals.
Douglas S. Fuller	Mr. Fuller has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Mr. Fuller has stock in Jazz Pharmaceuticals.
Todd Kirby, PhD	Dr. Kirby has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Kirby has stock in Jazz Pharmaceuticals.
Sarah Akerman, MD	Dr. Akerman has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Akerman has stock in Jazz Pharmaceuticals.
Jessica K. Alexander, PhD	Jessica K. Alexander has received personal compensation for serving as an employee of Teva Pharmaceuticals. Jessica K. Alexander has received stock or an ownership interest from Teva Pharmaceuticals.
Alyssa Cairns, PhD	Dr. Cairns has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Cairns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals.
Cassandra DeMarshall, PhD	Dr. DeMarshall has received personal compensation for serving as an employee of Durin Life Sciences.
Jeffrey Viviano, PhD	Dr. Viviano has received personal compensation for serving as an employee of Durin Technolofies.
Anuradha Krishnan, PhD	Dr. Krishnan has nothing to disclose.
Dennis Hutchison, JD	Mr. Hutchison has nothing to disclose.
Mert Sahin, PhD	Dr. Sahin has received personal compensation for serving as an employee of Durin Technologies.
Robert G. Nagele, PhD	Dr. Nagele has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Durin Life Sciences. Dr. Nagele has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Durin Life Sciences. Dr. Nagele has stock in Durin Life Sciences.
Shadi Shams	Dr. Shams has nothing to disclose.
Jennifer H. Yang, MD	Dr. Yang has received research support from Pediatric Epilepsy Research Foundation. Dr. Yang has received research support from NIH.
Shahad Olsson, CGC	Mrs. Olsson has nothing to disclose.
Sophia Ceulemans, MS, CGC	Ms. Ceulemans has a non-compensated relationship as a Member of Professional Advisory Board with Epilepsy Foundation of San Diego that is relevant to AAN interests or activities.
Lucia Guidugli, PhD	Dr. Guidugli has nothing to disclose.
Diana Alzate, LCGC	Ms. Alzate has nothing to disclose.
Brian Sacks, DO	Dr. Sacks has nothing to disclose.
Harry Zobel, Jr., DO	Dr. Zobel has nothing to disclose.
Dmitry Khaitov, MD	Dr. Khaitov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Irving Fuentes	Mr. Fuentes has nothing to disclose.
Jimena Gonzalez Salido, MD	Miss Gonzalez Salido has nothing to disclose.
Jimena Colado, MD	Dr. Colado has nothing to disclose.
Fernando Vasquez Lopez, MD	Dr. Vasquez Lopez has nothing to disclose.
Betsy C. Vazquez, MD	Dr. Vazquez has nothing to disclose.
Luis A. Marin-Castañeda, Sr.	Mr. Marin-Castañeda has nothing to disclose.
Mijail A. Rivas, Sr., MD	Dr. Rivas has nothing to disclose.
Eithel A. Valenzuela Mendivil	Eithel A. Valenzuela Mendivil has nothing to disclose.
Salvador Martinez-Medina, MD	Dr. Martinez-Medina has nothing to disclose.
Mario Sebastian-Diaz, MD, PhD	Dr. Sebastian-Diaz has nothing to disclose.
Iris E. Martinez-Juarez, MD	No disclosure on file
Stefanía Forero Caldas, MD	Dr. Forero Caldas has nothing to disclose.
Annelise Pereira	Mrs. Pereira has nothing to disclose.
Juan D. Martinez Lemus, MD	Dr. Martinez Lemus has nothing to disclose.
Mariana Medina, Sr., MD	Dr. Medina has nothing to disclose.
Juana V. Navarro, MD	Dr. Navarro has nothing to disclose.
Yula A. Ponguta Merchan	Mrs. Ponguta has nothing to disclose.
Neiry Maria Zapa Pérez	Ms. Zapa Pérez has nothing to disclose.
Delia S. Giraldo Peñuela, MD	Dr. Giraldo Peñuela has nothing to disclose.
Hernan Bayona, MD	Dr. Bayona has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Aventis. Dr. Bayona has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer-Ingelheim. Dr. Bayona has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer SA. Dr. Bayona has received publishing royalties from a publication relating to health care.
Claudio A. Monsalve, MD	Mr. Monsalve has nothing to disclose.
Felicia Chow, MD	Dr. Chow has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Medicolegal consulting. The institution of Dr. Chow has received research support from NIH.
Arantxa N. Sanchez Boluarte, MD, MPH	Dr. Sanchez Boluarte has received research support from NIH Fogarty International Center .
Meg Wilson	No disclosure on file
Elana Farrell, BA	Ms. Farrell has nothing to disclose.
Soonmee Cha, MD	Dr. Cha has nothing to disclose.
Jasleen K. Bains, Undergraduate Student	Miss Bains has nothing to disclose.
Amanda Currie, MD	Dr. Currie has nothing to disclose.
Patricia Jokl Graese, MD	Dr. Graese has nothing to disclose.
Adolfo Ramirez Zamora, MD	Dr. Ramirez Zamora has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Ramirez Zamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel therapeutics. Dr. Ramirez Zamora has received personal compensation in the range of $0-$499 for serving as a Consultant for NeuroPacs. Dr. Ramirez Zamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Ramirez Zamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iota Inc. Dr. Ramirez Zamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maplight. Dr. Ramirez Zamora has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. The institution of Dr. Ramirez Zamora has received research support from Parkinsons Foundation.
Edwina abou haidar, MBBS, MS	Dr. abou haidar has nothing to disclose.
Xandra O. Breakefield, PhD	Dr. Breakefield has nothing to disclose.
Shilpa Prabhakar, MSc	Ms. Prabhakar has nothing to disclose.
Tomeh Tomeh, MD	Mr. Tomeh has nothing to disclose.
Vijaya Ramesh, PhD	Dr. Ramesh has nothing to disclose.
Roberta Beauchamp, BA	Ms. Beauchamp has nothing to disclose.
Koen Breyne, PhD	Dr. Breyne has nothing to disclose.
Ivan Coto Hernandez, PhD	Dr. Coto Hernandez has nothing to disclose.
Ryan Naum, DO	Dr. Naum has nothing to disclose.
Jonathan Morena, DO	The institution of Dr. Morena has received research support from Grifols.
Fernando D. Testai, MD, PhD, FAAN	Dr. Testai has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Testai has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Livingston, Barger, Brandt & Schroeder, L.L.P.. Dr. Testai has received publishing royalties from a publication relating to health care.
Gabriela Trifan, MD	Dr. Trifan has nothing to disclose.
Nidhal Siddig, MD	Dr. Siddig has nothing to disclose.
Lucia LeBlanc Perez	Ms. LeBlanc Perez has nothing to disclose.
Andreas Straube	Andreas Straube has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Andreas Straube has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Andreas Straube has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis.
Gregor Broessner	Gregor Broessner has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Gregor Broessner has received personal compensation in the range of $0-$499 for serving as a Consultant for TEVA. Gregor Broessner has received personal compensation in the range of $0-$499 for serving as a Consultant for Lilly. Gregor Broessner has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Gregor Broessner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Gregor Broessner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly.
Charly Gaul	The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of an immediate family member of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vectura. The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Charly Gaul has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz. The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dr. Reddy. Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Perfood. Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reckitt-Benckiser . The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Hormosan. The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chordate. The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Dr. Reddy. The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie.
Xenia Hamann	Xenia Hamann has received personal compensation for serving as an employee of Teva GmbH.
Torsten Kraya, MD	Dr. Kraya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA, Novartis, Lilly. Dr. Kraya has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA, Novartis, Lilly, Hormosan, Abbvie.
Lars Oliver Neeb	No disclosure on file
Hannah Kopinsky, MD	Dr. Kopinsky has nothing to disclose.
Ilya Kister, MD, FAAN	Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Angie H. Kim	Ms. Kim has nothing to disclose.
Gregg J. Silverman	No disclosure on file
Abhimanyu Amarnani, MD, PhD	Dr. Amarnani has nothing to disclose.
Arnaldo A. Arbini, MD	Dr. Arbini has nothing to disclose.
David Fenyo, PhD	Dr. Fenyo has nothing to disclose.
Eshita Sharma	Miss Sharma has nothing to disclose.
Mrinal M. Murali Krishna, MBBS	Dr. Murali Krishna has nothing to disclose.
Meghna Joseph, MBBS	Dr. Joseph has nothing to disclose.
Vinicius Pereira, MD	Mr. Pereira has nothing to disclose.
Chidubem Ezenna, MD	Dr. Ezenna has nothing to disclose.
Julyana M. Dantas, MD	Dr. Dantas has nothing to disclose.
Mithun M. Krishna, MD, MBBS	Dr. Krishna has nothing to disclose.
Isaac Yang, MD	Dr. Yang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Baxter. The institution of Dr. Yang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainlab. Dr. Yang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Dr. Yang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Yang has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Isaac Yang MD. Dr. Yang has received research support from Acoustic Neuroma Association. Dr. Yang has received publishing royalties from a publication relating to health care.
Giulia Giacomucci, MD	Ms. Giacomucci has nothing to disclose.
Silvia Bagnoli, PhD	Dr. bagnoli has nothing to disclose.
Assunta Ingannato, PhD	Miss Ingannato has nothing to disclose.
Chiara Crucitti, MD	Dr. Crucitti has nothing to disclose.
Sonia Padiglioni, PhD	Dr. Padiglioni has nothing to disclose.
Valentina Moschini, Psy	Dr. Moschini has nothing to disclose.
Carmen Morinelli	Miss Morinelli has nothing to disclose.
Salvatore Mazzeo	Mr. Mazzeo has nothing to disclose.
Sandro Sorbi	Sandro Sorbi has nothing to disclose.
Benedetta Nacmias	Benedetta Nacmias has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Valentina Bessi, Sr., MD	Prof. Bessi has nothing to disclose.
Hoor Ul Ain	Hoor Ul Ain has nothing to disclose.
Waleed Tariq, MBBS	Mr. Tariq has nothing to disclose.
Neha Waseem, MBBS	Ms. Waseem has nothing to disclose.
Muhammad U. Khan, MD, MBBS	Dr. KHAN has nothing to disclose.
Mohammad Munim Zahoor, MD	Mr. Zahoor has nothing to disclose.
Sophia Ahmed, MBBS	Miss Ahmed has nothing to disclose.
Shahzaib Ahmed	Shahzaib Ahmed has nothing to disclose.
Eeman Ahmad	Eeman Ahmad has nothing to disclose.
Philip Harvey, PhD	Prof. Harvey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alkermes. Prof. Harvey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer-Ingelheim. Prof. Harvey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Karuna Therapeutics. Prof. Harvey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Minerva Neurosciences. Prof. Harvey has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Prof. Harvey has received intellectual property interests from a discovery or technology relating to health care. Prof. Harvey has received intellectual property interests from a discovery or technology relating to health care.
Carl I. Schulman, MD, PhD	Dr. Schulman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for PMI. Dr. Schulman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zoll. Dr. Schulman has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Williams Hart & Boundas, LLP . Dr. Schulman has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MASE SEITZ BRIGGS. Dr. Schulman has received intellectual property interests from a discovery or technology relating to health care.
hadia ahmad, MBBS	Miss ahmad has nothing to disclose.
Mohammad Ammar Ur Rahman, MBBS	Dr. Ammar Ur Rahman has nothing to disclose.
Filza Waqar, MBBS	Miss Waqar has nothing to disclose.
Luqman Munir	Mr. Munir has nothing to disclose.
Sarah N. Glisan, DO	Ms. Glisan has nothing to disclose.
Preet M. Varade, MD	Dr. Varade has nothing to disclose.
Bilal Darwish, DO	Dr. Darwish has nothing to disclose.
Sridhar Narayan, PhD	Dr. Narayan has received personal compensation for serving as an employee of ReviR Therapeutics.
Mary McMahon, PhD	Dr. McMahon has received personal compensation for serving as an employee of ReviR Therapeutics .
Jawad Abid	Mr. Abid has nothing to disclose.
Shilin Chen	No disclosure on file
Jiacheng Zhang, PhD	Dr. Zhang has nothing to disclose.
Kendra Lew	No disclosure on file
Jacqueline Salotti, PhD	Dr. Salotti has received personal compensation for serving as an employee of ReviR Therapeutics.
Xing Tang	No disclosure on file
Steve Lianoglou, PhD	Mr. Lianoglou has received personal compensation for serving as an employee of ReviR Therapeutics.
Jinxing Li, PhD	Dr. Li has nothing to disclose.
Yang Liu	No disclosure on file
Paul R. August, PhD	Dr. August has received personal compensation for serving as an employee of ReviR Therapeutics. Dr. August has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Charcot Marie Tooth Research Foundation. Dr. August has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for AcuraStem. Dr. August has stock in Acurastem. Dr. August has stock in ReviR Therapeutics. The institution of Dr. August has received research support from CMTRF.
Grainne Mulkerrin, MB BCh BAO MSc	Dr. Mulkerrin has nothing to disclose.
Patrick W. Cullinane, MBBS	No disclosure on file
Alan Beausang, MD	Dr. Beausang has nothing to disclose.
Sean O'Riordan, MD	Dr. O'Riordan has nothing to disclose.
Chloe Villars	Ms. Villars has nothing to disclose.
Victoria Stewart, MS2	Mrs. Stewart has nothing to disclose.
Gianna M. Fote	Ms. Fote has nothing to disclose.
Joffre Olaya, MD	The institution of Dr. Olaya has received research support from NIH.
Raymond Wang, MD	Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zevra Therapeutics. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Denali Therapeutics. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Green Cross Therapeutics. Dr. Wang has stock in Biomarin Pharmaceuticals. The institution of Dr. Wang has received research support from Biomarin Pharmaceuticals.
Taoufik Alsaadi, MD, FAAN	Dr. Alsaadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Alsaadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Alsaadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Alsaadi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Alsaadi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer. Dr. Alsaadi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GSK. The institution of Dr. Alsaadi has received research support from Novartis. The institution of Dr. Alsaadi has received research support from Abbvie. The institution of Dr. Alsaadi has received research support from Pfizer.
Reem Suliman	Ms. Suliman has nothing to disclose.
Jerry Yang	Jerry Yang has received personal compensation for serving as an employee of Pfizer Inc. Jerry Yang has stock in Pfizer Inc.
Ekta Agarwal, MPH, BHMS	Ms. Agarwal has received personal compensation for serving as an employee of Pfizer. Ms. Agarwal has stock in Pfizer Inc..
Terence Fullerton, PharmD	Dr. Fullerton has received personal compensation for serving as an employee of Pfizer. Dr. Fullerton has stock in Pfizer.
Denise E. Chou, MD	Dr. Chou has received personal compensation for serving as an employee of Pfizer. Dr. Chou has received personal compensation for serving as an employee of Amgen. Dr. Chou has stock in Pfizer. Dr. Chou has stock in Amgen.
Ed Whalen	Ed Whalen has received personal compensation for serving as an employee of Pfizer. Ed Whalen has stock in Pfizer.
CALINE Y. EL JADAM, MD	Dr. EL JADAM has nothing to disclose.
Ibrahim Al Qaisi, PharmD	Dr. Al Qaisi has nothing to disclose.
Youssef Amin	Mr. Amin has nothing to disclose.
Athra A. Alkhateri, Clinical research coordinator	Miss Alkhateri has nothing to disclose.
Kareem W. Alsaffarini, MBBS	Dr. Alsaffarini has nothing to disclose.
Zahra Zunaed, PharmD	Dr. Zunaed has received personal compensation for serving as an employee of Pfizer Inc..
Haytham Mohamed, Bsc , CMD	Mr. Mohamed has received personal compensation for serving as an employee of Pfizer .
Mohamed Fathy, MD	Dr. Fathy has received personal compensation for serving as an employee of Pfizer Gulf. Dr. Fathy has stock in Pfizer. Dr. Fathy has stock in Pfizer.
Mohamed F. Hegab, Sr., Medical Science Liaison	Mr. Hegab has received personal compensation for serving as an employee of Pfizer.
Nora Vainstein, MD	Dr. Vainstein has nothing to disclose.
Mahsa Mohajery, MD	Dr. Mohajery has nothing to disclose.
Saud Sadiq, BS, FAAN	Ms. Brewi has nothing to disclose.
Olimpia Carbunar, MD	The institution of Dr. Carbunar has received research support from National Institute of Arthritis and Musculoskeletal and Skin Diseases. The institution of Dr. Carbunar has received research support from ARGENX/PPD.
Andrea Zhang, MD	Dr. Zhang has nothing to disclose.
Kole Sedlack, MD	Dr. Sedlack has nothing to disclose.
Lina Nguyen	Lina Nguyen has nothing to disclose.
Nicole Nishimori	Ms. Nishimori has nothing to disclose.
Benjamin Vogel	Benjamin Vogel has nothing to disclose.
Natalie Boyd	Natalie Boyd has nothing to disclose.
Lilia Kazerooni, BS	Miss Kazerooni has nothing to disclose.
Shermila Pia, MD	Dr. Pia has nothing to disclose.
Mellad Khoshnood, MD	Dr. Khoshnood has nothing to disclose.
Saba Jafarpour, MD	Dr. Jafarpour has nothing to disclose.
Jonathan Santoro, MD	Dr. Santoro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Santoro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cycle Pharma. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Down Syndrome Society.
Michael Grunstein, DO	Dr. Grunstein has nothing to disclose.
Anthony Di Caro, DO	Dr. Di Caro has nothing to disclose.
Cristina Fernandez-Carbonell, MD	Dr. Fernandez-Carbonell has nothing to disclose.
Samir Alkabie, MD, MSc	Dr. Alkabie has nothing to disclose.
Asaff Harel, MD	Dr. Harel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Harel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Harel has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Expert Institute.
Tyler Heinrich, DO	Dr. Heinrich has nothing to disclose.
Vishal Pandya, MD	Dr. Pandya has nothing to disclose.
Carlos A. Rodríguez Alarcón, MD	Dr. Rodríguez Alarcón has nothing to disclose.
Alejandro Benavides	Mr. Benavides has nothing to disclose.
Ricardo Murguia Fuentes, MD	Dr. Murguia Fuentes has nothing to disclose.
Danny J. Japon	Mr. Japon has nothing to disclose.
Luis Yepez	Luis Yepez has nothing to disclose.
Maria de Los Angeles Alvarez Falcon	Ms. Alvarez Falcon has nothing to disclose.
Mateo R. Haro-Vallazza, MD	Dr. Haro-Vallazza has nothing to disclose.
Kai M. Jimenez, Sr., MD	Mr. Jimenez has nothing to disclose.
Zahra Kolahchi, MD	Dr. Kolahchi has nothing to disclose.
Kunal V. Desai, MD	Dr. Desai has nothing to disclose.
Liam Townley, MD	Dr. Townley has nothing to disclose.
Samantha DiSalvo, MD	Dr. DiSalvo has nothing to disclose.
Anna Sosa	Anna Sosa has nothing to disclose.
Ruben Jauregui, MD	Dr. Jauregui has nothing to disclose.
Ugo Nwigwe	Mr. Nwigwe has nothing to disclose.
Kimberly O'Neill, MD	Dr. O'Neill has nothing to disclose.
Rachel Kenney	Rachel Kenney has received personal compensation for serving as an employee of Optum. Rachel Kenney has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Minton ��ɫ�� LLC.
Lauren B. Krupp, MD, FAAN	Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care.
Steven Galetta, MD, FAAN	Dr. Galetta has nothing to disclose.
Scott Grossman, MD	Dr. Grossman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acuta Pharmaceuticals.
Muhammad Fawad Tahir, MBBS	Dr. Fawad Tahir has nothing to disclose.
Hassan Waseem	Hassan Waseem has nothing to disclose.
Zain U. Abideen, MBBS	Dr. Abideen has nothing to disclose.
Sania Aimen, MBBS	Dr. Aimen has nothing to disclose.
Khadija Ahmed, MBBS	Dr. Ahmed has nothing to disclose.
Maimoona Khan, MBBS	Ms. Khan has nothing to disclose.
Sami Ullah Khan, MBBS	Dr. Khan has nothing to disclose.
Muhammad Ahmed Ayaz, MBBS	Dr. Ayaz has nothing to disclose.
Simon Laganiere, MD	Dr. Laganiere has nothing to disclose.
Anastasia Barnes, MD	Dr. Barnes has nothing to disclose.
Muhammad Sohaib Khan	Mr. Khan has nothing to disclose.
Muhammad Jansher, MBBS	Mr. Jansher has nothing to disclose.
Wania Moeen	Dr. Moeen has nothing to disclose.
Muzamil Khan, MBBS	Dr. Khan has nothing to disclose.
Waseem Nabi, MD	Dr. Nabi has nothing to disclose.
Maryam Inam Zaroo, MBBS	Dr. Zaroo has nothing to disclose.
Mohammad Danish, MBBS	Mr. Danish has nothing to disclose.
Reyan Hussain Shaikh, MBBS	Mr. Shaikh has nothing to disclose.
Wajeeh A. Khan	Dr. Khan has nothing to disclose.
Fariha Shariq, MBBS	Dr. Shariq has nothing to disclose.
Sakshi Roy, MBBS	Miss Roy has nothing to disclose.
Jiri Aubrecht, PhD, PharmD	Dr. Aubrecht has received personal compensation for serving as an employee of Prothena Biosciences. Dr. Aubrecht has stock in Pfizer. Dr. Aubrecht has stock in Prothena. Dr. Aubrecht has stock in Eli Lilli.
Karen J. Quadrini, PhD	Ms. Quadrini has received personal compensation for serving as an employee of Prothena Biosciences. Ms. Quadrini has stock in Prothena Biosciences.
Ann D. Johnson, MS	Mrs. Johnson has received personal compensation for serving as an employee of Prothena Biosciences.
Ryan Tooker, PhD	Dr. Tooker has received personal compensation for serving as an employee of Prothena Biosciences Inc. Dr. Tooker has stock in Prothena Biosciences Inc.
Mary E. Quiceno, MD, FAAN	Dr. Quiceno has received personal compensation for serving as an employee of Prothena Biosciences. Dr. Quiceno has received personal compensation for serving as an employee of Johnson & Johnson. Dr. Quiceno has stock in Prothena Biosciences. Dr. Quiceno has stock in Johnson & Johnson.
Kevin Dougherty	Mr. Dougherty has received personal compensation for serving as an employee of Prothena Biosciences. Mr. Dougherty has stock in Prothena Biosciences.
Courtney Fitzgerald	Ms. Fitzgerald has nothing to disclose.
Chad Swanson, PhD	Dr. Swanson has stock in Prothena Biosciences. Dr. Swanson has received personal compensation in the range of $500-$4,999 for serving as a Grant Application Scientific Reviewer with Weston Family Foundation.
Brian Campbell	Dr. Campbell has received personal compensation for serving as an employee of Prothena Biosciences. Dr. Campbell has received personal compensation in the range of $0-$499 for serving as a Consultant for Mindimmune Therapeutics. Dr. Campbell has stock in Prothena Biosciences. Dr. Campbell has stock in MindImmune Therapeutics.
Wagner Zago	Wagner Zago has received personal compensation for serving as an employee of Prothena Biosciences. Wagner Zago has stock in Prothena Biosciences. Wagner Zago has received intellectual property interests from a discovery or technology relating to health care.
Mahmoud M. Elsayed, MD	Dr. Elsayed has nothing to disclose.
Dina A. Ramadan, Jr., MbbCH	Miss Ramadan has nothing to disclose.
Mariam E. Hussein	Dr. Hussein has nothing to disclose.
MOHANAD T. ALNAHDI, student	Dr. ALNAHDI has nothing to disclose.
Brenda Pulgarin, MD	Ms. Pulgarin has nothing to disclose.
Hamza Coban, MD	Dr. Coban has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono.
Ayatalla Ahmed, MBBS	Dr. Ahmed has nothing to disclose.
Lavanya Sambaraju, BS	Ms. Sambaraju has nothing to disclose.
Muhammad Hussain, MD	Dr. Hussain has nothing to disclose.
Soundarya Gowda, MD	Dr. Gowda has nothing to disclose.
Aashit K. Shah, MD, FAAN	Dr. Shah has stock in Abbot, Abbivie, Gilead, Johnson and Johnson, Pfizer. The institution of Dr. Shah has received research support from Xenon Pharma.
Haseeb Goheer	Haseeb Goheer has nothing to disclose.
Zain A. Nadeem	Mr. Nadeem has nothing to disclose.
Faraz Arshad	Mr. Arshad has nothing to disclose.
Wajeeh Hassan, MBBS	Mr. Hassan has nothing to disclose.
Rohab Sohail, MD	Dr. Sohail has nothing to disclose.
Tahseen Mozaffar, MD, FAAN	Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas Gene Therapy. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Sanofi. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Astellas Gene Therpay. The institution of Dr. Mozaffar has received research support from Cartesian. The institution of Dr. Mozaffar has received research support from Cabaletta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Barry Byrne	Barry Byrne has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Barry Byrne has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rocket Pharma. Barry Byrne has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Muscular Dystrophy Association.
Mazen M. Dimachkie, MD, FAAN	Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/Immunovant. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ��ɫ�� (AAN). Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon Biosciences. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Candid Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creyon Bio, Inc.. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig Therapeutics. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB Biopharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fortrea. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kriya Therapeutics. The institution of Dr. Dimachkie has received research support from NIH. The institution of Dr. Dimachkie has received research support from The Myositis Association. The institution of Dr. Dimachkie has received research support from Biosensics. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
Robert Hopkin, MD	Dr. Hopkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amicus Corp, Sanofi, Cheisi, Sangamo, and Hanmi. Dr. Hopkin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Denali and Acadia. Dr. Hopkin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Hopkin has a non-compensated relationship as a Board Member with ThinkGenetic Foundation that is relevant to AAN interests or activities. Dr. Hopkin has a non-compensated relationship as a Medical Advisory Board Chair with National Fabry Disease Foundation that is relevant to AAN interests or activities. Dr. Hopkin has a non-compensated relationship as a Medical Advisor with Fabry Support and Information Group that is relevant to AAN interests or activities. Dr. Hopkin has a non-compensated relationship as a Medical Advisor with 1p36 support group that is relevant to AAN interests or activities.
Priya Kishnani, MD	Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme. Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amicus Therapeutics. Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Maze Therapeutics. Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for JCR Pharmaceutical. Priya Kishnani, MD has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Asklepios Biopharmaceutical Inc. (AskBio). Priya Kishnani, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Priya Kishnani, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus Therapeutics. Priya Kishnani, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Baebies, Inc.. The institution of Priya Kishnani, MD has received research support from Sanofi/Genzyme. Priya Kishnani, MD has received research support from Amicus Therapeutics. Priya Kishnani, MD has received intellectual property interests from a discovery or technology relating to health care. Priya Kishnani, MD has received intellectual property interests from a discovery or technology relating to health care.
Mark Roberts	Mark Roberts has nothing to disclose.
Benedikt Schoser	Benedikt Schoser has received personal compensation for serving as an employee of Alexion. Benedikt Schoser has received personal compensation for serving as an employee of Argenx. Benedikt Schoser has received personal compensation for serving as an employee of Amicus. Benedikt Schoser has received personal compensation for serving as an employee of Astellas. Benedikt Schoser has received personal compensation for serving as an employee of Denali. Benedikt Schoser has received personal compensation for serving as an employee of Avidity . Benedikt Schoser has received personal compensation for serving as an employee of Sanofi. Benedikt Schoser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Taysha. Benedikt Schoser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astellas. Benedikt Schoser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Encoded. Benedikt Schoser has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kedrion.
Ans Van Der Ploeg	The institution of Ans Van Der Ploeg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . The institution of Ans Van Der Ploeg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. The institution of Ans Van Der Ploeg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics . The institution of Ans Van Der Ploeg has received research support from Sanofi Genzyme.
Jon Brudvig, PhD	Dr. Brudvig has received personal compensation for serving as an employee of Amicus Therapeutics.
Brian Fox, PhD	Dr. Fox has received personal compensation for serving as an employee of Amicus Therapeutics. Dr. Fox has stock in Amicus Therapeutics.
Frederick Holdbrook	Frederick Holdbrook has received personal compensation for serving as an employee of Amicus Therapeutics, Inc. Frederick Holdbrook has stock in Amicus Therapeutics, Inc.
Vipul Jain, Programmer	Mr. Jain has nothing to disclose.
Franklin Johnson, MS	Mr. Johnson has received personal compensation for serving as an employee of Amicus Therapeutics, Inc. Mr. Johnson has stock in Amicus Therapeutics, Inc.
Jennifer (. Zhang, MD	Ms. Zhang has nothing to disclose.
Giancarlo Parenti, MD	Prof. parenti has nothing to disclose.
Raja Mehanna, MD	Dr. Mehanna has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Mehanna has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. The institution of Dr. Mehanna has received research support from Cerevel. The institution of Dr. Mehanna has received research support from Neurocrine.
Erin Furr-Stimming, MD, FAAN	Dr. Furr-Stimming has received personal compensation for serving as an employee of Help4HD International. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedPage. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Life Sciences. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Latus Bio. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atalanta Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SkyHawk Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atalanta Therapeutics. The institution of Dr. Furr-Stimming has received research support from Roche/Genetech. The institution of Dr. Furr-Stimming has received research support from Uniqure. The institution of Dr. Furr-Stimming has received research support from CHDI. The institution of Dr. Furr-Stimming has received research support from Huntington Study Group/Neurocrine Bioscienes. The institution of Dr. Furr-Stimming has received research support from NIH/University of Iowa. The institution of Dr. Furr-Stimming has received research support from Sage Therapeutics. The institution of Dr. Furr-Stimming has received research support from HDSA. The institution of Dr. Furr-Stimming has received research support from Prilennia. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has a non-compensated relationship as a Committee member with AAN UES Committee that is relevant to AAN interests or activities.
Elise Kayson, NP	Ms. Kayson has nothing to disclose.
Jody Goldstein, BS	Miss Goldstein has nothing to disclose.
Olga Klepitskaya, MD, FAAN	Dr. Klepitskaya has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc. Dr. Klepitskaya has or had stock in Neurocrine Biosciences.
Sean Hinton, PhD	Dr. Hinton has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc. Dr. Hinton has stock in Neurocrine Biosciences, Inc..
Hui Zhang	Hui Zhang has received personal compensation for serving as an employee of Neurocrine Bioscience Inc..
Eduardo Dunayevich, MD	Eduardo Dunayevich has received personal compensation for serving as an employee of Neurocrine Biosciences. Eduardo Dunayevich has stock in Neurocrine Biosciences.
Grace L. Liang, MD	Dr. Liang has received personal compensation for serving as an employee of Neurocrine Biosciences. Dr. Liang has stock in Neurocrine Biosciences.
Dietrich Haubenberger, MD, FAAN	Dr. Haubenberger has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc. Dr. Haubenberger has stock in Neurocrine Biosciences. Dr. Haubenberger has a non-compensated relationship as a Member of the Board with American Society for Experimental Neurotherapeutics that is relevant to AAN interests or activities.
Ashna Aggarwal	Miss Aggarwal has nothing to disclose.
Anil Wadhwani, MD, PhD	Dr. Wadhwani has stock in Eli Lilly. The institution of Dr. Wadhwani has received research support from NIH.
Steven Loscalzo, MD	Dr. Loscalzo has nothing to disclose.
Megan McSherry, MD	The institution of Dr. McSherry has received research support from NIH Postdoctoral Research Training in Perioperative Medicine (5T32GM112596-09).
Justin Lockman, MD	Dr. Lockman has nothing to disclose.
John Brandsema, MD	Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC Therapeutics. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Brandsema has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Brandsema has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scholar Rock. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for CureSMA. The institution of Dr. Brandsema has received research support from Novartis. The institution of Dr. Brandsema has received research support from Biogen. The institution of Dr. Brandsema has received research support from Alexion. The institution of Dr. Brandsema has received research support from CSL Behring. The institution of Dr. Brandsema has received research support from Pfizer. The institution of Dr. Brandsema has received research support from PTC Therapeutics. The institution of Dr. Brandsema has received research support from Sarepta. The institution of Dr. Brandsema has received research support from Astellas. The institution of Dr. Brandsema has received research support from Fibrogen. The institution of Dr. Brandsema has received research support from Genentech. The institution of Dr. Brandsema has received research support from Janssen. The institution of Dr. Brandsema has received research support from Scholar Rock.
Jennifer McGuire, MD	Dr. McGuire has received research support from NIH.
Susan Matesanz, MD	Dr. Matesanz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Matesanz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Matesanz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atamyo . The institution of Dr. Matesanz has received research support from Sarepta . The institution of Dr. Matesanz has received research support from Pfizer. The institution of Dr. Matesanz has received research support from Genentech/Roche.
Giovanna Gilioli da Costa Nunes, Jr., Medical Student	Miss Gilioli da Costa Nunes has nothing to disclose.
Samuel Luca R. Pinheiro	Mr. Pinheiro has nothing to disclose.
Francisco de Moraes	Francisco de Moraes has nothing to disclose.
Ling-Zhi Ma	Ling-Zhi Ma has nothing to disclose.
Govind S. Mann, MBBS	Dr. Mann has nothing to disclose.
Ahmed Farid, MD	Dr. Farid has nothing to disclose.
ali dway	Dr. dway has nothing to disclose.
Fathima Hayathi Fayaz, MBBS	Dr. Fayaz has nothing to disclose.
Eleni A. Kebede, MD	Dr. Kebede has nothing to disclose.
Nandha Kumar Varadharaj, MBBS	Dr. Varadharaj has nothing to disclose.
Ayesha Akram, MBBS	Dr. Akram has nothing to disclose.
Aneeza Khan, MBBS	Ms. Khan has nothing to disclose.
Uchechi B. Azuwike	Miss Azuwike has nothing to disclose.
BHARATH KANUMURI SAMPANGI, ASSISTANT PROFESSOR	Mr. KANUMURI SAMPANGI has nothing to disclose.
Oluwaseun A. Ogundijo, DVM	Dr. Ogundijo has nothing to disclose.
Joanne Lau, MD	Dr. Lau has nothing to disclose.
Yi Li, MD	The institution of Dr. Li has received research support from AES. The institution of Dr. Li has received research support from NIH.
Victória Siebel	Victória Siebel has nothing to disclose.
Lais T. Reis	Miss Reis has nothing to disclose.
Maria Eduarda Souza	Maria Eduarda Souza has nothing to disclose.
Vitor K. Sano, MS	Mr. Sano has nothing to disclose.
Artur Menegaz de Almeida, MS	Mr. Menegaz de Almeida has nothing to disclose.
Francinny A. Kelly, MD	Dr. kelly has nothing to disclose.
Clara Tierney, MD	Dr. Tierney has nothing to disclose.
Maksim Bakrenev, MD	Dr. Bakrenev has nothing to disclose.
Michael L. Swerdlow, MD	Dr. Swerdlow has nothing to disclose.
Adomas Bunevicius, MD, PhD	Dr. Bunevicius has nothing to disclose.
Gabriele Darge, PhD	Mrs. Darge has nothing to disclose.
Gabriele Kasputyte, Researcher	Ms. Kasputyte has nothing to disclose.
Romas Bunevicius	No disclosure on file
Tomas Krilavicius	No disclosure on file
Jonas Venius, PhD	Dr. Venius has nothing to disclose.
Daiva Sendiuliene, MD	Mrs. Sendiuliene has nothing to disclose.
Rita Steponaviciene	No disclosure on file
Vita Zeromskiene, MD	Mrs. Zeromskiene has nothing to disclose.
Juras Kišonas, PhD	Dr. Kišonas has nothing to disclose.
Kristen Kelly, MD	Dr. Kelly has nothing to disclose.
Thomas Covey	The institution of Thomas Covey has received research support from Department of Defense. Thomas Covey has received research support from National Institutes of Health. The institution of Thomas Covey has received research support from National Science Foundation. The institution of Thomas Covey has received research support from National Multiple Sclerosis Society.
Amit Kandel, MD	Dr. Kandel has nothing to disclose.
Farrah J. Mateen, MD, PhD, FAAN	Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from Amgen. The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care.
Seungwon Lee, BA	Miss Lee has nothing to disclose.
Raphael Scheu, MD	Mr. Scheu has nothing to disclose.
Maya Mastick	Ms. Mastick has nothing to disclose.
Jin-Tai Yu, PhD	Prof. Yu has nothing to disclose.
Jenna L. Miller, MD	Dr. Miller has nothing to disclose.
Caroline Gentile Kruse, MD	Dr. Gentile Kruse has nothing to disclose.
Tony Pinto, NP	Mr. Pinto has nothing to disclose.
Karrima owens, RN	Ms. owens has nothing to disclose.
Andrea L. Schneider, MD, PhD	Dr. Schneider has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN - Neurology.
Christina Blum, MD	Dr. Blum has nothing to disclose.
Areej Javeid	Miss Javeid has nothing to disclose.
Muhammad Saim	Mr. Saim has nothing to disclose.
Nishitha Bujala, MBBS	Dr. Bujala has nothing to disclose.
Usama Ahmed, MBBS	Mr. Ahmed has nothing to disclose.
Muhammad Ahmad Sadiq, MD, MBBS	Dr. Sadiq has nothing to disclose.
Muhammad Sohaib, MBBS	Mr. Sohaib has nothing to disclose.
Muhammad Tayyab Muzaffar Chaychi, MD	Muhammad Tayyab Muzaffar Chaychi, MD has nothing to disclose.
Haider Ashfaq	Haider Ashfaq has nothing to disclose.
Hamza Ashraf	Hamza Ashraf has nothing to disclose.
Muhammad A. Nadir, MBBS	Mr. Nadir has nothing to disclose.
Jensine Sajan, DO	Dr. Sajan has nothing to disclose.
Karim Makhoul, Sr., MD	Dr. Makhoul has nothing to disclose.
Isaac Lipsky, MD	Mr. Lipsky has nothing to disclose.
Brendan Huang, MD	Dr. Huang has nothing to disclose.
Frederick E. Munschauer III, MD, FAAN	Dr. Munschauer has received personal compensation for serving as an employee of Emalex Biosciences. Dr. Munschauer has stock in Emalex Biosciences.
Stephen Wanaski, PhD	Dr. Wanaski has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Wanaski has or had stock in Paragon Biosciences.Dr. Wanaski has or had stock in Emalex Biosciences.
Timothy Cunniff, PharmD	Dr. Cunniff has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Cunniff has stock in Harmony Biosciences. Dr. Cunniff has stock in Emalex Biosciences.
Joy Schleyer	Joy Schleyer has received personal compensation for serving as an employee of Emalex Biosciences.
Patricia Rice	Patricia Rice has received personal compensation for serving as an employee of Emalex Biosciences.
Hongqi Xue, PhD	Dr. Xue has nothing to disclose.
Borje B. Darpo, MD, PhD	Dr. Darpo has stock in Clario.
Virginia Schmith, PhD	Dr. Schmith has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Emalex Biosciences.
Michele Persico, MD	Dr. Persico has nothing to disclose.
Brent D. Weinberg, MD, PhD	Dr. Weinberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Canon USA. Dr. Weinberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avicenna.ai. Dr. Weinberg has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple law firms.
Tsion Assaye, MD	Ms. Assaye has nothing to disclose.
Michael Essien, MBChB, MPH	Dr. Essien has nothing to disclose.
Mikayla M. Spott	Miss Spott has nothing to disclose.
Shaifali Arora, MD	Dr. Arora has nothing to disclose.
Christopher A. Sanfilippo, DO	Dr. Sanfilippo has nothing to disclose.
LeeAnn Chang	Ms. Chang has nothing to disclose.
James P. Valeriano, MD	Dr. Valeriano has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ucb. Dr. Valeriano has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for neurilis.
Carolina B. Moura, MD	Dr. Moura has nothing to disclose.
Caroline B. Braune, MD	Dr. Braune has nothing to disclose.
Luiza Oliveira	No disclosure on file
Roberto Navarro	No disclosure on file
Laisa Bonatto	No disclosure on file
Lya M. Marques, MD	Dr. Marques has nothing to disclose.
Anatevka S. Ribeiro, MD	Dr. Ribeiro has nothing to disclose.
Xiao-Tang Kong, MD, PhD	Dr. Kong has nothing to disclose.
Mesude Tutuncu	Dr. Tutuncu has nothing to disclose.
Merve Iris, MD	Dr. Iris has nothing to disclose.
serdal ugurlu	Prof. ugurlu has nothing to disclose.
Batuhan Ayci, MD	Mr. Ayci has nothing to disclose.
Linda Barasa, MBChB	Dr. Barasa has nothing to disclose.
Dilraj S. Sokhi, FRCP	The institution of Dr. Sokhi has received research support from Genentech.
Anne Mwirigi, MD	Dr. Mwirigi has nothing to disclose.
Malkit Riyat, FRCPath (Hematology)	Dr. Riyat has nothing to disclose.
Laura Kirui, MD	Dr. Kirui has nothing to disclose.
Herman Ekea	An immediate family member of Herman Ekea has stock in Maxiray Diagnostic Centre.
Omar Elmandouh, MD	Dr. Elmandouh has nothing to disclose.
Vinh N. Pham, MD	Dr. Pham has nothing to disclose.
Judy Y. Zheng, MD	Dr. Zheng has nothing to disclose.
Mehmood Rashid, MD	Dr. Rashid has nothing to disclose.
Joyeta Razzaque, MBBS	Dr. Razzaque has nothing to disclose.
Sahil Kapur	Sahil Kapur has nothing to disclose.
Tiffany A. Johnson, Medical student	Ms. Johnson has nothing to disclose.
Claire Popovich	Miss Popovich has nothing to disclose.
Matthew Preszler, MD	Dr. Preszler has nothing to disclose.
Yu Guo, PhD	Dr. Guo has nothing to disclose.
Ann Zheng, MD	Dr. Zheng has nothing to disclose.
Simona V. Proteasa, MD	Dr. Proteasa has nothing to disclose.
Stephanie M. Roses, MD	Dr. Roses has nothing to disclose.
Linda Anh Nguyen, MD	Dr. Nguyen has nothing to disclose.
fnu teena, MBBS	Dr. teena has nothing to disclose.
Harendra Kumar	Mr. Kumar has nothing to disclose.
JINAL CHOUDHARI, MD, MBBS	Ms. CHOUDHARI has nothing to disclose.
Yamila Remon Gonzalez, MD	Dr. Remon Gonzalez has nothing to disclose.
Wilson C. Cueva, MD	Dr. Cueva has nothing to disclose.
Kester J. Nedd, DO	No disclosure on file
Jing Du, MD	Dr. Du has nothing to disclose.
Shugang Cao	No disclosure on file
Lei Cao	No disclosure on file
Yanghua Tian	No disclosure on file
XIAOKUN QI, PhD	No disclosure on file
Colleen G. Lechtenberg, MD	The institution of Dr. Lechtenberg has received research support from The Department of Neurology.
Sarah Langston	No disclosure on file
Jill Peltzer	No disclosure on file
Suzanne Hunt	No disclosure on file
Ahmed M. Yassin, MD	Dr. Yassin has nothing to disclose.
ABDEL RAHMAN ALKASABRAH, MD	Dr. ALKASABRAH has nothing to disclose.
Mohmmad M. Alawajneh	Mr. Alawajneh has nothing to disclose.
Salma Bashayreh, MD	Dr. Bashayreh has nothing to disclose.
Khalid I. El-Salem, MD, FAAN	Dr. El-Salem has nothing to disclose.
Juan D. Oyola, MD	Dr. Oyola has nothing to disclose.
Nicolas D. Rincón, Sr., MD	Dr. Rincón has nothing to disclose.
Andrés Villamil	Andrés Villamil has nothing to disclose.
Amr M. Yousef, MBBS	Dr. Yousef has nothing to disclose.
Hossam T. Ali, MD	Dr. Ali has nothing to disclose.
Ahmed M. Afifi, MD	Dr. Afifi has nothing to disclose.
Ahmed Mamdoh Mahmoud	Dr. Mahmoud has nothing to disclose.
Ammar A. Elsayed, MD	Dr. Elsayed has nothing to disclose.
‪Sara Hosny ‬‏El-Farargy	Dr. ??El-Farargy has nothing to disclose.
Vera Kulikov	Mrs. Kulikov has nothing to disclose.
Carine W. Maurer, MD, PhD, FAAN	Dr. Maurer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal Pharmaceuticals. The institution of Dr. Maurer has received research support from Alzheimer's Association & the Foundation of the American Society of Neuroradiology. The institution of Dr. Maurer has received research support from UCB Biopharma SRL. The institution of Dr. Maurer has received research support from Emalex Biosciences. The institution of Dr. Maurer has received research support from Noema Pharma. Dr. Maurer has received publishing royalties from a publication relating to health care.
Margherita Milone, MD, FAAN	Dr. Milone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Milone has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics, AAN. The institution of Dr. Milone has received research support from Mayo Clinic, CCaTS-CBD. The institution of Dr. Milone has received research support from Mayo Clinic, SGP Award. The institution of Dr. Milone has received research support from MDA for Care Center grant. The institution of Dr. Milone has received research support from Regenerative medicine Minnesota.
Teerin Liewluck, MD, FAAN	Dr. Liewluck has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. Liewluck has received publishing royalties from a publication relating to health care.
Jacob Goodwin, MD	Dr. Goodwin has nothing to disclose.
Bob Bucelli, MD, PhD	Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen . Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bucelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Bucelli has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Hamilton Weber. Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for O'Bryan Brown and Toner. Dr. Bucelli has stock in Neuroquestions.com. An immediate family member of Dr. Bucelli has stock in Neuroquestions.com. The institution of Dr. Bucelli has received research support from Biogen. The institution of Dr. Bucelli has received research support from Ionis.
Alan Pestronk, MD, FAAN	The institution of Dr. Pestronk has received research support from Jain. The institution of Dr. Pestronk has received research support from Fulcrum. The institution of Dr. Pestronk has received research support from Argenyx. The institution of Dr. Pestronk has received research support from NeuroNext.
Ikreet Cheema, MD	Dr. Cheema has nothing to disclose.
Samantha Mohl, MD	Dr. Kropp has nothing to disclose.
Sam Tenhoeve	Mr. Tenhoeve has nothing to disclose.
Joe S. Mendez, MD	Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cohne Kinghorn.
Rachna Malani, MD	Dr. Malani has nothing to disclose.
Yian A. Chen, PhD	The institution of Dr. Chen has received research support from NIH.
Yuxin Zhao, MS	Miss Zhao has nothing to disclose.
Tatianna M. Howard, Research Assistant	Ms. Howard has nothing to disclose.
Charlotte Casselton, Research Assistant	Miss Casselton has nothing to disclose.
Gang Seo, PhD	Dr. Seo has nothing to disclose.
Annie Abay	Miss Abay has nothing to disclose.
Kevin Wilkins, PhD	Dr. Wilkins has nothing to disclose.
Rachel Crockett, PhD	Dr. Crockett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for VerityXR.
Siara M. Clos, MD	Dr. Clos has nothing to disclose.
Demi Ajao	Ms. Ajao has nothing to disclose.
Kyle C. Sporn, MS	Mr. Sporn has nothing to disclose.
Tuncay Delibasi, MD	The institution of Prof. DELIBASI has received research support from SUNY UPSTATE MEDICAL UNIVERSITY.
Corey A. McGraw, MD	The institution of Dr. McGraw has received research support from Novartis. The institution of Dr. McGraw has received research support from F. Hoffmann - La Roche. The institution of Dr. McGraw has received research support from Genentech. The institution of Dr. McGraw has received research support from Neurona Therapeutics. The institution of Dr. McGraw has received research support from Instituto Grifols, S.A..
Isra Masood, MBBS	Miss Masood has nothing to disclose.
Syed Adeel Hassan, MBBS	Dr. Hassan has nothing to disclose.
Mark T. Roberts, MD	Dr. Roberts has nothing to disclose.
Amaris Alayon, MD	Ms. Alayon has nothing to disclose.
Mahsa Ghajarzadeh, MD, PhD	Dr. GHAJARZADEH has nothing to disclose.
Zahra Shahraki	No disclosure on file
Mohsen Rastkar, MD	Mr. Rastkar has nothing to disclose.
Andrew Eldeiry, MB BCh BAO	Dr. Eldeiry has nothing to disclose.
Robert L. Glover, MD	Dr. Glover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Livanova. Dr. Glover has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Livanova. Dr. Glover has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis.
Zhen Wang	No disclosure on file
Leslie Citrome	Leslie Citrome has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for AbbVie, Acadia, Alkermes, Allergan, Avanir, BioXcel, Cadent Therapeutics, Eisai, Impel, Intra-Cellular Therapies, Janssen, Lundbeck, Luye, Merck, Neurocrine, Noven, Osmotica, Otsuka, Sage, Shire, Sunovion, Takeda, Teva. Leslie Citrome has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for AbbVie, Acadia, Alkermes, Allergan, Eisai, Intra-Cellular Therapies, Janssen, Lundbeck, Merck, Neurocrine, Noven, Otsuka, Sage, Shire, Sunovion, Takeda, Teva. Leslie Citrome has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley, Elsevier. Leslie Citrome has stock in Bristol-Myers Squibb, Eli Lilly, J & J, Merck, Pfizer . Leslie Citrome has received publishing royalties from a publication relating to health care.
Robert A. Hauser, MD, MBA, FAAN	Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoparkinson. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Intrance. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NanoPharmasolutions. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll BioPharma. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cerevance. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clario. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sumitomo. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Taurus Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sorriddi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Contera. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alterity Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec Inc. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Knight Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biorasi. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicure Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. The institution of Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson. The institution of Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Photopharmics. The institution of Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal . Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Hauser has or had stock in Inhibikase.Dr. Hauser has or had stock in Axial Therapeutics.Dr. Hauser has or had stock in Enterin.Dr. Hauser has or had stock in Photopharmics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from UCB BioPharma. The institution of Dr. Hauser has received research support from UCB. The institution of Dr. Hauser has received research support from Amneal Pharmaceuticals. The institution of Dr. Hauser has received research support from Motric Bio, Inc.. The institution of Dr. Hauser has received research support from Sun Pharma Advanced Research Company. The institution of Dr. Hauser has received research support from Teva Branded Pharmaceuticals. The institution of Dr. Hauser has received research support from Truebinding, Inc.. The institution of Dr. Hauser has received research support from Jazz Pharmaceuticals. The institution of Dr. Hauser has received research support from Ipsen. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Kira Aldrich	Dr. Aldrich has received personal compensation for serving as an employee of Neurocrine Biosciences. Dr. Aldrich has stock in Neurocrine Biosciences.
Sardar Muhammad Imran Khan, MBBS	Dr. Khan has nothing to disclose.
Muhammad Waqas, MBBS	Mr. Waqas has nothing to disclose.
Syed Zaeem Ahmed, MBBS	Dr. Ahmed has nothing to disclose.
Muhammad Abdul Qadeer, MBBS	Mr. Qadeer has nothing to disclose.
Mariam Shabih, MD	Dr. Shabih has nothing to disclose.
Luke Fischer, MD, PhD	The institution of Dr. Fischer has received research support from Alzheimer's Association. The institution of Dr. Fischer has received research support from Lewy Body Dementia Association. The institution of Dr. Fischer has received research support from NINDS. Dr. Fischer has received personal compensation in the range of $0-$499 for serving as a Author with MedLink, LLC.
Bruce L. Miller, MD, FAAN	Dr. Miller has nothing to disclose.
Lawren VandeVrede, MD, PhD	Dr. VandeVrede has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. VandeVrede has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. VandeVrede has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CND Life Sciences. Dr. VandeVrede has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Siemens. Dr. VandeVrede has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. VandeVrede has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Peerview CME. Dr. VandeVrede has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Haymarket. Dr. VandeVrede has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Peter Lacques, LLC. Dr. VandeVrede has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Cunningham Bounds. The institution of Dr. VandeVrede has received research support from Alzheimer's Association. The institution of Dr. VandeVrede has received research support from NIH.
Tara N. Ellingson	Miss Ellingson has nothing to disclose.
Thomas Flagiello, MD	Dr. Flagiello has nothing to disclose.
Benjamin H. Fuchs, MD	Dr. Fuchs has nothing to disclose.
Quoc Bao Nguyen, MD	Mr. Nguyen has nothing to disclose.
Bhrugav G. Raval, MD	Dr. Raval has nothing to disclose.
Philion L. Hoff	No disclosure on file
Jorge Alejandro Arias Vega	Mr. Arias Vega has nothing to disclose.
Aurelio Mendez-Dominguez, MD	Dr. Mendez-Dominguez has nothing to disclose.
Pedro Gil Landeros	Pedro Gil Landeros has nothing to disclose.
María F. Ortega Ibarra	Miss Ortega Ibarra has nothing to disclose.
Diego Muñoz, Jr.	Mr. Muñoz has nothing to disclose.
Frida Q. Montoya Delgado	Mrs. Montoya Delgado has nothing to disclose.
Oziel Leyva Dolores	Ms. Leyva Dolores has nothing to disclose.
Paulina Jaime Flores, Jr.	Miss Jaime Flores has nothing to disclose.
Fatima Shahid	FATIMA SHAHID has nothing to disclose.
Iqra Shahid, MBBS	Dr. Shahid has nothing to disclose.
Sara Sohail	Sara Sohail has nothing to disclose.
FNU Kalpina, MBBS	Dr. Ramesh has nothing to disclose.
Pushpa Narayanaswami, MD, MBBS, FAAN	Dr. Narayanaswami has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for UCB. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx USA. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD pharma. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD-Serono (Merck usa). Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Immuneabs. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viridian. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta-Bio. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vor Bio. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Muscle and Nerve, Wiley. Dr. Narayanaswami has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Narayanaswami has or had stock in Dr. Reddys laboratories.Dr. Narayanaswami has or had stock in Doximity. The institution of Dr. Narayanaswami has received research support from Alexion. The institution of Dr. Narayanaswami has received research support from NIH. The institution of Dr. Narayanaswami has received research support from Argenx. The institution of Dr. Narayanaswami has received research support from Cabaletta Bio. Dr. Narayanaswami has received publishing royalties from a publication relating to health care. Dr. Narayanaswami has a non-compensated relationship as a Member, Finance Committee with AANEM that is relevant to AAN interests or activities.
Karthik Jagannath, MD	Dr. Jagannath has nothing to disclose.
Aarushi Negi, BA	Ms. Negi has nothing to disclose.
Helen Bronte-Stewart, MD, MSE	Dr. Bronte-Stewart has stock in QDG Health. Dr. Bronte-Stewart has received intellectual property interests from a discovery or technology relating to health care.
Faten Awwad, MD	Dr. Awwad has nothing to disclose.
Lama Bani Salameh	Miss Bani Salameh has nothing to disclose.
Sara O. Abualinin, MD	Miss Abualinin has nothing to disclose.
Eslam Hussein, MD, PhD	Dr. Hussein has nothing to disclose.
Mouness Obeidat, MBBS, MRCS, FEBNS, FRCS (SN)	Dr. Obeidat has nothing to disclose.
Rachael Cella	Ms. Cella has nothing to disclose.
Qingli Hu	Miss Hu has nothing to disclose.
Syed D. Asad, MD	Dr. Asad has nothing to disclose.
Mohammed El-hunjul, MD	Dr. El-hunjul has nothing to disclose.
Nathaniel Fleming, MD	Dr. Fleming has nothing to disclose.
Liza Solovey, MD	Liza Solovey, MD has nothing to disclose.
Anthony S. Kim, MD	Dr. Kim has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for New England Journal of Medicine: Journal Watch. Dr. Kim has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Quintairos, Prieto, Wood & Boyer, PA. The institution of Dr. Kim has received research support from NIH/NCATS. The institution of Dr. Kim has received research support from NIH/NINDS. The institution of Dr. Kim has received research support from NIH/NIHMD. The institution of Dr. Kim has received research support from Patient-Centered Outcome Research Institute. The institution of Dr. Kim has received research support from American Heart Association. Dr. Kim has received personal compensation in the range of $500-$4,999 for serving as a Speaker with American Neurological Association.
Renee Hsia, MD	The institution of Dr. Hsia has received research support from NHLBI. The institution of Dr. Hsia has received research support from NIMHD. The institution of Dr. Hsia has received research support from NIA.
Yu-Chu Shen, PhD	The institution of Dr. Shen has received research support from Defense Health Agency. The institution of Dr. Shen has received research support from National Institute of Health.
Dhaval P. Desai, MD	Dr. Desai has nothing to disclose.
Rimal Bera	Dr. Bera has nothing to disclose.
Justin Nedzesky, PharmD, MS	Dr. Nedzesky has received personal compensation for serving as an employee of Neurocrine Biosciences. Dr. Nedzesky has stock in Neurocrine Biosciences.
Ivan Gandayuwana	Mr. Gandayuwana has nothing to disclose.
Dan Winkelman	Mr. Winkelman has received personal compensation for serving as an employee of IQVIA.
Dawn Vanderhoef	Dr. Vanderhoef has received personal compensation for serving as an employee of Neurocrine Biosciences Inc. Dr. Vanderhoef has stock in Neurocrine Biosciences, Inc.
Morgan Bron	Morgan Bron has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc.. Morgan Bron has or had stock in Neurocrine.
Gabriel A. Bitar	Mr. Bitar has nothing to disclose.
Sierra L. Alban	Ms. Alban has nothing to disclose.
Boris Decourt, PhD	Dr. Decourt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Light House Pharmaceuticals. The institution of Dr. Decourt has received research support from National Institute on Aging. Dr. Decourt has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with National Institute on Aging.
Marwan N. Sabbagh, MD, FAAN	Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
Kassu Mehari Beyene, PhD	Dr. Beyene has nothing to disclose.
Nasrin Rahimian, MD	Dr. Rahimian has nothing to disclose.
Lakshman N. Arcot Jayagopal, MD	Dr. Arcot Jayagopal has nothing to disclose.
Rana K. Zabad, MD, FAAN	Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene/BMS. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Neurosciences. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. The institution of Dr. Zabad has received research support from Adamas. The institution of Dr. Zabad has received research support from Biogen. The institution of Dr. Zabad has received research support from Novartis. The institution of Dr. Zabad has received research support from Sun Pharma. The institution of Dr. Zabad has received research support from Parexel & MedDay Pharmaceuticals.
Tiffany A. Eatz, MD	Dr. Eatz has nothing to disclose.
Alexandra N. Cocores, MD	Dr. Cocores has nothing to disclose.
Sweta Komanduru, DO	Dr. Komanduru has nothing to disclose.
Matthew J. Ebright, MD	Dr. Ebright has nothing to disclose.
Hamilton Roberto Moreira de Oliveira Carrico	Mr. Roberto Moreira de Oliveira Carrico has nothing to disclose.
Helen C. Beckert	Miss Beckert has nothing to disclose.
Andressa G. Cardoso, Medicine student	Mrs. Cardoso has nothing to disclose.
Francisco Jose Germano Hennemann	Mr. Germano Hennemann has nothing to disclose.
Barbara Antonia D. Talah, Medical Student	Miss Talah has nothing to disclose.
Julia Mello, Student	Mrs. Mello has nothing to disclose.
Nuris M. Torres Argota, Sr.	Dr. Torres Argota has nothing to disclose.
Tiffany Hu, MD	Dr. Hu has nothing to disclose.
Katrina A. Pasao, MD	Dr. Pasao has nothing to disclose.
Christopher J. Campos, DO	Dr. Campos has nothing to disclose.
Kathleen Irwin, RN	Mrs. Irwin has nothing to disclose.
Juliana Stoilova, MD	Ms. Stoilova has nothing to disclose.
Kenneth P. Martinez, MD	The institution of Dr. Martinez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. The institution of Dr. Martinez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie/Allergan. The institution of Dr. Martinez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance. The institution of Dr. Martinez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Martinez has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie/Allergan. The institution of Dr. Martinez has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merz. The institution of Dr. Martinez has received research support from Medtronic. The institution of Dr. Martinez has received research support from Abbvie/Allergan.
Natalya Ahsan, MBBS	Mrs. Ahsan has nothing to disclose.
Muhammad Abdullah, MBBS	Dr. Abdullah has nothing to disclose.
Salman Muddassir, MD	Dr. Muddassir has nothing to disclose.
Ahmad Mushtaq	No disclosure on file
Hania Sana, Medical student	Miss Sana has nothing to disclose.
Noman Khalid, MD	Dr. Khalid has nothing to disclose.
Tooba Sana, MBBS	Ms. Sana has nothing to disclose.
Muhammad I. Yousaf, MD	Dr. Yousaf has nothing to disclose.
Bilal Ahmad	Mr. Ahmad has nothing to disclose.
Advait Teli, MBBS	Dr. Teli has nothing to disclose.
Ananya Talukdar	Ms. Talukdar has nothing to disclose.
Siddhartha Kakani	Mr. Kakani has nothing to disclose.
Trisha Shivashankar	Trisha Shivashankar has nothing to disclose.
Claire Alcus	Miss Alcus has nothing to disclose.
Eleonora Napoli, PhD	Dr. Napoli has nothing to disclose.
Kristina Simonyan, MD, PhD	The institution of Dr. Simonyan has received research support from NIH. The institution of Dr. Simonyan has received research support from DoD. The institution of Dr. Simonyan has received research support from Amazon Research Award.
Laurie J. Ozelius, PhD	The institution of Dr. Ozelius has received research support from NIH. Dr. Ozelius has received intellectual property interests from a discovery or technology relating to health care.
Beverly Snively	The institution of Beverly Snively has received research support from National Institutes of Health. The institution of Beverly Snively has received research support from Duke Endowment. The institution of Beverly Snively has received research support from Department of Defense. The institution of Beverly Snively has received research support from PCORI.
Kathleen J. Sweadner, PhD	The institution of Dr. Sweadner has received research support from Hope for Annabel, AHC Foundation, and CureAHC. The institution of Dr. Sweadner has received research support from the Chan-Zuckerberg Initiative.
Allison Brashear, MD, MBA, FAAN	Dr. Brashear has received personal compensation for serving as an employee of McKnight Brain Res Found. Dr. Brashear has received personal compensation for serving as an employee of American Board of Psychiatry and Neurology. Dr. Brashear has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. Dr. Brashear has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for McKnight Brain Research Foundation i. Dr. Brashear has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Care Directions- start up . Dr. Brashear has stock in Caredirections . The institution of Dr. Brashear has received research support from NINDS. Dr. Brashear has received publishing royalties from a publication relating to health care. Dr. Brashear has received personal compensation in the range of $500-$4,999 for serving as a Special government employee and study section reviewer with NIH. Dr. Brashear has received personal compensation in the range of $0-$499 for serving as a Adminstrative board -travel reimbursement with AAMC.
Ihtsham Haq, MD, FAAN	The institution of Dr. Haq has received research support from NINDS. The institution of Dr. Haq has received research support from the Parkinson's Foundation.
Tara Najafi	Ms. Najafi has nothing to disclose.
Yolianys C. Villalobos, LMHC	Mrs. Villalobos has nothing to disclose.
Katalina McInerney	Katalina McInerney has nothing to disclose.
Jaclyn H. Wohn, PT	Dr. Wohn has nothing to disclose.
Dylan F. Del Papa, MD	Dr. Del Papa has nothing to disclose.
Victoria Divino	Ms. Divino has received personal compensation for serving as an employee of IQVIA.
Rajiv Mallick, PhD	Dr. Mallick has received personal compensation for serving as an employee of CSL Behring.
Betsy J. Lahue, MPH	Ms. Lahue has received personal compensation for serving as an employee of Alkemi . An immediate family member of Ms. Lahue has received personal compensation for serving as an employee of Alkemi. Ms. Lahue has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for EvoEndo. An immediate family member of Ms. Lahue has stock in Pfizer.
Katharine B. Coyle, BA	Ms. Coyle has received personal compensation for serving as an employee of IQVIA.
Yi Wang, MPH	Ms. Wang has received personal compensation for serving as an employee of IQVIA.
Mitch (. Dekoven, MHSA	Mr. Dekoven has received personal compensation for serving as an employee of IQVIA.
Alphonse Hubsch	Alphonse Hubsch has received personal compensation for serving as an employee of CSL Behring. Alphonse Hubsch has stock in CSL Behring .
Ali M. Bani Hani, MD	Dr. Bani Hani has nothing to disclose.
Ali M. Smadi, MD	Dr. Smadi has nothing to disclose.
Layan Abu Ali, MD	Miss Abu Ali has nothing to disclose.
Khaled O. AlWaqfi, MD	Dr. AlWaqfi has nothing to disclose.
Mohammad Al-Bdour	Mohammad Al-Bdour has nothing to disclose.
Qais I. Sa'di, MD	Dr. Sa'di has nothing to disclose.
Michael T. Pulley, MD, PhD, FAAN	Dr. Pulley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amylyx. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for csl/behring. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta. Dr. Pulley has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Multiple law firms.
Sami L. Khella, MD, FAAN	Dr. Khella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ionis. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eidos.
Amanda C. Peltier, MD, MS	Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for astrazeneca. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Csl Behring. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for alnylam. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for astrazeneca. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Goldman Ismail. The institution of Dr. Peltier has received research support from NIH. The institution of Dr. Peltier has received research support from CSL Behring.
Tuan H. Vu, MD	Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen (Horizon). Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Vu has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Alexion. The institution of Dr. Vu has received research support from RA Pharma/UCB. The institution of Dr. Vu has received research support from Mass Gen Hospital/Healy Platform Study. The institution of Dr. Vu has received research support from ARGENX. The institution of Dr. Vu has received research support from Horizon/Amgen. The institution of Dr. Vu has received research support from Woolsey Pharma. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Cartesian Therapeutics. The institution of Dr. Vu has received research support from Janssen/Johnson & Johnson. The institution of Dr. Vu has received research support from Immunovant. The institution of Dr. Vu has received research support from Regeneron. The institution of Dr. Vu has received research support from Dianthus. The institution of Dr. Vu has received research support from COUR.
Nan Jiang, MD	Dr. Jiang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for • Amylyx . Dr. Jiang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen .
Jeffrey A. Allen, MD	Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for csl behring. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson and Johnson. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for CSL behring. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Johnson and Johnson.
Jie Lin	No disclosure on file
Mark Stettner, MD	No disclosure on file
Ingemar S. Merkies, MD, PhD	The institution of Prof. merkies has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Argenx/.
Jeff Guptill, MD, FAAN	Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has or had stock in argenx.
Kelly G. Gwathmey, MD	Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strongbridge. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Gwathmey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals.
Geoffrey Istas	No disclosure on file
Arne De Roeck, PhD	Mr. De Roeck has received personal compensation for serving as an employee of argenx. Mr. De Roeck has stock in argenx.
Satoshi Kuwabara	Satoshi Kuwabara has nothing to disclose.
Giuseppe Lauria	Giuseppe Lauria has nothing to disclose.
Luis Querol, MD, PhD	Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. The institution of Dr. Querol has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Querol has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ArgenX. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avilar. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocryst. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KPL. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lycia. The institution of Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Querol has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Querol has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Querol has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Grifols. The institution of Dr. Querol has received research support from GBS-CIDP Foundation International. The institution of Dr. Querol has received research support from Grifols. The institution of Dr. Querol has received research support from ISCIII. The institution of Dr. Querol has received research support from CIBERER. The institution of Dr. Querol has received research support from UCB. The institution of Dr. Querol has received research support from ArgenX.
Niraja S. Suresh, MD	Dr. Suresh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anylam . Dr. Suresh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexeion. Dr. Suresh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenex. Dr. Suresh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda . Dr. Suresh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer.
Chafic Y. Karam, MD	Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alnylam. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Applied therapeutics. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intellia. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex.
Thomas Skripuletz	Thomas Skripuletz has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Alnylam Pharmaceuticals, Biogen, Centogene, CSL Behring, Grifols, Hexal AG, Janssen-Cilag, Merck Serono, Novartis, Roche, Sanofi, Swedish Orphan Biovitrum, Viatris. Thomas Skripuletz has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for from Alexion, Alnylam Pharmaceuticals, argenx, Bayer Vital, Biogen, Bristol Myers Squibb, Celgene, Centogene, CSL Behring, Euroimmun, Grifols, Hexal AG, Horizon, Janssen-Cilag, Merck Serono, Novartis, Pfizer, Roche, Sanofi, Siemens, Swedish Orphan Biovitrum, Teva, Viatris.
Simon Rinaldi, PhD, MBChB	Dr. Rinaldi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aregnx. Dr. Rinaldi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hansa. Dr. Rinaldi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Rinaldi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Rinaldi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. The institution of Dr. Rinaldi has received research support from MRC. The institution of Dr. Rinaldi has received research support from BMA. The institution of Dr. Rinaldi has received research support from GBS/CIDP Foundation International.
Andoni ECHANIZ-LAGUNA, MD, PhD	Prof. ECHANIZ-LAGUNA has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LFB. Prof. ECHANIZ-LAGUNA has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ARGENX. Prof. ECHANIZ-LAGUNA has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SANOFI.
Benjamin Van Hoorick	Dr. Van Hoorick has received personal compensation for serving as an employee of argenx. Dr. Van Hoorick has stock in argenx.
Ryo Yamasaki	Ryo Yamasaki has nothing to disclose.
Pieter Van Doorn, MD	The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hansa. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grifols. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Van Doorn has received publishing royalties from a publication relating to health care.
Richard A. Lewis, MD, FAAN	Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nuvig. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medscape. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioCryst. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NervoSave. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TGTX. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boehringer-Ingleheim. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intellia. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cartesian. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CME Outfitters. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVision. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Up to Date. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Shernoff et al. Dr. Lewis has received publishing royalties from a publication relating to health care.
Kevin Duque, MD	Dr. Duque has nothing to disclose.
Alberto J. Espay, MD, FAAN	Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tanabe Pharma America (formerly, Neuroderm). Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaps Dx. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDiagnostics, Inc (SYNAPS Dx). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intrance Medical Systems, Inc.. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis Precision Medicines. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Citrus Health. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.
Abhimanyu Mahajan, MD, MHS, FAAN	Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vima Therapeutics, Inc.. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Mahajan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie . Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspen Neuroscience. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Adaptive Biosciences . Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement disorders clinical practice. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with Texas Alzheimer's Research And Care Consortium .
Kelsey McDonald, Medical Student	Ms. McDonald has nothing to disclose.
Yessar M. Hussain, MD	The institution of Dr. Hussain has received research support from Alnylam Pharma.
Jon Beauchamp	No disclosure on file
Anneleen Remmerie, PhD	Ms. Remmerie has received personal compensation for serving as an employee of argenx. Ms. Remmerie has stock in argenx.
Erik Hofman	Erik Hofman has received personal compensation for serving as an employee of argenx BV. Erik Hofman has stock in argenx BV.
Katerina Anokhina, MD	Dr. Anokhina has received personal compensation for serving as an employee of argenx.
Bianca Le, MA-P	Ms. Le has nothing to disclose.
Eardi Lila, PhD	Dr. Lila has nothing to disclose.
David Hunt, PhD	Dr. Hunt has nothing to disclose.
Daniel D. Child, MD, PhD	Dr. Child has nothing to disclose.
Caitlin S. Latimer, MD, PhD	Dr. Latimer has nothing to disclose.
Marie Y. Davis, MD, PhD	Dr. Davis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Davis has received research support from NIH NINDS. The institution of Dr. Davis has received research support from University of Washington Institute for Stem Cell and Regenerative Medicine. The institution of Dr. Davis has received research support from VA BLRD. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a study section grant reviewer with NIH. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with Parkinson's Foundation.
Suman Jayadev, MD	Dr. Jayadev has nothing to disclose.
Thomas D. Bird, MD, FAAN	Dr. Bird has nothing to disclose.
Ali Shojaie, PhD	Prof. Shojaie has nothing to disclose.
Christine MacDonald, PhD	The institution of Dr. MacDonald has received research support from NIH. The institution of Dr. MacDonald has received research support from Department of Defense.
Claudia Sommer, MD, PhD	Dr. Sommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akigai. Dr. Sommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nevro. Dr. Sommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kedrion. Dr. Sommer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Sommer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Sommer has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Sommer has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Takeda. Dr. Sommer has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Pfizer. Dr. Sommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Sommer has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of Dr. Sommer has received research support from DFG. The institution of Dr. Sommer has received research support from BMBf.
Erik Wallstroem, MD, PhD	Dr. Wallstroem has received personal compensation for serving as an employee of Sanofi. Dr. Wallstroem has stock in Sanofi. Dr. Wallstroem has received intellectual property interests from a discovery or technology relating to health care.
Xiaodong Luo	Xiaodong Luo has received personal compensation for serving as an employee of Sanofi. An immediate family member of Xiaodong Luo has received personal compensation for serving as an employee of Beigene. Xiaodong Luo has stock in Sanofi. An immediate family member of Xiaodong Luo has stock in Beigene. An immediate family member of Xiaodong Luo has stock in Johnson and Johnson.
Miguel Alonso Alonso	Miguel Alonso Alonso has received personal compensation for serving as an employee of Sanofi. Miguel Alonso Alonso has stock in Sanofi.
Nazem Atassi, MD	Dr. Atassi has received personal compensation for serving as an employee of Sanofi. Dr. Atassi has stock in Sanofi.
Mona Elsakka	Mona Elsakka has nothing to disclose.
Sally Shayeb, MD	Mrs. Shayeb has nothing to disclose.
Islam M. Nadeem	Islam M. Nadeem has nothing to disclose.
Khalid W. Sarhan	Mr. Sarhan has nothing to disclose.
Amy Lin, MD	Dr. Lin has nothing to disclose.
Richard L. Barbano, MD, PhD, FAAN	Dr. Barbano has received personal compensation for serving as an employee of State of New York/Office of Mental Health. Dr. Barbano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie/Allergan. Dr. Barbano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 2nd MD. Dr. Barbano has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Barbano has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Visual Dx. Dr. Barbano has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for R L Barbano, MD,PhD, PLLC. The institution of Dr. Barbano has received research support from Fox Foundation. The institution of Dr. Barbano has received research support from Dystonia Study Coalition. The institution of Dr. Barbano has received research support from Revance. Dr. Barbano has received intellectual property interests from a discovery or technology relating to health care.
Brian Berman, MD, MS, FAAN	The institution of Dr. Berman has received research support from Dystonia Medical Research Foundation. The institution of Dr. Berman has received research support from National Institutes of Health. The institution of Dr. Berman has received research support from Neurocrine Biosciences. The institution of Dr. Berman has received research support from Benign Essential Blepharospasm Research Foundation. The institution of Dr. Berman has received research support from National Institutes of Health.
Cynthia L. Comella, MD, FAAN	Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vima. Dr. Comella has received publishing royalties from a publication relating to health care. Dr. Comella has received publishing royalties from a publication relating to health care.
Jeanne Feuerstein, MD	Dr. Feuerstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceutical. The institution of Dr. Feuerstein has received research support from Mowry Fund Grant. The institution of Dr. Feuerstein has received research support from Davis Phinney. Dr. Feuerstein has received research support from MJFF - Write Now Initiative. Dr. Feuerstein has received personal compensation in the range of $500-$4,999 for serving as a Parkinson's Expert for Legal Case with Keating Wagner Palidori. Dr. Feuerstein has received personal compensation in the range of $100,000-$499,999 for serving as a Attending Neurologist with VAMC. Dr. Feuerstein has received personal compensation in the range of $100,000-$499,999 for serving as a Assistant Professor of Neurology with University of Colorado.
Yukang Han	Miss Han has nothing to disclose.
H. A. Jinnah, MD, PhD, FAAN	Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takaha/Ene. Dr. Jinnah has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Jinnah has received research support from Addex. The institution of Dr. Jinnah has received research support from Aeon. The institution of Dr. Jinnah has received research support from Revance. The institution of Dr. Jinnah has received research support from Jazz.
Minnie Luu	Ms. Luu has nothing to disclose.
Davide Martino, MD, PhD	Dr. Martino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Martino has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merz Pharma Canada Ltd..
Raphael V. Pamintuan	Mr. Pamintuan has nothing to disclose.
Joel S. Perlmutter, MD, FAAN	Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for CHDI. Dr. Perlmutter has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Parkinson Study Group. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wood, Cooper and Peterson, LLC . Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Simmons and Simmons LLP . The institution of Dr. Perlmutter has received research support from NIH. The institution of Dr. Perlmutter has received research support from American Parkinson Disease Association (Advanced Research Center at Washington University). The institution of Dr. Perlmutter has received research support from CHDI. The institution of Dr. Perlmutter has received research support from Huntington Disease Society of America. The institution of Dr. Perlmutter has received research support from University of Western Toronto. The institution of Dr. Perlmutter has received research support from Barnes-Jewish Hospital Foundation. The institution of Dr. Perlmutter has received research support from Michael J Fox Foundation. The institution of Dr. Perlmutter has received research support from UCSD. The institution of Dr. Perlmutter has received research support from Paula & Rodger Riney FUnd. The institution of Dr. Perlmutter has received research support from Jo Oertli Fund. The institution of Dr. Perlmutter has received research support from Murphy FUnd. The institution of Dr. Perlmutter has received research support from Fixel Fund. The institution of Dr. Perlmutter has received research support from N Grant WIlliams Fund. The institution of Dr. Perlmutter has received research support from Pohlman Fund. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a lecturer with Boston University. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a external advisor with Stanford University. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a visiting professor with Beth Israel Hospital. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a visiting professor with U Pennsylvania.
David Peterson, PhD	The institution of Dr. Peterson has received research support from NIH. The institution of Dr. Peterson has received research support from DoD.
Sarah Pirio Richardson, MD, FAAN	Dr. Pirio Richardson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Pirio Richardson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH/NINDS. The institution of Dr. Pirio Richardson has received research support from NIH. The institution of Dr. Pirio Richardson has received research support from DOD. The institution of Dr. Pirio Richardson has received research support from Scion. The institution of Dr. Pirio Richardson has received research support from Jazz Pharmaceuticals. The institution of Dr. Pirio Richardson has received research support from UCB. The institution of Dr. Pirio Richardson has received research support from Buk-wang Pharmaceuticals.
Glenn T. Stebbins, PhD	Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Partners Healthcare System. Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CHDI. The institution of Dr. Stebbins has received research support from Department of Defense. Dr. Stebbins has received research support from Cleveland Clinic Health Systems. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Course Director with MDS.
Rashad Carlton, PharmD	Mr. Carlton has received personal compensation for serving as an employee of Cencora. Mr. Carlton has stock in Cencora.
Joris van Stiphout, MSc	Mr. van Stiphout has nothing to disclose.
Roopa Sharma, MD	Dr. Sharma has nothing to disclose.
Kazim Jaffry	Mr. Jaffry has nothing to disclose.
Machteld E. Hillen, MD, FAAN	The institution of Dr. Hillen has received research support from Genentech.
Alexander Wang, MD	Dr. Wang has nothing to disclose.
Aasef Shaikh, MD	Dr. Shaikh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda.
Steven A. Gunzler, MD, FAAN	Dr. Gunzler has received research support from NIH/NINDS. Dr. Gunzler has received research support from Parkinson's Foundation. The institution of Dr. Gunzler has received research support from UCB. The institution of Dr. Gunzler has received research support from Bial.
Camilla Kilbane, MD, FAAN	Dr. Kilbane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for acorda. Dr. Kilbane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for abbvie. Dr. Kilbane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for kyowa kirin. Dr. Kilbane has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medronic. Dr. Kilbane has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for US world Meds. Dr. Kilbane has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for teva. Dr. Kilbane has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acorda. The institution of Dr. Kilbane has received research support from Abbott.
Aetan Parmar, Undergraduate	Mr. Parmar has nothing to disclose.
Lauren A. Cameron, MD	Dr. Cameron has nothing to disclose.
Hanieh Agharazi	Hanieh Agharazi has nothing to disclose.
Michal Geva	Michal Geva has received personal compensation for serving as an employee of Prilenia Therapeutics. Michal Geva has received intellectual property interests from a discovery or technology relating to health care.
Paul Goldberg	Paul Goldberg has received personal compensation for serving as an employee of Prilenia. Paul Goldberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ionis Pharmaceuticals. Paul Goldberg has stock in Prilenia.
Kelly Chen	Kelly Chen has received personal compensation for serving as an employee of Prilenia Therapeutics.
Randal Hand	Dr. Hand has received personal compensation for serving as an employee of Prilenia Therapeutics.
Jeffrey D. Long	Jeffrey Long has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Triplet. Jeffrey Long has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vacinnex. Jeffrey Long has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave. Jeffrey Long has received personal compensation in the range of $0-$499 for serving as a Consultant for PTC. Jeffrey Long has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Jeffrey Long has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Jeffrey Long has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for uniQure. Jeffrey Long has received research support from NIH DSMB.
Michael Hayden	Michael Hayden has received personal compensation for serving as an employee of Prilenia Therapeutics. Michael Hayden has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CAMP4. Michael Hayden has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for AbCellera Biologics Inc.. Michael Hayden has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Ionis Pharmaceuticals . Michael Hayden has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for 89 Bio. Michael Hayden has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Oxford Biomedica . Michael Hayden has stock in Ionis Pharmaceuticals. Michael Hayden has stock in AbCellera Biologics Inc.. Michael Hayden has stock in 89 Bio. The institution of Michael Hayden has received research support from Canadian Institutes of Health Research. The institution of Michael Hayden has received research support from National Research Council Canada. The institution of Michael Hayden has received research support from Huntington Society of Canada. The institution of Michael Hayden has received research support from Bev Hartig Huntington Disease Foundation. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care.
Antoine Gueguen, MD	An immediate family member of Dr. Gueguen has received personal compensation for serving as an employee of ABBVIE. Dr. Gueguen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ALEXION. Dr. Gueguen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Jonhson&Jonhson. Dr. Gueguen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson&Johnson. The institution of Dr. Gueguen has received research support from BrainEver. The institution of Dr. Gueguen has received research support from Pixyl. The institution of Dr. Gueguen has received research support from Kalsiom. The institution of Dr. Gueguen has received research support from Ministére de la Santé, France.
Vincent Brochard	No disclosure on file
Marie Scuccimarra	No disclosure on file
Christophe Carreau	No disclosure on file
Claire Fieschi	No disclosure on file
Marion Malphettes, MD	Dr. Malphettes has nothing to disclose.
Ergun Y. Uc, MD	An immediate family member of Dr. Uc has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American Board of Pediatrics. The institution of Dr. Uc has received research support from Department of Veterans Affairs. The institution of Dr. Uc has received research support from Department of Defense. The institution of an immediate family member of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from Parkinson's Foundation. The institution of Dr. Uc has received research support from NIH.
Matthew Rizzo, MD, FAAN	The institution of Dr. Rizzo has received research support from NIH.
Jun Ha Chang, PhD	Jun Ha Chang has nothing to disclose.
Beata A. Filipek, MD, PhD	Dr. Filipek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Filipek has received research support from National Centre of Science, Poland - Preludium Bis 2019/35/O/NZ5/02270.
Tomasz Poplawski	Tomasz Poplawski has nothing to disclose.
Anna Macieja, PhD	Ms. Macieja has nothing to disclose.
Bhaskar Roy, MD, FAAN	Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Roy has stock in Cabaletta bio. . Dr. Roy has stock in Pfizer. Dr. Roy has stock in CAVA. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals. The institution of Dr. Roy has received research support from Immunovant. The institution of Dr. Roy has received research support from argenx.
Ireneusz Majsterek, PhD	Prof. Majsterek has nothing to disclose.
Tejal Shelat, MBBS	Dr. Shelat has nothing to disclose.
Prashant Natteru, MBBS	Dr. Natteru has nothing to disclose.
matthew klumpp, MD	Dr. klumpp has nothing to disclose.
Himanshu Verma, MBBS	Dr. Verma has nothing to disclose.
Laura Danielson, MD	Dr. Danielson has nothing to disclose.
Saif S. Bawaneh, MD	Dr. Bawaneh has nothing to disclose.
Mittal S. Prajapati, MD	Dr. Prajapati has nothing to disclose.
Grace Swart, MD	Dr. Swart has received research support from National Health and Medical Research Council. Dr. Swart has received personal compensation in the range of $5,000-$9,999 for serving as a MS Masters Forum Attendee (sponsored education) with Merck.
Nidhi Garg, MBBS	Dr. Garg has nothing to disclose.
Michael P. Skolka, MD	Dr. Skolka has nothing to disclose.
Con Yiannikas, MBBS	Dr. Yiannikas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Ostoja (Steve) Vucic, MBBS, FRACP	Prof. Vucic has a non-compensated relationship as a Member-Advisory Board with Biogen Idec Australia that is relevant to AAN interests or activities. Prof. Vucic has a non-compensated relationship as a Honorarium with Merkc Serono Ausralia that is relevant to AAN interests or activities.
John Pollard, MD	Dr. Pollard has nothing to disclose.
Antonia S. Carroll, MBBS	Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam and Sanofi. Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL.
Judith M. Spies, MBBS, PhD	Dr. Spies has nothing to disclose.
Matthew C. Kiernan, MBBS, PhD, FRACP	The institution of Prof. Kiernan has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for British Medical Journal Publishers (UK).
Christopher J. Klein, MD, FAAN	Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
Susanna B. Park, PhD	Dr. Park has a non-compensated relationship as a Board Member with Toxic Neuropathy Consortium, Peripheral Nerve Society that is relevant to AAN interests or activities.
Deborah Kuk, MS	Ms. Kuk has received personal compensation for serving as an employee of Inspire.
Ade Ajibade, PhD	Dr. Ajibade has received personal compensation for serving as an employee of Takeda. Dr. Ajibade has or had stock in Takeda.
Michelle Kirby, MS	Mrs. Kirby has stock in Takeda.
Megan m. Gower, PharmD	Dr. Gower has received personal compensation for serving as an employee of Takeda Pharmaceuticals USA, Inc.. Dr. Gower has stock in Takeda Pharmaceuticals USA, Inc..
Christopher Blair, MS	Mr. Blair has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Mr. Blair has stock in Takeda Pharmaceuticals .
Faisal Riaz, MD	Dr. Riaz has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Riaz has stock in Takeda.
Valmeek Kudesia, MD	Dr. Kudesia has received personal compensation for serving as an employee of Inspire Patient Communities.
Brian Chen, ScM	Mr. Chen has received personal compensation for serving as an employee of Inspire.
Christina Alexandres, MD	Dr. Alexandres has nothing to disclose.
Michael Serbin	Michael Serbin has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc. Michael Serbin has stock in Neurocrine Biosciences, Inc.
James Issa, Student	Mr. Issa has nothing to disclose.
Davinder Singh, MD	No disclosure on file
Tom Punnen	Mr. Punnen has nothing to disclose.
Darin T. Okuda, MD, FAAN	Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cortechs AI. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bioscience. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Zenas BioPharma. The institution of Dr. Okuda has received research support from Novartis. The institution of Dr. Okuda has received research support from Alexion. Dr. Okuda has received intellectual property interests from a discovery or technology relating to health care.
Jacob M. Romano, PharmD	Dr. Romano has received personal compensation for serving as an employee of CSL Behring. Dr. Romano has stock in CSL Behring.
Bill Maltas, Other	Mr. Maltas has received personal compensation for serving as an employee of CSL Behring.
Christine Holman, PharmD	Dr. Holman has received personal compensation for serving as an employee of Neurocrine Biosciences. Dr. Holman has stock in Neurocrine Biosciences.
Shannon Brewi	Ms. Brewi has nothing to disclose.
David Plante	David Plante has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. David Plante has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony Biosciences. David Plante has received personal compensation in the range of $0-$499 for serving as a Consultant for Aditum Bio. David Plante has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. David Plante has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. David Plante has received intellectual property interests from a discovery or technology relating to health care. David Plante has received publishing royalties from a publication relating to health care.
Chad Ruoff, MD	Dr. Ruoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alkermes. Dr. Ruoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Ruoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Ruoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda . The institution of Dr. Ruoff has received research support from Jazz Pharmaceuticals. Dr. Ruoff has received personal compensation in the range of $10,000-$49,999 for serving as a lecturer with CME lectures .
Elyse Murphy, RN, Msl	Elyse Murphy, RN, Msl has received personal compensation for serving as an employee of CSL Behring.
Louis Ferrari	Louis Ferrari has received personal compensation for serving as an employee of SK Life science.
Verena Ramirez Campos, MD	Dr. Ramirez Campos has received personal compensation for serving as an employee of teva.
Mohamed Derhab, MD, MBBCH	Dr. Derhab has nothing to disclose.
Berk Gürdamar	No disclosure on file
Sameer Ansari, BS	Mr. Ansari has nothing to disclose.
Khema R. Sharma, MBBS, FAAN	Dr. Sharma has nothing to disclose.
Qiongyao Li, PhD	Ms. Li has nothing to disclose.
Brandon S. Wright	Mr. Wright has nothing to disclose.
Meziyet D. Reda, Master Of Science Student	Miss Reda has nothing to disclose.
özge çetin	No disclosure on file
beril tasdelen	No disclosure on file
gülgün uncu	No disclosure on file
Muzaffer Mutluer	Dr. Mutluer has nothing to disclose.
Azhar Said, MD	Dr. Said has nothing to disclose.
Abdullah A. Alruwaita, MBBS	Dr. Alruwaita has nothing to disclose.
Katrina Bakhl	Miss Bakhl has nothing to disclose.
Rachel E. Dum, MD	Mrs. Dum has nothing to disclose.
Deborah A. Nichols, MS	Ms. Nichols has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Ms. Nichols has stock in Jazz Pharmaceuticals.

��ɫ����

��ɫ����

��ɫ��

��ɫ��